





The cellular and molecular consequences of 
maternal immune activation on the 





Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy  
 
 
Rebecca C Anderson 
 
Supervisor: Professor Kieran McDermott 




February 2020  
 
Table of Contents: 
Declaration: ........................................................................................................................ i 
Acknowledgements: .......................................................................................................... ii 
Abstract: ............................................................................................................................ v 
Abbreviations: ................................................................................................................ viii 
Table of Figures: ............................................................................................................. xv 
Table of Tables:............................................................................................................ xviii 
 
 
Chapter 1. Introduction .................................................................................................. 1 
1.1 Nervous system development ...................................................................................... 2 
1.1.1 Neurulation ...................................................................................................................... 2 
1.1.2 Cell signalling and nervous system development ............................................................ 4 
1.1.2.1 Stem cell renewal and pluripotency .......................................................................... 4 
1.1.2.2 Migration ................................................................................................................... 5 
1.1.2.4 Cytokines, signalling, and nervous system development .......................................... 7 
1.1.3 Spinal cord development & anatomy ............................................................................... 8 
1.2. Cellular development ............................................................................................... 11 
1.2.1  Neurogenesis ................................................................................................................. 11 
1.2.2 Oligodendrogliogenesis .......................................................................................... 13 
1.2.3 Astrogliogenesis ...................................................................................................... 17 
1.2.4 Microgliogenesis ..................................................................................................... 19 
1.3 Maternal immune activation ..................................................................................... 22 
1.3.1 Epidemiological studies ................................................................................................. 22 
1.3.2 Animal models ............................................................................................................... 24 
1.3.2.1 Polyinosinic:polycytidylic acid ............................................................................... 24 
1.3.2.2 Lipopolysaccharide ................................................................................................. 24 
1.3.2.3 Other models of maternal infection......................................................................... 25 
1.3.3 The rodent spinal cord as a model of MIA .................................................................... 25 
1.3.4 MIA and Neurons .......................................................................................................... 26 
1.3.5 MIA and oligodendrocytes............................................................................................. 31 
1.3.5.1 Cytokines, inflammation and oligodendrocyte development .................................. 31 
1.3.5.2 The consequences of MIA on the developing oligodendrocyte .............................. 32 
1.3.6 MIA and Astrocytes ....................................................................................................... 37 
1.3.6.1 The role of astrocytes in mediating the consequences of MIA ............................... 37 
1.3.6.2 The consequences of MIA on the developing astrocyte ......................................... 37 
 
1.3.7 MIA and Microglia ........................................................................................................ 40 
1.3.7.1 Cytokines, inflammation and microglial development ........................................... 40 
1.3.7.2 The consequences of MIA on the developing microglia......................................... 41 
1.4 MicroRNAs ............................................................................................................... 44 
1.4.1 Structure and function of microRNAs ........................................................................... 45 
1.4.2 Nomenclature ................................................................................................................. 46 
1.4.3 MicroRNAs and cellular development .......................................................................... 47 
1.4.3.1 MicroRNAs in neurogenesis ................................................................................... 47 
1.4.3.2 MicroRNAs in astrogliogenesis .............................................................................. 49 
1.4.3.3 MicroRNAs in microgliogenesis............................................................................. 50 
1.4.3.4 MicroRNAs in Oligodendrogliogenesis .................................................................. 50 
1.5 Aims and objectives: ................................................................................................. 51 
 
Chapter 2. Methodology ............................................................................................... 52 
2.1 Time mating and maternal immune activation.......................................................... 53 
2.2 Tissue collection and processing ............................................................................... 54 
2.2.1 Tissue collection for embryonic study ........................................................................... 54 
2.2.2 Tissue collection for postnatal study .............................................................................. 54 
2.2.3 Gelation coating of slides ............................................................................................... 55 
2.2.4 Cryosectioning ............................................................................................................... 55 
2.3 Immunohistochemical staining ................................................................................. 57 
2.3.1 Immunofluorescent staining ........................................................................................... 57 
2.3.2 Quantification of immunofluorescent staining............................................................... 60 
2.3.2.1 Olig2 analysis .......................................................................................................... 61 
2.3.2.2 MBP ........................................................................................................................ 63 
2.3.2.3 Iba-1 ........................................................................................................................ 64 
2.3.2.4 GFAP ...................................................................................................................... 64 
2.3.2.5 Reelin ...................................................................................................................... 65 
2.4 RNA extraction and yield determination .................................................................. 66 
2.4.1 Total RNA extraction ..................................................................................................... 66 
2.4.2 Quality and yield determination ..................................................................................... 66 
2.5 RNA expression studies ............................................................................................ 67 
2.5.1 Microarray expression profiling..................................................................................... 67 
2.5.2 RNASeq ......................................................................................................................... 68 
2.5.3 RT qPCR ASSAY .......................................................................................................... 68 
2.6 Bioinformatic analysis .............................................................................................. 71 
2.6.1 Literature review ............................................................................................................ 71 
 
2.6.2 miRECORDS ................................................................................................................. 71 
2.6.3 Webgestalt...................................................................................................................... 72 
2.6.4 String analysis ................................................................................................................ 72 
 
Chapter 3. The effect of MIA on the oligodendrocytes of the spinal cord ............... 74 
3.1 Chapter Abstract........................................................................................................ 75 
3.2 Introduction ............................................................................................................... 76 
3.3 Chapter aims.............................................................................................................. 79 
3.4 Results: ...................................................................................................................... 80 
3.4.1 Characterisation of Olig2+ cell distribution in the embryonic spinal cord during normal 
development at E12 and E16; and following MIA at E12 and E16 ........................................ 80 
3.4.1.1 Olig2+ cell distribution in the E12 spinal cord in normal development, and post 
MIA with 100µg/kg LPS .................................................................................................... 80 
3.4.1.2 Olig2+ cell distribution in the E16 spinal cord in normal development, and post 
MIA with 100µg/kg LPS .................................................................................................... 82 
3.4.2 Characterisation of Olig2+ cell distribution in the postnatal spinal cord during normal 
development; and following MIA at E12 and E16 ................................................................. 87 
3.4.2.1 Olig2+ cell distribution in the P14 spinal cord during normal development .......... 87 
3.4.2.2 Olig2+ cell number in the P14 spinal cord following MIA with 100µg/kg LPS on 
E12 or E16 .......................................................................................................................... 88 
3.4.3 Characterisation of MBP expression in the postnatal spinal cord during normal 
development; and following MIA at E12 and E16 ................................................................. 90 
3.4.3.1  MBP expression in the P14 spinal cord during normal development .................... 90 
3.4.3.2 MBP expression in the P14 spinal cord following MIA with 100µg/kg LPS on E12 
or E16 .................................................................................................................................. 92 
3.5 Discussion ................................................................................................................. 95 
 
Chapter 4. The effect of MIA on the microglia and astrocytes of the spinal cord 103 
4.1 Chapter Abstract...................................................................................................... 104 
4.2 Introduction ............................................................................................................. 105 
4.3 Chapter aims............................................................................................................ 109 
4.4 Results ..................................................................................................................... 110 
4.4.1 Characterisation of Iba-1+ cell distribution in the embryonic spinal cord during normal 
development at E12, E14 and E16; and following MIA at E12 and E16 ............................. 110 
4.4.1.1 Iba-1+ cell distribution in the E12 spinal cord in normal development and post MIA  
with 100µg/kg LPS ........................................................................................................... 110 
4.4.1.2 Iba-1+ cell distribution in the E14 spinal cord in normal development and post MIA 
with 50µg/kg LPS ............................................................................................................. 112 
4.4.1.3 Iba-1+ cell distribution in the E16 spinal cord in normal development and post MIA  
with 100µg/kg LPS ........................................................................................................... 115 
 
4.4.2 Characterisation of Iba-1+ cell distribution in the rostral P14 spinal during normal 
postnatal development; and following MIA at E12 and E16 ................................................ 119 
4.4.2.1 Iba-1+ cell distribution in the P14 spinal cord during normal postnatal development
 .......................................................................................................................................... 119 
4.4.2.2 Iba-1+cell number in the P14 spinal cord following MIA with 100µg/kg LPS on 
E12 or E16 ........................................................................................................................ 120 
4.4.3 Characterisation of GFAP expression in the rostral P14 spinal cord during normal 
postnatal development; and following MIA at E12 and E16 ................................................ 121 
4.4.3.1 GFAP expression in the P14 spinal cord during normal postnatal development .. 121 
4.4.3.2 GFAP expression in the P14 spinal cord following MIA with 100µg/kg LPS on E12 
or E16 ................................................................................................................................ 123 
4.5 Discussion ............................................................................................................... 126 
 
Chapter 5. The effect of Maternal Immune Activation on Reelin expression in the 
spinal cord .................................................................................................................... 132 
5.1 Chapter Abstract...................................................................................................... 133 
5.2 Introduction: ............................................................................................................ 134 
5.3 Chapter Aims .......................................................................................................... 142 
5.4 Results ..................................................................................................................... 143 
5.4.1 Characterisation of reelin expression in the embryonic spinal cord at E12 and E16 
during normal development; and following MIA at E12 and E16 ........................................ 143 
5.4.1.1 Reelin expression in the E12 spinal cord in normal development and post MIA with 
100µg/kg LPS ................................................................................................................... 143 
5.4.1.2 Reelin expression in the E16 spinal cord in normal development and post MIA with 
50µg/kg or 100µg/kg LPS ................................................................................................. 145 
5.4.2 Characterisation of reelin expression in the P14 spinal cord during normal development; 
and following MIA at E12 and E16 ...................................................................................... 147 
5.4.2.1 Reelin expression in the rostral P14 spinal cord during normal postnatal 
development ...................................................................................................................... 147 
5.4.2.2 Reelin expression in the P14 spinal cord following MIA with 100µg/kg LPS on 
E12 or E16 ........................................................................................................................ 149 
5.4.3 Co-localisation of reelin with markers of neurons, oligodendrocytes and microglia in the 
E16 and P14 spinal cords during normal development ......................................................... 151 
5.5 Discussion ............................................................................................................... 153 
 
Chapter 6. Gene expression changes in the developing spinal cord following 
MIA .............................................................................................................................. 158 
6.1 Chapter Abstract...................................................................................................... 159 
6.2 Introduction: ............................................................................................................ 160 
6.3 Chapter Aims .......................................................................................................... 162 
6.4 Results ..................................................................................................................... 163 
 
6.4.1 Microarray analysis ...................................................................................................... 163 
6.4.1.1 Principal component analysis ................................................................................ 163 
6.4.1.2 Gene expression 5hr post MIA with 100µg/kg LPS at E12 or E16 ...................... 164 
6.4.1.3 Bioinformatic interrogation of genes differentially expressed in the microarray 
analysis 5hr post MIA with 100µg/kg LPS at E16 ........................................................... 168 
6.4.2 RNASeq analysis ......................................................................................................... 170 
6.4.2.1 Principal component analysis ................................................................................ 170 
6.4.2.2 Gene expression at P14 following MIA with 100µg/kg LPS at E12 or E16 ........ 172 
6.4.2.3 Bioinformatic interrogation of genes differentially expressed in RNASeq analysis at 
P14 post MIA with 100µg/kg LPS at E16 ........................................................................ 175 
6.4.2.4 PCR confirmation of gene expression changes at P14 following MIA with 
100µg/kg LPS at E16 ........................................................................................................ 178 
6.5 Discussion ............................................................................................................... 180 
 
Chapter 7. The role of miRNAs in Oligodendrogliogenesis: an in-silico study ..... 186 
7.1 Chapter Abstract...................................................................................................... 187 
7.2 Introduction: ............................................................................................................ 188 
7.3 Chapter Aims .......................................................................................................... 192 
7.4 Results ..................................................................................................................... 193 
7.4.1 Identification of predicted targets ................................................................................ 193 
7.4.2 Gene ontology analysis. ............................................................................................... 193 
7.4.3 STRING analysis of protein-protein interactions ........................................................ 194 
7.5 Discussion ............................................................................................................... 202 
 
Chapter 8. General Discussion ................................................................................... 210 
 
Bibliography ................................................................................................................ 218 
 
Appendix A .................................................................................................................. 265 
Appendix B .................................................................................................................. 276 









I hereby declare that I am the sole author of this thesis. I declare that it has not been 
submitted to any other University or higher education institution, or for any other 
academic award in this University. References and acknowledgements have been made, 





Signature:        Date: 
    27/02/2020 
------------------------------------------------------------                         --------------------------- 
Rebecca Anderson 
Graduate Entry Medical School 














There are so many people to thank for their role in the completion of this PhD. First and 
foremost I would like to thank my supervisor Professor Kieran McDermott for his 
knowledge, guidance and support over the years, as well as the laughs. They were 
plentiful. Thank you for being just down the hall whenever I needed help, I appreciate 
it. I would also like to thank my co-supervisor Dr Gerard O’Keeffe for his constant 
presence on the end of an email as well as his feedback and suggestions. Thanks also to 
the staff of the Graduate Entry Medical School for making UL feel like home, and to 
Tara Enright and Jason Radford for their help with the animal work and making UCC  a 
home away from home for the short time I was there.  
A PhD would be impossible without a building full of friends. A massive thanks goes 
out to the ladies of the graduate entry medical school lab for their help, suggestions, 
troubleshooting, laughter and at times of trouble (or dark room days!) sympathy. A 
special thanks is due to Joanne for coaxing me through PCR protocols for months on 
end! Thank you to Johnny for the year one company, and the summer students that 
came and went each year without fail for making the long days of summer in the lab 
more fun. Lex, Diane, Jane and Swiri Limerick would have been nothing without you 
(and this thesis still wouldn’t be done!). Thanks for the chats and the support. The 
cawfii dates, the nights out and the loops around the pitches when everything was just a 
bit too overwhelming. 
Thank you to my non-UL friends, you all know who you are. To the non-scientists 
among you for listening to my constant talk of embryos and spinal cords with only the 
iii 
 
barest grimace, and to my fellow science nerds for your infectious interest and 
commiserations.  
Stuart, Ruth and Ben, it’s finally happening! Your big sister is leaving school! Thanks 
for all the support, and for making home a great place to hide away from the books. 
Ken, I could never have done this without you. Thank you for your unending love and 
support, and for your unwavering belief that I could do it even at the hardest of times. 
Finally I’d like to thank my parents for fostering a love of learning that lead me to this 
point. That said, I know you’re looking forward to telling people I’m something other 
than a student! Thank you for your endless love, support and patience, and for 
‘swinging by Limerick’ to pick me up on the way from Cork so I might come home for 
a weekend.  











































Epidemiological studies have suggested that maternal immune activation (MIA) during 
gestation is a risk factor for the development of neuropsychiatric and neurological 
disorders. These epidemiological studies have indicated that specific trimesters during 
human gestation may be more susceptible to the effects of MIA. Studies in animal 
models have attempted to delineate further the temporal specificity of this vulnerability. 
These animal studies have corroborated the claims made in epidemiological studies, but 
have not yet precisely identified individual windows of vulnerability. 
The first study in this thesis investigated the effect of MIA on the oligodendrocytes of 
the spinal cord, using immunofluorescence microscopy to investigate the expression of 
the markers Olig2 and MBP following MIA with 50µg/kg or 100µg/kg at E12 or E16. 
Olig2 and MBP expression were examined 5h post MIA (Olig2 only) and at P14 (Olig2 
and MBP). The number of Olig2+ cell nuclei in the grey and white matter of the rostral 
spinal cord of offspring decreased 5h post MIA with 100µg/kg LPS. The number of 
Olig2+ cell nuclei was unchanged at P14 following MIA at E16. Conversely, Olig2+ 
cell number was unchanged in the E12 spinal cord 5h post MIA. However, Olig2+ cell 
number was decreased in the ventral grey matter of the rostral spinal cord at P14 
following MIA at E12. MBP expression was unchanged at P14 following MIA with 
100µg/kg LPS at the E12 and E16 time points. 
The second study investigated the effect of MIA on microglia and astrocytes of the 
spinal cord, using immunofluorescence microscopy to investigate expression of the 
markers Iba-1 and GFAP following MIA with 50µg/kg or 100µg/kg LPS at E12, E14 or 
E16. Iba-1 and GFAP expression were examined 5h post MIA (Iba-1 only) and at P14 
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(Iba-1 and GFAP). MIA at E16 with 100µg/kg LPS decreased Iba-1+ cell number in the 
grey and white matter of the rostral and middle spinal cord 5h post MIA. Iba-1+ cell 
number was unchanged 5h post MIA at E12, and at P14 following MIA at E12 or E16. 
GFAP expression was unchanged at P14 following MIA at E12 and E16.  
The third study investigated the effect of MIA on reelin expression in the spinal cord. The 
study used immunofluorescence microscopy to investigate Reelin expression after MIA 
with 50µg/kg or 100µg/kg at E12 or E16. Expression was examined 5h post MIA and at 
P14. Reelin expression decreased 5h post MIA with 100µg/kg LPS at E16 in the rostral, 
middle and caudal cord. Semi-quantitative analysis of reelin expression at E12 5h post 
MIA suggested decreased expression. No change was observed at P14 following MIA at 
E12 or E16.  
The fourth study examined gene expression following MIA at E12 and E16 with 
100µg/kg LPS using microarray and RNA Seq. Examination points were again 5h and 
P14. Microarray analysis showed no change in gene expression 5h post MIA at E12. RNA 
Seq showed that gene expression was also unchanged at P14 after MIA at E12. In contrast, 
microarray analysis identified 42 differentially regulated genes 5h post MIA at E16. RNA 
Seq identified 19 differentially regulated genes at P14. 
The final study used an in-silico investigation to interrogate pathways and processes 
predicted to be targeted by microRNAs which function in oligodendrogliogenesis and 
may be vulnerable to episodes of MIA. The study identified inflammatory pathways, 
developmental pathways and apoptotic pathways which may be modulated by 
microRNAs during development, and potential targets which may function in the cell’s 
response to MIA.  
In conclusion, MIA effects on some aspects of CNS development significantly. E16 may 
be a particularly vulnerable period, at least in the spinal cord. The acute effects of MIA 
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at E16 have prolonged and far-reaching consequences on the cytoarchitecture and normal 
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The development of neural tissue begins early in embryonic development, in the third 
week of human gestation (embryonic day (E)9-E12 in rats). Gastrulation results in the 
release of diffusible factors such as chordin, noggin, follistatin, and Cerberus, as well as 
FGF, IGF and Wnt signals, by a layer of mesodermal cells along the dorsal midline, the 
notochord, initiating neural induction and specifying the ectoderm to a neural fate. The 
thickening of the midline neuro-ectoderm leads to the formation of the neural plate. This 
occurs around day 17 in human development. The neural plate, around day 18 in human 
development, begins to involute and forms the neural groove. The neural folds are formed 
at the lateral margins of the neural plate, ultimately coming together in a process known 
as convergence to form the neural tube through neurulation (Figure 1). Neural tube 
formation is usually complete around day 21 in human development,  however the 
anterior and posterior neuropores do not close until day 24 and day 26 respectively. Cells 
dorsolateral of the neural tube, which have proliferated and differentiated at the edges of 
the neural groove during convergence, become the neural crest (Bassuk and Kibar 2009). 
The cells of the neural crest give rise to the peripheral and enteric nervous systems, glial 
cells, melanocytes, craniofacial cartilage and bone, and smoot muscle(Trainor et al. 
2004). Over time, through both cell intrinsic programs and cell extrinsic factors, the 
neural tube gives rise to neurons, astrocytes and oligodendrocytes, which themselves can 
be categorised into the vast array of cellular subtypes, which make up the complex 





Figure 1.1 Neurulation. Diffusible factors such as chordin, noggin, FGF and WNT are 
released by the notochord, initiating neural induction and specifying the ectoderm to a 
neural fate. Thickening of the midline neuro-ectoderm leads to the formation of the neural 
plate (A). The neural folds are formed at the lateral margins of the involuting neural plate 
(B), coming together through convergence to form the neural tube (C). The neural crest 
is formed from proliferating cells at the edge of the neural folds (B), and separates from 








ganglions, as well as the peripheral and enteric nervous systems, peripheral glia like the 
myelinating Schwann cells, smooth muscle, melanocytes, cartilage and bone (D). 
 
1.1.2 Cell signalling and nervous system development 
 
CNS development is dependent on the complex interaction of a large number of 
transcription factors which control cell proliferation, migration and differentiation. These 
transcription factors can be inducible or constitutive and are expressed in a regionally and 
temporally precise manner.  
1.1.2.1 Stem cell renewal and pluripotency 
 
Stem cell renewal is maintained by the combination of a number of complex cell 
signalling cascades. Activation of the insulin growth factor receptor (IGF-R) and the 
fibroblast growth factor receptor (FGF-R) leads to the activation of the phosphoinositide-
3-kinase (PI3K), protein kinase B (AKT) signalling and self-renewal via the activation of 
the pluripotency genes Oct-4, Sox-2 and Nanog among others (Maric et al. 2007; L. Wang 
et al. 2007). FGFR activation can also lead to the activation of extracellular signal–
regulated kinase (Erk) signalling, which is necessary for telomere maintenance, genomic 
stability, and self-renewal of mouse ESCs (Maric et al. 2007; Chen et al. 2015). WNT 
signalling, via the frizzled and Low-density lipoprotein receptor-related protein (LRP) 
receptors, also promotes self-renewal in cells. The activation of WNT signalling is 
transduced to ß-catenin via a number of cytoplasmic intermediaries, namely Axin, APC, 
GSK3β, which form the destruction complex. ß-catenin then translocates to the nucleus 
and forms a complex with T-cell factor (TCF) to activate WNT target genes (Xu et al. 
2016). Smad signalling, specifically Smad2/3 signalling via the transforming growth 
factor (TGF)-β receptor also promotes self-renewal. Conversely, Smad1, 5 and 9 




negatively regulate the process of self-renewal by repressing the expression of 
pluripotency genes or triggering the activation of genes associated with differentiation 
(Hegarty et al. 2013; Mullen and Wrana 2017). 
1.1.2.2 Migration 
 
Migration of CNS cells is dependent on a wide range of factors such as physical contact, 
chemotaxis (for example in response to cytokines or extracellular matrix proteins like 
reelin), and neurotrophins like nerve growth factor (NGF) and brain derived neurotrophic 
factor (BDNF) (Maisonpierre et al. 1990; Zhang et al. 2010; Courtès et al. 2011). All of 
these factors act upon signalling cascades involved in neurite outgrowth and growth cone 
formation, affecting cytoskeletal dynamics and inducing movement. The most important 
of these signalling cascades is the mitogen activated protein kinase (MAPK) Erk pathway, 
downstream targets of which include cytoskeletal genes like Neurofillament (NF)-H and 
paxillin (Veeranna et al. 1998; Teranishi et al. 2009). Neuronal migration may be radial, 
following the radial path, for example the pyramidal and excitatory neurons of the 
cerebral cortex, or tangential, across the radial plane, for example the inhibitory neurons 
of the cortex (Reiner and Gerlitz 2013). 
Cells which migrate radially do so along the radial glial cells (RGCs). RGCs are a type 
of glial cell present predominantly during development, which may divide to produce 
more radial glia, further progenitor cells, neurons or glia. First identified in the spinal cord 
by Camillo Golgi in 1885, they possess a long radial process (Rakic 1972; Barry et al. 
2014). They act as cables to direct the migration of newborn neurons through the cerebral 
cortex into the correct cortical lamina, as well as providing a source of newborn neurons 
and neuronal progenitors (Rakic 2003). It is important to note that in the spinal cord RGCs 
appear to play a different role. Present from E14 in rats, RGCs appear to play a role in 




oligodendrogliogenesis and astrogliogenesis in the spinal cord suggesting that they may 
not contribute to neurogenesis here (McDermott et al. 2005). 
1.1.2.3 Differentiation 
 
As differentiation of cells is ultimately the result of withdrawal from the cell cycle, it is 
perhaps unsurprising that a number of the signalling cascades involved in the 
differentiation of progenitor cells are negative regulators of proliferation and self-
renewal. BMP signalling, particularly BMP signalling through smad 1/5/8 effectors, is 
known to play a pivotal role in neurogenesis. BMP signalling is involved in the 
specification of dopaminergic neurons in the ventral midbrain, Gamma aminobutyric acid 
(GABA)ergic neurons in the cortex, cholinergic neurons of the basal forebrain and 
granular cells of the dentate gyrus (DG) during development (Yung et al. 2002; Lopez-
Coviella et al. 2005; Clayton and Sullivan 2007; Caronia et al. 2010). Notch signalling is 
also a key regulator of differentiation. Activation of notch signalling leads to proteolytic 
cleavage of the notch intracellular domain (NICD), which translocates to the nucleus and 
alters gene expression. A key target of NICD is the hairy/ enhancer of split (Hes) gene 
family, known transcription factors in the process of self-renewal (Kageyama and 
Ohtsuka 1999). Modulation of Notch signalling, for example by notch antagonists Delta 
or Numb, leads to differentiation. Notch mediated lateral inhibition is necessary for binary 
cell fate decisions and notch has been shown to play a role in asymmetric cell division 
(Wakamatsu et al. 2000). Notch signalling has been known to play a role in the 
differentiation of neurons, oligodendrocytes and astrocytes (Wakamatsu et al. 2000; 
Scheer et al. 2001; Grandbarbe et al. 2003). Other known modulators of differentiation 
include the hedgehog signalling pathways and receptor tyrosine kinases (RTKs) ligands, 
for example EGF, FGF, Platelet derived growth factor (PDGF) and vascular endothelial 





1.1.2.4 Cytokines, signalling, and nervous system development 
 
Cytokines, small pleiotropic molecules largely associated with the immune system, play 
a significant role in nervous system development at all levels. Cytokines of the 
glycoprotein (gp)130 family such as leukaemia inhibitory factor (LIF) and ciliary 
neurotrophic factor (CNTF), working in conjunction with growth factors such as FGF and 
notch signalling, are instrumental in the self-renewal of radial glial cells (RGCs), 
structural scaffolds and precursors of glia (Li and Grumet 2007). Gp130 family cytokines 
are involved in the subsequent differentiation of these cells into glia alongside BMPs (also 
cytokines) and notch modulation (Hatta et al. 2002; Gregg and Weiss 2005), (For review 
see (Pinto and Gotz 2007)). Chemokines, or chemoattractant cytokines, play roles in axon 
pathfinding and migration of both neurons and glia. CXCL12 and it’s receptor CXCR4 
are responsible for normal migration and proliferation in a number of brain regions 
including the spinal cord, the cerebellum, the dentate gyrus of the hippocampus and the 
cortex, where CXCL12 controls the migration of the Cajal-Retzius cells, a transient 
population critical for the formation of the inside-out laminar development of the cortex 
(Zou et al. 1998; M. Lu et al. 2002; Dziembowska et al. 2005; Borrell and Marin 2006). 
During development microglia express interleukin (IL)-1, a known astrocyte mitogen, 
and may play a role in their migration during normal development (Giulian et al. 1988).  
During development more cells than are necessary are produced in the CNS. The excess 
cells must be pruned via apoptosis and in this way cytokines also play a role in cell 
survival. Members of the TGF-β superfamily in particular are involved in apoptotic 
processes in neurons (Barker et al. 2001). The gp130 family member cardiotrophin-1 
(CT-1) negatively regulates the apoptosis of motor neurons during development while il-
9 and its receptor are important for neuronal survival in the cortex (Oppenheim et al. 
2001; Fontaine et al. 2008). In oligodendrocyte progenitor cells (OPCs) gp130 family 




promotes OPC death (Louis et al. 1993; LaFerla et al. 2000; Pizzi et al. 2004; Zhang et 
al. 2006). For a full review of the multi-faceted role of cytokine signalling during CNS 
development see (Deverman and Patterson 2009). 
 
1.1.3 Spinal cord development & anatomy 
 
During development, the spinal cord arises from the caudal region of the neural tube, with 
the central cavity of the neural tube forming the central canal of the spinal cord and the 
neural crests giving rise to the ganglia of the spinal nerves. The neuroepithelial cells 
which line the cavity of the neural tube proliferate, giving rise to the mantel layer. The 
mantel layer can be further divided into cells which have proliferated in the dorsal neural 
tube, which form the alar plate, and cells which have proliferated in the ventral neural 
tube, which form the basal plate. These plates are divided geographically by the sulcus 
limitans, located in the lateral walls of the developing spinal cord. In the thoracic and  
upper lumbar regions of the cord a third plate forms. This is known as the intermediate 
plate and is found between the alar and basal plates. These plates give rise to distinct 
neuronal populations in the adult spinal cord. The alar plate gives rise to the sensory tracts 
of the dorsal horn, which transmit information to the brain. The basal plate gives rise to 
the motor neurons of the ventral horn, which transmit information to the periphery, and 
finally the intermediate plate gives rise to the preganglonic sympathetic neurons of the 
dorsolateral spinal cord. The marginal zone, containing the roofplate and floorplate, will 
form the white matter in the adult spinal cord while the neuroepithelial cells will become 
the ependymal cells lining the central canal (Bakkum and Bachop 2014). 
The spinal cord exhibits a rostro-caudal gradient of development, with cells of the rostral 
spinal cord developmentally more mature than cells of the caudal spinal cord. Similar to 




gradient (Ericson et al. 1997). Graded signalling of sonic hedgehog (SHH), produced in 
the floorplate, leads to the production of five molecularly distinct regions of the ventral 
spinal cord from which specific neuronal cell types arise (Ericson et al. 1995; Ericson et 
al. 1997; Fuccillo et al. 2006; Richardson et al. 2006). The more dorsal the region the 
less SHH is required for differentiation of the particular neuronal subgroup. This SHH 
gradient modulates the expression of the homeodomain proteins Pax7, Dbx1, Dbx2, Irx3 
and Pax6 (class I) and  Nkx6.1 and Nkx2.2 (class II) to define discrete progenitor domains 
from which distinct cell types arise (Yamada et al. 1991; Ribes and Briscoe 2009). Some 
progenitor domains, like the motor neuron progenitor (pMN) domain, give rise to multiple 
distinct cell types depending on the developmental timing, indicating that although SHH 
signalling and its effect on homeodomain proteins can tell us much about cell 
specification in the ventral spinal cord other factors contribute. This can be illustrated by 
the diversity of the motor neurons of the cord, all of which arise from the pMN domain 
(Stifani 2014). The birth of specific cell types in the spinal cord will be further discussed 
in section two of this chapter. 
In the adult, the function of the spinal cord is to send and receive information between 
the periphery and the brain. As previously alluded to the dorsal horn gives rise the the 
second order sensory neurons, which relay information to the brain. The first order 
sensory neurons are part of the peripheral nervous system, formed during development 
from neural crest cells, and enter the spinal cord via the spinal nerve and dorsal root 
ganglion. The ventral horn on the other hand houses the motor neurons, the function of 
which is to transmit information from the brain to the periphery. These neurons arise from 
the basal plate during development and exit the cord via the ventral root, joining the spinal 
nerve. The preganglionic sympathetic neurons derived from the intermediate plate also 




postganglionic sympathetic neurons, also derived from the neural crest cells, which rejoin 
the spinal nerve (Bakkum and Bachop 2014).  
  
Figure 1.2. Progenitor domains of the ventral spinal cord develop along the 
gradient of SHH expression. Each domain gives rise to distinct progenitors.V0 is a 
source of commissural neurons which project rostrally. V1 gives rise to inhibitory 
interneurons which project rostrally and ipsilaterally.  Both excitatory glutamatergic 
interneurons (V2a) and inhibitory interneurons (V2b) arise from V2 and project 
ipsilaterally and caudally, while inhibitory commissural interneurons arise from V3 and 
project caudally. The MN gives rise to motor neurons (Goulding 2009). FP –floor plate, 








1.2. Cellular development 
 
1.2.1  Neurogenesis  
 
Neurogenesis is the first event in a stepwise process to produce the cells of the central 
nervous system. Cellular division within an embryo is usually mitotic in nature, producing 
two daughter cells. Symmetric cell division produces two identical daughter cells while 
asymmetric cell division involves the production of two cells that are not identical. Cells 
may also divide to produce daughter cells that are identical at a physical level, but differ 
at a molecular level. These divisions are “molecularly asymmetric” and add to the 
complexity of the CNS (Hartenstein and Stollewerk 2015). 
During neurogenesis cells of the neuroectoderm can give rise to neuronal precursors. 
These precursors may directly differentiate into neurons, through asymmetric neurogenic 
division, or differentiate into proliferating progenitor cells, through asymmetric 
proliferative division. In neurogenesis the asymmetric proliferative form of division is the 
more common, allowing a stepwise progression of cell fate specification. RGCs, a type 
of apical progenitor cell, arise from the neuroectoderm at the onset of neurogenesis, and 
give rise to many of these asymmetric divisions. Asymmetric division of an RGC 
typically produces an identical daughter RGC, and a daughter cell that has progressed 
further through the fate specification process (Paridaen and Huttner 2014). This cell 
terminally differentiates into a neuron, or, in the case of more complex regions such as 
the human neocortex, into an intermediate or basal progenitor, which carries further cell 
fate restrictions (Figure 1.3). Asymmetric differentiation has been attributed at least in 
part to asymmetric Delta-Notch expression in the daughter cells, with the cell possessing 
the lower level of notch signalling undergoing differentiation. This apical daughter cell is 
the source of notch ligand for the basal, self-renewing, daughter cell due to the polarity 




mind bomb to the apical daughter cell restricting self-renewal (Dong et al. 2012). Both 
RGCs and basal progenitors are capable of symmetric neurogenic division to terminally 
differentiate (Gotz and Huttner 2005). 
This manner of neurogenesis has interesting spatial and temporal consequences, allowing 
for terminal differentiation at differing times, and via differing and oftentimes 
increasingly complex routes of differentiation through multiple classes of basal 
progenitors. The cell cycle length of cells undergoing terminal differentiation is longer 
than that of cells undergoing proliferative division, adding to the temporal complexity of 
neurogenesis (Gotz and Huttner 2005). These temporal and spatial consequences are 
particularly obvious in the neurogenesis of the human neocortex. Here neurogenesis 
occurs in an inside-out pattern, resulting in structurally distinct layers, with neurons of 
the inner layer born first, while the neurons of subsequent outer layers are born later 
(Florio and Huttner 2014). These layers have individual structural and functional 
characteristics, with differing gene expression (Franco et al. 2011).  
 
Figure 1.3. Neurogenesis. During neurogenesis a neuroectodermal cell may divide 
symmetrically to produce an identical daughter cell (red arrow), asymmetrically, to 
produce a radial glial cell (blue arrow) or differentiate into a neuron (black arrow). 




symmetrically or divide asymmetrically to produce an intermediate or basal progenitor, 
which itself may differentiate, divide symmetrically or divide asymmetrically to 
produce a progenitor with further cell fate specifications. This process accounts for the 




Oligodendrocytes (OLs) are one of three types of glial cells of the CNS, the others being 
microglia and astrocytes (Stern 2010). OLs produce myelin, a lipid based substance that 
produces an insulating sheath for axons and is essential for proper conduction of action 
potential between neurons. OLs can be found ubiquitously throughout the CNS, and are 
present in both white and grey matter (Miller 1996). Data obtained from rodent studies 
on OL development show that in the spinal cord, the majority of oligodendrocyte 
progenitor cells (OPCs) originate in the ventral ventricular zone (VZ), from motor neuron 
progenitors following a neurogenic-gliogenic switch (Rabadan et al. 2012). These OPCs 
migrate throughout the cord, eventually undergoing differentiation into mature 
myelinating OLs (Q.R. Lu et al. 2002; Takebayashi et al. 2002). As development 
progresses a second wave of OPCs are produced in the dorsal spinal cord. These cells 
contribute 10-15% of the total oligodendrocyte number (Cai et al. 2005; Fogarty et al. 
2005). In mice and rats, generation of ventral and dorsal OL progenitors begins at E12.5 
and E14.5 respectively (Cai et al. 2005). In the rodent brain OPCs arise in three distinct 
waves, first in the medial ganglionic eminence and anterior entopeduncular area of the 
ventral forebrain, then in the lateral or caudal ganglionic eminence, and finally in the 
postnatal cortex (Kessaris et al. 2006). 
Tight molecular control of oligodendrogliogenesis is important to ensure timely 




(Figure 1.4). Newly specified OPCs migrate to their final destination in response to a 
variety of signalling molecules, including BMPs, Shh and WNT morphogens, as well as 
under the control other factors, such as growth factors (e.g PDGF, VEGF, FGF and 
hepatocyte growth factor (HGF)) (Yan and Rivkees 2002; Kakinuma et al. 2004; Bribian 
et al. 2006; Merchan et al. 2007; Hayakawa et al. 2012; Choe et al. 2014; Tripathi et al. 
2017). Extracellular matrix proteins such as laminin and fibronectin, cell adhesion 
molecules (CAMs), sempaphorins and chemokines have all been described as influencing 
oligodendrocyte migration through either attraction or repulsion (Barral-Moran et al. 
2003; Bernard et al. 2012; Vora et al. 2012; Linneberg et al. 2015; Tripathi et al. 2017). 
On arrival at their destination OPCs proliferate under the control of pathways such as 
PDGF, Notch and WNT, which simultaneously inhibit differentiation (Calver et al. 1998; 
Wang et al. 1998; Fancy et al. 2011). Transcription factors such as inhibitor of 
differentiation (Id)2, Id4 and Hes5 act downstream of these signalling molecules to 
supress premature maturation. Suppression of these inhibitory factors is necessary to 
allow differentiation to pre-oligodendrocytes and finally to mature oligodendrocytes to 
occur (Liu et al. 2006; Zhao et al. 2010; Emery and Lu 2015). Differentiation of OPCs 
involves the co-expression of NKX2.2 and Olig2, factors which actively repress each 
other in proliferative stages. To induce differentiation Olig2 induces the expression of 
SOX10, a transcription factor and determinant of OL maturation. Sox10 maintains Olig2 
expression while inducing expression of NKX2.2 following the inhibition of Olig2 
mediated NKX2.2 repression by NFAT family member NFATC2 (Figure 1.5). SOX10 
also induces the expression of transcription factors such as myelin regulatory factor 
(Myrf), resulting in the expression of myelin genes such as myelin associated 
glycoprotein (MAG), myelin oligodendrocyte glycoprotein (MOG), phospholipid protein 
(PLP) and myelin basic protein (MBP) to produce mature, myelinating oligodendrocytes 





Figure 1.4: Oligodendrocyte differentiation is a multistep process. Neural stem cells 
(NSCs) undergo differentiation to oligodendrocyte progenitor cells (OPCs). This 
differentiation can be inhibited by factors which promote NSC proliferation (eg BMPs), 
or promote motor neuron proliferation (eg Insulin gene enhancer protein (Isl1)). OPCs 
undergo further proliferation to pre-myelinating oligodendrocytes, a process which can 
be inhibited by downstream targets of PDGF, notch and WNT signalling (PDGFRα, Id2, 
Id4, Hes5). Pre-myelinating oligodendrocytes finally become mature myelinating 
oligodendrocytes. This process can be inhibited by Ubiquitin-like, containing PHD and 
RING finger domains, 1 (UHRF1, soluble neuregulin) (Grinspan et al. 2000; Dugas et al. 





Figure 1.5. Molecular control of oligodendrogliogenesis. Differentiation of OPCs 
involves the co-expression of NKX2.2 and Olig2, which actively repress each other 
during proliferation. To induce differentiation Olig2 induces the expression of SRY-box 
10 (Sox10). Sox10 maintains Olig2 expression while inducing expression of NKX2.2 
following the inhibition of Olig2 mediated NKX2.2 repression by Nuclear factor of 
activated T cells (NFAT) family member NFATC2 (adapted from (Elbaz and Popko 
2019)). 
 
 Data on human OL development is largely circumstantial although the same core 
principles seem to apply to both rodents and humans. Understanding of human OL 
development has been garnered from studies of the human foetal forebrain during 
midgestation, which suggests the existence the three differing OPC populations: cortical, 
dorsal, and OPCs migrating between ganglionic eminences and subventricular zone 
(SVZ) (Rakic and Zecevic 2003). The first myelination of axons occurs at midgestation 




life (Baumann and Pham-Dinh 2001). In order to fully elucidate the myelination process 
in the human studies need to continue into adolescence. 
OLs are notorious for being a highly vulnerable cell population, particularly during 
development. It has been estimated that OLs can support membrane up to 100x the weight 
of its cell body (McTigue and Tripathi 2008), which results in a vulnerable cell 
phenotype, largely due to the metabolic demands placed upon the cell. Briefly, OLs have 
many differing ways of malfunctioning. For example, OLs have high metabolic rates and 
iron levels and require large amounts of oxygen and ATP. Waste metabolites can produce 
reactive oxygen species (ROS), toxic by-products, free radicals and can result in lipid 
peroxidation (Bradl and Lassmann 2010). However, OLs contain low levels of the anti-




Astrocytes are the most abundant macroglia in the CNS, accounting for approximately 
50% of all CNS cells (Azevedo et al. 2009). Originally believed to be a homogeneous 
cell population with a structural support function, more recent evidence has implicated 
astrocytes in a diverse array of processes including structural support, maintenance of 
water balance, blood-brain barrier formation as well as the secretion of factors influencing 
neuronal function (Sofroniew and Vinters 2010). Astrocytes can be divided 
morphologically into two types, fibrous astrocytes, which populate the white matter, and 
protoplasmic astrocytes which populate the grey matter (Goursaud et al. 2009). 
Astrogliogenesis, generally occurs after neurogenesis although some overlap does exist. 
Astrocytes are derived from a number of sources, the most common of which, like in 
neurogenesis, is asymmetrical cell division of a radial glial cell in the SVZ, which can 




(Barry and McDermott 2005). These immature astrocytes migrate before undergoing 
further proliferation and eventually differentiating into mature astrocytes (Ge et al. 2012).  
Astrogliogenesis from specific intermediate progenitors, for example Neural/glial antigen 
2 – positive (NG2+) progenitors in the forebrain and Empty Spiracles Homeobox 1 – 
positive (emx1+) progenitors in cortex, appears to be responsible for the generation of an 
array of astrocyte subtypes, and the regional restriction of astrocytes of a specific lineage 
(Gorski et al. 2002; Zhu et al. 2008). Originally termed astrocytes for their star shaped 
morphology it is now clear that astrocytes are a family of structurally and functionally 
distinct cells. Muller glia of the retina provide an inarguable example of the adaptability 
of astrocytes to their cellular and molecular environment, with processes of these radially 
polarised astrocytes adapting to the anatomical and molecular features of the individual 
retinal layers to which they project (for review see (Derouiche et al. 2012)). Bergmann 
glia of the cerebellar cortex are a molecularly distinct group of astrocytes. These cells are 
polarised, with the soma of these cells being closely associated with neighbouring 
purkinje cells while their processes extend throughout the molecular layer to envelope 
synapses (Miyazaki et al. 2017). Bergmann cells are uniquely equipped to survive the 
dense glutamatergic innervation of this layer, expressing high levels of glutamatergic 
transporters as well as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors, the presence of which is necessary for glutamate detection, glutamine synthase 
production, and fine motor coordination (Saab et al. 2012; Miyazaki et al. 2017; Tiburcio-
Felix et al. 2018). Astroglia of the arcuate nucleus of the hypothalamus are hormone 
sensitive and influence neuronal activity in response to hormones like leptin while 
suprachiasmatic astrocytes of the dorsal suprachiasmatic nucleus are critical to the 
regulation of the circadian rhythm (J.G. Kim et al. 2014; Brancaccio et al. 2017).  
Hochstim and colleagues have identified three distinct subgroups of white matter 




These subgroups are positionally distinct. Reelin+ Slit1- astrocytes lie dorsolaterally and 
ventrolaterally in the white matter, Reelin- Slit1+ astrocytes are found close to the ventral 
midline, and Reelin+ Slit1+ astrocytes are found between them. This positional 
distinction was found to result from the distinct progenitor domain expression of 
homeodomain proteins Pax6 and Nkx6.1 (Hochstim et al. 2008). Far from the 
homogeneous population astrocytes were once believed to be, these cells are now known 
to be morphologically and molecularly diverse. 
In response to this new understanding of the functional significance of astrocytes the 
mechanisms controlling astrogliogenesis have become an area of interest. Evidence has 
implicated modulation of the JAK-STAT3 signalling pathway as a core regulator of the 
onset of astrocyte development (Bonni et al. 1997). Interestingly, the JAK/STAT3 
pathway is activated by the il-6 family of cytokines, resulting in receptor dimerization, 
either with other il-6 receptors, or with other family members. This dimerization occurs 
with the aid of gp130, a signal transducer, to ultimately induce the transcription of 
astrocytic genes (Heinrich et al. 1998). Importantly the promotors of these genes are 
insensitive to il-6 family cytokines and JAK-STAT3 activation in early and mid-
gestational periods, an important clue in the temporal control of astrocyte development 
as well as the step-wise development of the CNS as a whole (Takizawa et al. 2001). This 
insensitivity appears to be mediated by epigenetic changes, specifically methylation of 
astrocytic promoters and chromatin modification (Song and Ghosh 2004; Shaked et al. 
2008). For full review see (Namihira and Nakashima 2013). 
1.2.4 Microgliogenesis 
 
Microglia, unlike the macroglia previously discussed in this introduction, originate 
outside the CNS (Rezaie and Male 1999; Ginhoux et al. 2010). Microglia are known as 




complex roles in cell survival, cell death and dendritic and synaptic pruning during 
development (Lawson et al. 1990; Lawson et al. 1992; Nayak et al. 2014; Fernandez de 
Cossio et al. 2017).  Microglial development begins at roughly E8.5 in the mouse with 
the emergence of CD45+ cKit- erythromyeloid progenitors in the yolk sac. A subset of 
these progenitors mature to express CX3CR1. These microglial progenitors undergo 
Matrix metalloproteinase (MMP)-dependent, circulation-dependent ,migration into the 
brain between E9.5 and E10.5. They comprise the sole source of microglia in the brain 
after blood-brain-barrier formation and self-renew within the CNS (Ajami et al. 2007; 
Ginhoux et al. 2010; Schulz et al. 2012; Kierdorf et al. 2013; Gomez Perdiguero et al. 
2015). 
Investigations into the heterogeneity of microglial cells have been fewer than their 
astrocytic and oligodendrogliogenic counterparts, this is partially due to the problematic 
nature of cryopreservation of microglia, known alterations to microglial phenotype in 
cultures, and the auto-fluorescence of human post-mortem tissue (Böttcher et al. 2019). 
The first study to identify heterogeneity in microglial expression was performed in 1980, 
identifying a higher density of microglial cells in the hippocampus and thalamus than in 
the cortex and cerebellum of mice. Interestingly this study noted a lower level of 
expression of the marker F4/80 in microglia of the cerebellum, which was the first 
suggestion of regional heterogeneity in microglial cells (Lawson et al. 1990). Microglia 
have subsequently been divided into two subclasses, ameboid and ramified. These 
subclasses are both present within all  brain regions, but appear to have distinct molecular 
expression. In the corpus callosum for example ameboid microglia express similar levels 
of cytokines and chemokines to ramified microglia, but also cell cycle molecules 
CyclinA2 and B2 as well as caspase molecules (Casp2 and Casp3) (Parakalan et al. 2012). 
A 2008 study by De Haas et al. was one of the first to show a regional phenotypic 




CD40, CD45, CD80, CD86, EGF module-containing mucin-like receptor (EMR)1 , 
Triggering receptor expressed on myeloid cells (TREM)‐2b, CXCR3, and CCR9 in the 
hippocampus, cerebellum, cerebellar cortex, striatum and spinal cord (de Haas et al. 
2008). A microarray study in adult murine populations found a distinct spatial and 
temporal heterogeneity in microglial phenotype, with distinct bioenergetic and 
immunomodulatory pathways in the microglia of the hippocampus and cerebellum of 
young adults suggesting that microglia may be in a more immune vigilant state. The 
augmentation of these pathways in cerebellar microglia and contrasting loss of phenotype 
in the hippocampus appear to be distinct occurrences during aging (Grabert et al. 2016). 
In contrast another single cell transcriptomic study, investigating microglial development 
as a stepwise process, found microglial populations to be surprisingly homogeneous 
across their established phases of development (Matcovitch-Natan et al. 2016).  A human 
study using multiplexed single-cell mass cytometry found that the subventricular zone 
and thalamus displayed a similar microglial phenotype that was distinct from that 
displayed in the frontal and temporal lobes and the cerebellum. Higher levels of 
expression of CD11c, CCR5, CD45, CD64, CD68, CX3CR1, EMR1 and Human 
Leukocyte Antigen – DR isotype (HLA-DR) were observed in the SVZ and thalamus. 
Higher levels of expression of CD 206 were observed in the frontal and temporal lobes. 
The microglial phenotype found in the cerebellum was distinct from the other regions, 
displaying low levels of all of these markers (Böttcher et al. 2019). Another recent study 
utilising single cell RNA-seq investigated the spatiotemporal heterogeneity of microglia 
at E14.5, Postnatal (P)7 and P60 in the cortex, cerebellum, hippocampus, striatum, 
olfactory bulb and choroid plexus of mice. This study found little heterogeneity in the 
different regions of the adult brain but did identify a proliferation associated microglia 




al. 2019). Much work remains in order to fully elucidate the heterogeneity of microglia 
in the CNS and the importance of this heterogeneity to development. 
1.3 Maternal immune activation 
 
Maternal immune activation (MIA) refers to the activation of the immune system of a 
pregnant female during the gestational process, frequently by accidental infection or 
injury in humans, but also deliberately in animals, by infection, injury or the use of 
specified immunoreactive agents in a laboratory setting. In recent decades, there has been 
an intensive focus on investigating the impact of MIA on the proliferation and 
differentiation of cells in the developing CNS. 
 
1.3.1 Epidemiological studies 
 
Epidemiological studies were the first to suggest that MIA during gestation may be a risk 
factor in the development of numerous neurological disorders in offspring (Brown et al. 
2004b; Buka et al. 2008; Sun et al. 2008; Brown 2012; Wu et al. 2013). Since the original 
retrospective studies linked maternal influenza infection during pregnancy to an increased 
incidence of schizophrenia in offspring numerous studies, both retrospective and 
prospective in nature, have linked a wide variety of maternal infections to an increased 
incidence of schizophrenia in offspring. These infections include influenza, toxoplasma 
gondii, rubella and herpes simplex virus type 2 (Brown et al. 2000; Brown et al. 2004a; 
Babulas et al. 2006; Alan S. Brown and Elena J. Derkits 2010; Brown 2012). Autism 
spectrum disorder (ASD), like schizophrenia, has also been linked to MIA through 
epidemiological cohort studies and meta-analyses (Atladottir et al. 2010; Brown 2012; 
Hornig et al. 2018). More recently cohort studies have implicated MIA in both cerebral 
palsy and epilepsy (Sun et al. 2008; Brown 2012; Miller et al. 2012; Miller et al. 2013; 




Intriguingly, some epidemiological studies have highlighted the gestational timing at 
which the insult occurs as a key determinant of the neurological outcome of MIA, 
however there is no clear consensus. A large nested cohort study in a Californian 
population between 1959 and 1967 suggested that the incidence of schizophrenia in 
offspring was 3-fold higher in children of mothers who suffered an influenza infection  
during the first half of gestation and 7-fold higher in offspring of those suffering infection 
in the first trimester. No such increase was seen in the second half of gestation (Brown et 
al. 2004a; Brown 2012). In contrast a retrospective study in a Danish population over a 
40 year period between 1911-1950 found that maternal influenza infection during the 
sixth month of gestation was associated with an increased incidence of schizophrenia in 
offspring (Barr et al. 1990). This is in line with a number of other previous studies which 
have largely linked influenza exposure in the second trimester (for review see (Alan S. 
Brown and Elena J. Derkits 2010)). Epidemiological studies examining the association 
between MIA and ASDs have also reported similar findings. A Danish study following 
the children of women hospitalised for infections during pregnancy over a 25 year period 
showed no association between infection and ASDs in offspring when investigating the 
total gestational period, however maternal viral infection during the first trimester, and 
maternal bacterial infection during the second trimester, were both associated with 
increased risk of ASDs (Atladottir et al. 2010). Contrary to this a Swedish study 
encompassing births between 1984 and 2007 found that maternal infection requiring 
hospitalisation increased the incidence of ASDs regardless of insult type or gestational 
period. A third, smaller study using a Californian population associated maternal 
infection requiring hospitalisation with an increased incidence of ASD that was 
particularly associated with bacterial infections diagnosed in the second and third 




1.3.2 Animal models 
 
Epidemiological studies, while intriguing and highly informative in many ways, have 
raised numerous questions with their lack of general consensus. This has resulted in the 
development of a number of animal models in which to better study the effects of MIA 
on offspring outcomes. Animal models allow for the control of the numerous variables 
encountered in human studies. Tight control over insult timing allows researchers to more 
accurately investigate windows of vulnerability associated with MIA. Other factors easily 
controlled in animal models include insult type, bacterial or viral, and critically, insult 
severity. Animal models also eliminate other confounding factors such as maternal stress 
or deprivation. Today animal models mimicking specific infections, and indeed general 
immune activation using specific inflammatory cytokines, exist. However, the most 
commonly utilised models mimic viral infection using polyinosinic:polycytidylic acid 
(Poly(I:C)), and bacterial infection using Lipopolysaccharide (LPS). 
1.3.2.1 Polyinosinic:polycytidylic acid 
 
Poly(I:C) is a viral mimetic and an immunostimulant. It consists of a mis-matched double-
stranded RNA, one a polymer of inosinic acid and the other a polymer of cytidlylic acid. 
Double-stranded RNA is a feature of many viruses and Poly(I:C) is known to interact 
with toll-like receptor 3 (TLR3) present on the surface of many immune cells leading to 
the activation of the cytokine cascade, the common downstream pathway of immune 
system activation (Homan et al. 1972; Fortier et al. 2004). 
1.3.2.2 Lipopolysaccharide  
 
Lipopolysaccharide (LPS) is a bacterial mimetic and an immunostimulant. It is a 
prototypical endotoxin consisting of a lipid and an O-polysaccharide and is found in the 
outer membrane of gram-negative bacteria. LPS binds the CD14/TLR4/MD2 receptor 




responsible for the natural immune response to gram-negative bacteria (Rietschel et al. 
1994; Palsson-McDermott and O'Neill 2004). 
1.3.2.3 Other models of maternal infection 
 
Other models of MIA are less common, namely due to inability to control the severity of 
the infection, but commonly include inoculation with a sublethal dose of the Influenza A 
virus subtype H1N1 (H1N1) or other influenza strains, exposure to Escherichia coli (E-
coli) or exposure to inactivated Group B streptococcus (GBS). MIA studies using 
individual cytokines such as IL-6 have also been completed (Fatemi et al. 1998; Fatemi 
et al. 2005a; Pang et al. 2005; Smith et al. 2007; Garbett et al. 2012; Bergeron et al. 2013).  
1.3.3 The rodent spinal cord as a model of MIA 
 
Although it is likely that any major cognitive deficits resulting from MIA will arise in the 
cortical structures, the complexity of cortical development makes it challenging to 
unravel the small cellular and structural deficits that may arise. The spinal cord provides 
a number of key advantages for the study of MIA at a cellular level. Spinal cord 
development is particularly well characterised, owing largely to the fact that a number of 
the seminal works in early neuroscience were carried out in the region. Papers by Bidder 
and Kuffner (1857), His (1886, 1889), Retzius (1898) and Ramon y Cajal (1909) all 
investigated and characterised  the anatomy of the spinal cord (Altman and Bayer 1984; 
Altman and Bayer 2001). The spinal cord provides an abundant tissue source for 
investigation, particularly in embryological studies where traditionally tissue from 
specific CNS regions may be scarce. One unique aspect of the spinal cord is the ability to 
study multiple points of development within the cord of the same animal due to the rostro-
caudal gradient of development (Hajihosseini et al. 1997; Nakayama et al. 1999). This 
allows precise identification not only of the windows of vulnerability of cells in the spinal 




affected.  When investigating MIA from a cellular perspective the spinal cord proves a 
straightforward model as a result of this detailed characterisation and relative simplicity 
when compared to other regions of the CNS which may not be as well characterised. 
(Lumsden and Kiecker 2013; Horiuchi et al. 2017; Spitzer et al. 2019) . 
1.3.4 MIA and Neurons 
 
A large volume of literature has suggested that MIA can alter neurogenesis and circuit 
formation in offspring. This is particularly true in the case of GABAergic neurogenesis 
and the establishment of inhibitory circuitry. Incorrect GABAergic signalling and 
neuronal circuitry development has been linked to the development of a number of 
neuropsychiatric disorders including schizophrenia and ASD (Fatemi et al. 2002a; 
Fazzari et al. 2010; Curley et al. 2011; Penagarikano et al. 2011). 
MIA as early as E9 has been shown to affect GABAergic neurotransmission. In a study 
by Corradini et al offspring of mice who received an intraperitoneal (i.p) injection of 
2mg/kg poly(I:C) displayed a delayed excitatory to inhibitory GABAegric switch and a 
higher susceptibility to seizures. This susceptibility endured at P90, due to dysregulation 
of potassium chloride cotransporter (KCC2) activity and higher intracellular chloride 
levels (Corradini et al. 2018). KCC2 activity maintains the Cl- gradient necessary for the 
inhibitory actions of the GABAA receptor in neurons (Price et al. 2005). Similarly another 
study, also in mice at E9 but this time utilising an intravenous (i.v) injection of 1mg/kg 
poly(I:C), showed reduced functional GABAergic neurotransmission in the medial PFC. 
This reduced functionality was shown to be due to a decrease in release probability and 
was specific to paravalbumin expressing interneurons (Canetta et al. 2016). A third study 
at E9 by Harvey and Boska utilised a stereological approach to investigate the effect of 
MIA with either poly(I:C) or LPS on Glutamate decarboxylase (GAD)67 and Reelin 




Interestingly this study saw age, sex and immunogen specific changes. At P14 neither 
GAD67 or reelin expression were changed in response to MIA with 20mg/kg i.v poly(I:C) 
or 200µg/kg i.v LPS, although offspring of dams treated with LPS showed an increased 
neuronal density as measured by NeuN+ cell number. At P28 offspring of dams exposed 
to poly(I:C) had a decreased number of reelin+ cells in the dorsal hippocampal stratum 
oriens. GAD67 expression was found to increase in the ventral striatum oriens of male 
offspring of LPS treated animals and female offspring of poly(I:C) treated animals 
(Harvey and Boksa 2012). 
Two studies at E12/E12.5 have further investigated changes in GABAergic 
neurotransmission postnatally in response to MIA. A study by Fernandez et al showed 
that an i.p injection of 20mg/kg poly(I:C) at E12 was enough to abolish the oxytocin-
mediated shift of GABAergic signalling from depolarising to hyperpolarising in CA3 
pyramidal neurons of the hippocampus at birth in offspring. These mice showed an 
increased apical arborisation and apical dendritic spine length of these neurons as well as 
a higher frequency of spontaneous post-synaptic currents, which persisted at P14 
(Fernandez et al. 2018). Another study at E12.5 looked at medial PFC – basal amgdayla 
GABAergic neurotransmission and showed that maternal i.p injection with 20mg/kg 
poly(I:C) increased the synaptic strength of glutamatergic projections from the mPFC to 
the basolateral amgdayla in mice. Changes in the excitatory/inhibitory balance were 
differentially translated into the modified spike output in neurons of the basal amgdayla. 
Interestingly when male offspring subsequently received a subcutaneous 10mg/kg 
poly(I:C) injection at P9 (roughly 39-40 weeks human gestation) they displayed decreases 
in feedforward GABAergic inhibitory postsynaptic responses resulting from activation of 
local circuit interneurons in the basal amgdayla by medial PFC-originating fibres (Li et 




A large number of studies between E15 and E16 have investigated the effect of MIA on 
GABAergic transmission. Many of these have focused specifically on the effect of MIA 
on parvalbumin expressing neurons. Boska et al identified an increased density of 
parvalbumin-immunoreactive neurons in the medial PFC, dorsolateral PFC, and ventral 
subiculum of offspring at P14, as well as increased cholecystokinin neuron density in the 
medial PFC at P28 following MIA at E15 and E16 with i.p injections of 50µg/kg LPS. 
The study illustrated the differing trajectories of parvalbumin and somatostatin neurons 
in the normally developing PFC, with an increase in parvalbumin neuron density from 
P14 to P28 in the medial PFC and subiculum that was not observed in other brain regions, 
and significant decreases in somatostatin neuron density from P14 to P28 in all brain 
regions. This differential trajectory indicates that MIA may affect different 
subpopulations of neurons in different ways at the same time point during development 
(Boksa et al. 2016). In another study GAD67 levels were assayed in the dorsal and ventral 
hippocampus and medial PFC of male adult offspring of dams which received an i.v 
injection of 4mg/kg poly(I:C) at E15. GAD67 expression in parvalbumin+ cells was 
reduced in the dorsal hippocampus relative to ventral hippocampus at P96. This decrease 
was observed in the absence of parvalbumin+ neuronal loss (Dickerson et al. 2014). In 
contrast, in an LPS study parvalbumin+ and somatostatin+ interneurons were decreased 
in layer II/III of the PFC of offspring of mice who received consecutive i.p injections of 
150µg/kg LPS on E15.5 and E16.5 at P30, but only in conjunction with chronic hypoxic 
conditions post-birth. GAD65+ and GAD67+ neuron number were also decreased at P30 
under these conditions. MIA alone was capable of altering the distribution and density of 
Vasoactive intestinal peptide (VIP)+, Calreticulin+ and NeuropeptideY+ interneurons in 
the ACC layer V and the prelimbic layer II/III. Reelin+ interneurons were the only 
subgroup examined which showed no change in expression following MIA (Lacaille et 




parvalbumin+ interneurons, this time following MIA on E15 and E16 with i.p injection 
of 100µg/kg LPS alone. This decrease in the number of parvalbumin+ cells was observed 
in the medial PFC, the entorhinal cortex and the hippocampus at adulthood in male 
offspring and was less severe in female offspring. This again suggests a sex-dependent 
effect of MIA on GABAergic neurotransmission, which may be an important factor in 
the prevalence of disorders such as ASD and schizophrenia in males over females. Indeed, 
in a study by Zhang and Van Praag male offspring showed a decrease in pavalbumin+ 
interneurons in the dentate gyrus of the hippocampus and a decreased dentate gyrus 
volume at P84 following i.p injection of 5mg/kg Poly(I:C) at E15. Both mature and new 
hippocampal neurons showed modifications in intrinsic properties such as increased input 
resistance and lower current threshold, and decreased action potential number. Reduced 
GABAergic inhibitory transmission was observed in mature dentate gyrus neurons only. 
The differential impairment of mature versus newly born dentate gyrus neurons may have 
implications in MIA attributed behavioural deficits (Zhang and van Praag 2015). These 
changes in interneuron distribution and density, and GABAergic transmission may be 
underpinned by alterations in specific gene expression profiles. MIA with an i.p injection 
of 250µg/kg of LPS at E15 resulted in decreased expression of both GAD1 and GAD2, 
as well as distal-less (Dlx)1,2 and 5, homeobox domain proteins in a whole-brain 
microarray study 4h post-injection. These proteins have roles in interneuron migration 
(Dlx1 and Dlx2) and preferential expression of parvalbumin+ cortical neurons (Dlx5 
expressing). Other changes in gene expression, related to neuronal migration and axon 
guidance more broadly, for example in semaphorins, their receptors the plexins, and in 
POU genes were also recorded (Oskvig et al. 2012). 
Three studies from the same laboratory have investigated the effect of MIA on 
GABAergic interneurons at E17 in the PFC. In all instances mice received a 5mg/kg i.v 




ribonucleic acid (mRNA) and protein expression of GAD65 and GAD67 and the vesicular 
GABA transporter (VGAT). In P100 offspring, the Na-K-Cl cotransporter (NKCC1), 
involved in excitatory GABAergic signalling, was significantly increased while KCC2, 
involved in inhibitory GABAergic transmission, was decreased. Age-related changes in 
GABA(A) α-receptor subunits were also observed. mRNA levels of the α2 and α4 
subunits were significantly increased in offspring at P35 but significantly decreased at 
P100. At P100 mRNA levels of α3 were upregulated and α5 were downregulated but no 
change was observed at P35 further illustrating the temporal nature of the effect of MIA 
on development. Methylation of the GAD1 and GAD2 promoters was higher in MIA 
offspring through increased binding of methyl CpG binding protein 2 (MeCP2). A 
number of the genes methylated at P114 in response to MIA at E17 were related to 
differentiation of GABAergic neurons. These included members of the LIM homeobox 
(Lhx) and Dlx transcription factor families. Interestingly, offspring of dams treated at E9 
rather than E17 in the same study showed differential methylation of genes involved in 
neuronal differentiation. In these animals many of the methylated genes were members 
of the WNT family (Richetto et al. 2014; Giovanoli et al. 2016; Richetto et al. 2017). A 
study looking at the effect of 3mg/kg i.p poly(I:C) injection at E12.5 and subsequent 
1.5mg/kg Poly(I:C) injection at E17.5 found further evidence of the effect of MIA on 
inhibitory neurotransmission. Patch clap recordings found that layer II/III pyramidal cells 
were hyperactive in the Anterior cingulate cortex (ACC) of offspring of MIA treated 
dams, and that this hyperexcitation was associated with a reduction in inhibitory synapse 
activity. Local injection of Clonazepam into the ACC restored deficient social behaviours 
observed in these offspring (Okamoto et al. 2018). A single study has looked later in 
gestation. Male offspring of dams which received an i.p injection of 500µg/kg LPS on 
E19 showed a premature loss of long-term depression in hippocampal neurons, occurring 




The deficit in GABAergic interneurons in the hippocampus following MIA, associated 
with presynaptic GABAergic transmission, was reversed by the GABA uptake inhibitor 
tiagabine (Rideau Batista Novais et al. 2014). 
 
1.3.5 MIA and oligodendrocytes 
 
1.3.5.1 Cytokines, inflammation and oligodendrocyte development 
 
The consequences of maternal inflammation on developing OLs are complex, and can 
result in devastating disorders such as periventricular leukomalacia (PVL), which 
involves the death or small areas of white matter around the ventricles, and cerebral palsy, 
a movement disorder resulting from white matter damage predominantly in the motor 
cortex (K. Kim et al. 2014). OLs are known to be particularly vulnerable to cytokines but, 
like in all cells in the CNS, cytokines also play a role in the normal physiological 
development of OLs. For example, in postnatal day 6 mouse pups, TGFβ signalling has 
a role in the regulation of normal myelination processes through modulation of c-myc and 
p21 gene expression by cooperation of SMAD3/4 with the transcription factors Forkhead 
Box O1 (FoxO1) and Specificity protein 1 (Sp1) resulting in cell cycle exit, OL 
differentiation and myelination (Palazuelos et al. 2014). In vitro studies on OL 
progenitors and OLs treated with IL-1β, found that IL-1β is capable of blocking 
proliferation of late-stage OL progenitors (O4+) but not earlier progenitors (A2B5+) while 
simultaneously promoting the maturation of cells to a mature MBP+ phenotype. 
Moreover, IL-1β decreases PDGFR-α gene expression, a marker of immature 
oligodendrocytes, in a time dependent manner, cumulatively suggesting a role for IL-1β 
in enhancing survival of differentiating OLs and playing a part in mitotic arrest and OL 
progenitor differentiation (Vela et al. 2002). On the other hand, transgenic mice that 




indicative of a potential interference with normal CNS development (Corbin et al. 1996). 
LIF receptor signalling has been shown to enhance of the myelination process in some 
mouse models. In mice exposed to cuprizone, a copper chelator which creates a toxic 
oligodendrocytopathy, exogenous LIF limited demyelination, while knockout of LIF 
potentiated the demyelination process, indicating a role for LIF in the myelination process 
at normal physiological levels (Marriott et al. 2008). Chemokines, in particular astrocytic 
chemokines such as CXCL1 and CXCL12, play roles in multiple facets of OL 
development including migration, proliferation and maturation (Maysami et al. 2006; 
Filipovic and Zecevic 2008). In vitro studies using an OL precursor-like cell line showed 
CXCL12, CXCL8 and CCL5 all increased proliferation while both CXCL8 and CXCL12 
also increased MBP production and maturation. CXCL12 induced proliferation of mixed 
cortical primary cultures through the receptor CXCR4 (Kadi et al. 2006). Another group 
have shown that activation of CXCR7 by CXCL12 induced maturation of OPCs both in 
vivo and in vitro (Gottle et al. 2010).  
1.3.5.2 The consequences of MIA on the developing oligodendrocyte 
 
It is perhaps unsurprising, therefore, that due to their complex developmental process OLs 
are particularly vulnerable to the effects of MIA. Maternal inflammation has been shown 
to alter cytokine levels in the fetal brain and to damage white matter (Cammer and Zhang 
1999; Cai et al. 2000). TNFα  is present in white matter lesions associated with PVL and 
plays a role in the potentiation of IFNɣ mediated oligodendroglial death during 
development. (Volpe et al. 2011). This alteration in cytokine levels can have varied 
effects on OLs, dependent on the severity of the insult, the specific brain region and the 
time at which the insult occurred. In the human, like in the rodent, myelination begins in 
late gestation and continues during postnatal life. Despite this however, the pathological 
effects of MIA are not limited to this vulnerable period of myelination. Indeed white 




disorders including schizophrenia, autism and PVL, suggesting that MIA during gestation 
may have serious consequences on the developing white matter (Gilstrap and Ramin 
2000; Volpe et al. 2011). 
White matter injury and abnormality can result following immune insult during multiple 
gestational windows. A number of studies by Fatemi and colleagues have investigated 
gene expression after maternal exposure to a sub-lethal dose of the H1N1 human 
influenza virus in mice at multiple time points; E9 (early gestation), E16 (mid-second 
trimester) and E18 (late second trimester) (Fatemi et al. 2005a; Fatemi et al. 2008b; 
Fatemi et al. 2009a; Fatemi et al. 2009b). The E16 time point revealed abnormal 
expression of a number of myelination genes in the cerebellum of offspring post maternal 
inflammation including MAG, MOG, myelin-associated oligodendrocytic basic protein 
(MOBP), MBP and PLP1. A number of these alterations were confirmed at a protein level 
and were long lasting, including a decrease in MBP isoforms at P14 and P56 time points, 
a decrease in MAG expression at P14 and P35, and, interestingly, an increase in DM20 
(a PLP1 splice variant) at P35 and P56, perhaps indicating a change to the molecular make 
up of myelin produced. Decreases in MBP were also observed in other studies by the 
group, including in the hippocampus, also at E16, and in whole brain homogenates of 
offspring of mice exposed to the human influenza virus at E9. Changes in MBP 
expression were not reported after E18 treatment in the hippocampus, frontal cortex or 
cerebellum. Despite it being difficult to make direct comparison between studies due to 
differences in time point of insult, the brain region examined, the type and severity of the 
insult, and in many cases the time point examined postnatally, Fatemi and colleagues 
have provided evidence strongly suggestive of a change in expression of proteins 
involved in myelination in response to influenza virus exposure that is temporally and 
spatially specific. This regional specificity is echoed in a study in mice in which dams 




MBP isoforms were found to be decreased in the hippocampus, but not in the cortex. 
Interestingly this effect was transient in the hippocampus and was not seen at P63, 
suggesting that myelination was delayed but not prevented in the hippocampus and 
unaffected in the cortex (M. Makinodan et al. 2008). 
Multiple further studies have investigated the effects of an array of different immune 
insults on developing oligodendrocytes at differing time points and levels of insult 
severity. These studies report a range of changes in myelin protein expression, 
oligodendrocyte number and function, and white matter connectivity while suggesting a 
number of causal mechanisms and potential treatments (Fatemi et al. 2008b; Li et al. 
2010). Sequential maternal injections of 100µg/kg LPS at E15 and E16 revealed a 
decrease in myelination of both the cortical and limbic regions in rat offspring, an effect 
that was more pronounced in male rodents than in female. Such sex difference is an 
important observation in schizophrenia, and as the authors noted in this study, is also 
potentially relevant to the clinical presentation of ASD, which is more common in males 
and also associated with white matter injury (Bergeron et al. 2013; L. Wischhof et al. 
2015). Recently, also at E15, a study by Makinson et al, in which dams received an 
intrauterine injection of 50µg/kg LPS. echoed these sex-specific differences in response 
to MIA. This study identified sex-specific differences in MBP expression in the P2 whole 
brain and the corpus callosum of mouse offspring at 28 weeks (Makinson et al. 2017). 
Finally at E15, a study using a 4mg/kg poly(I:C) injection showed a reduction in MBP 
and Rhombex 29 expression in the PFC of rat offspring after treatment which could be 
corrected by treatment with the atypical antipsychotic risperidone. Rhombex 29 is 
homologous to the PLP/DM20-M6 family (Shimokawa and Miura 2000; Farrelly et al. 
2015).  
Additional studies have furthered the scope of traditional MIA models to examine 




reparative or even preventative treatments for the effects of MIA. A study by Graf et al 
at E16 modelled PVL, a white matter disorder commonly associated with cerebral palsy 
in mice. They found that hyperoxia, like that experienced by a neonate in a ventilation 
chamber, exacerbated the response to an i.p 80µg/kg maternal LPS injection leading to 
decreased oligodendrocytes in the cortex and hippocampus as well as decreased MBP 
staining at P14 (Graf et al. 2014). Another study, also investigating PVL from an MIA 
perspective but in rats, found white matter injury in the periventricular region at P7 after 
a 500µg/kg i.p maternal LPS injection at E18 and E19, characterised by TUNEL+ cell 
death and a decrease in MBP staining. Interestingly this LPS induced injury was 
attenuated with Erythropoietin (EPO)   treatment, which stimulates red blood cell 
production in response to cellular hypoxia. EPO treatment was associated with a decrease 
in TNF alpha, IL-6 and IL-1 in this study, all of which were elevated in offspring in 
response to maternal LPS treatment (Kumral et al. 2007).  Maternal exposure to E.coli (1 
x 107 colony forming units (CFU)) via intrauterine inoculation at E17 induced white 
matter injury in rat offspring  characterised by a decrease in 2',3'-Cyclic-nucleotide 3'-
phosphodiesterase (CNPase) staining in the corpus callosum (CC), the cingulate region 
of the subcortex and the external capsule at P8. O4 immunostaining, marking an 
intermediate stage of oligodendrocyte development, was also decreased in white matter 
areas. Oligodendrocyte numbers were reduced in periventricular areas in offspring of 
E.coli exposed dams. At P15, decreased MBP staining indicated hypomyelination in line 
with these previous findings. IL-10 treatment partially repaired the damage caused by 
E.coli exposure, again potentially implicating pro-inflammatory cytokines in the 
pathogenesis of MIA. A previous study by Meyers et al showed that 2mg/kg intravenous 
Poly (I:C) induced changes in whole-brain levels of the proinflammatory cytokines IL-6 
and TNF-α, and that IL-10 could reverse the behavioural phenotypes induced by 




At the transcriptome level, a recent microarray study by Richetto et al identified a 
decrease in multiple genes involved in myelination in the mPFC and the nucleus 
accumbens (NAc) in mice following MIA induced by an i.v injection of 5mg/kg Poly(I:C) 
at E17. These included MAL, MAG, MOBP, MOG, and claudin 11. MOBP was 
confirmed to be decreased at the level of protein expression in the mPFC following MIA 
(Richetto et al. 2017). Maternal i.p 700µg/kg LPS injection at E18 induced peroxisome 
depletion in oligodendrocytes resulting in hypomyelination of the cingulum and corpus 
callosum in adolescent rat offspring. This peroxisome depletion was corrected by N-
acetylcysteine, an antioxidant and suggests a cellular mechanism by which 
oligodendrocytes are damaged during MIA (Paintlia et al. 2008). Maternal exposure to 
inactivated GBS by injection every 12 hours from E19 to E22 resulted in dysmyelination 
of the external capsule in rat offspring. Myelin density was reduced and the cellular 
architecture disorganised, characterised by the misalignment of nuclei and a decrease in 
the number of mature oligodendrocytes. These cellular deficits translated into behavioural 
manifestations such as a decrease in nest seeking behaviour (P9), reduced pre-pulse 
inhibition (PPI) (P30-35) and reduced social interaction (P40) all of which were more 
common in males than in females, again illustrating the applicability of MIA models to 
ASD (Bergeron et al. 2013). Interestingly just one study identified increases of white 
matter associated proteins in response to MIA. A recent study by Mouihate et al described 
increases in NG2+ cell density at P2 following an i.p 100µg/kg LPS injection at E12, 
indicative of an increase in the number of OPCs present in the corpus callosum. They 
found no change in the density of CC1+ cells indicating that OLs were not increased. 
Contrary to other studies the group also identified an increase in the 21.5kDa MBP 





1.3.6 MIA and Astrocytes 
 
1.3.6.1 The role of astrocytes in mediating the consequences of MIA 
 
The effect of MIA on developing astrocytes is an underexplored topic in the examination 
of the cellular consequences of MIA. Astrocytes are the most abundant of the macroglia 
in the CNS (Azevedo et al. 2009). Originally believed to be a homogeneous cell type with 
a structural support function, more recent evidence has implicated astrocytes in a diverse 
array of processes including structural support, maintenance of water balance, blood-
brain barrier formation and the secretion of factors influencing neuronal function 
(Sofroniew and Vinters 2010) . With such complex and varied roles in the everyday 
function of the CNS, there is a need to investigate the effects of MIA on the development 
of these cells. Astrocytes are capable of releasing a host of cytokines which can affect the 
normal function and development of surrounding cells (S.C. Lee et al. 1993). MIA is 
widely accepted to result in astrogliosis, and this effect is often the extent to which the 
effects of MIA on astrocytes is studied (Cai et al. 2000; Rousset et al. 2006; K. Kim et 
al. 2014; Zager et al. 2015). Astrogliosis is a normal response to a host of CNS insults 
and, like all inflammatory processes, can have both positive and negative results which 
are largely dependent on which intracellular signalling cascades are activated (Sofroniew 
2009; Sofroniew and Vinters 2010). Although it is critical to understand the astrogliosis 
induced by MIA and the effect of this astrogliosis on other cells of the CNS it is also 
necessary to understand the more intricate effects of MIA on astrocyte development and 
functionality.  
 
1.3.6.2 The consequences of MIA on the developing astrocyte 
 
Astrogliosis is strongly associated with disorders of the white matter such as PVL, 




Hartung et al. 2014). Reactive astrocytes often characterise the white matter lesions found 
in these disorders. Understandably then, most MIA studies which have investigated the 
effect of MIA on astrocytes have done so in the context of the effect of astrogliosis on 
oligodendrocytes. In line with the developmental timeline of the CNS, most studies 
investigating white matter damage (and often the resulting astrocytic response) have been 
carried out in later gestation. A PVL study, involving repeated intracervical injection of 
1mg/kg LPS at E9, E13 and E17 saw an increase in Glial fibrillary acidic protein (GFAP) 
expression in the striatum in rat offspring at P84. This study found that regular endurance 
exercise was capable of reversing this increase in GFAP (K. Kim et al. 2014). Another 
study, investigating a potential developmental origin of MS susceptibility, found that a 
120ug/kg i.p maternal LPS injection at E17 in mice exacerbated astrogliosis. This was 
characterised by an increase in GFAP protein levels and immunoreactivity in the cortex 
and cerebellum of an experimental autoimmune encephalomyelitis (EAE) model of MS 
offspring at P60 when compared to normal EAE model control offspring (Zager et al. 
2015). A further study at E18 using an i.p injection of a higher dose of LPS (500ug/kg) 
confirmed this upregulation of GFAP in cortical regions and also in hippocampal regions 
of rat offspring at P8 (Cai et al. 2000). A 300ug/kg i.p maternal LPS injection at E19 and 
E20 caused astrogliosis (again measured through increase in GFAP expression) in both 
the internal and external capsule of rat offspring at P7. These astrocytes had abnormal 
morphologies, exhibiting hypertrophy, and were spread diffusely through white matter 
regions (Rousset et al. 2006). These features are consistent with white matter damage 
observed clinically in human neonates (Back and Rosenberg 2014). Taken together these 
studies strongly support the association of a number of white matter disorders with 
astrogliosis but did not investigate the effect of MIA on the astrocyte outside of this 




other astrocytic functions, for example osmoregulation, neuronal communication and 
blood brain barrier formation.  
A group of studies by Fatemi et al., utilising microarray technology to investigate the 
effect of exposure to human influenza virus induced MIA in mice is appears to be the 
only investigation in the literature into the effects of MIA on expression of astrocytic 
genes outside of the realm of astrogliosis-induced white matter damage to date. The study 
identified alternations in Aquaporin 4 (Aqp4) expression, the most prevalent member of 
the aquaporin family of water channel proteins in the CNS (Saadoun and Papadopoulos 
2010). Expression of Aqp4 is restricted to astrocyte end feet, the glia limitans, and 
ependymal cells (Yoneda et al. 2001; Saadoun and Papadopoulos 2010).  It plays a role 
in the regulation of cerebral spinal fluid (CSF) in the ventricles and deletion of Aqp4 
reduces downstream activation of intracellular signalling cascades in response to oedema 
(Thrane et al. 2011; Desai et al. 2016). Aqp4 has been implicated in the processes of 
memory consolidation and cognition as well as in the pathogenesis of Alzheimer’s disease 
and ASD (Fatemi et al. 2008a; Lan et al. 2017).   In whole brain samples of offspring of 
mothers treated with Influenza virus at E9, Aquaporin 4 (Aqp4) was found to be 
downregulated (Fatemi et al. 2005a). Aqp4 was also decreased in the hippocampus after 
E16 influenza exposure and remained so at P56 (Fatemi et al. 2009b). When analysed by 
Reverse transcription polymerase chain reaction (RT-PCR), GFAP was increased by 
influenza virus exposure at E9 suggesting astrogliosis (Fatemi et al. 2005a). GFAP levels, 
which also increased after influenza treatment at E16, remained altered at P56 (Fatemi et 
al. 2009b). Interestingly when treatment was at E18, neither GFAP nor Aqp4 were altered 
significantly in the PFC, cerebellum or hippocampus suggesting a temporal dependence 





1.3.7 MIA and Microglia 
 
1.3.7.1 Cytokines, inflammation and microglial development  
 
Microglia, unlike macroglia, originate outside the CNS (Rezaie and Male 1999; Ginhoux 
et al. 2010). Microglia are known as the immune cells of the CNS, comprising 10-15% 
of the glial cell melieu, but also play complex roles in cell survival, cell death and synaptic 
pruning during development(Lawson et al. 1992; Nayak et al. 2014; Fernandez de Cossio 
et al. 2017).   
A recent study by Matcovitch-Natan et al.  in mice has identified dynamic changes in 
gene expression which divide microglia into early microglia (E10.5-E14), pre-microglia 
(E14 – P9), and adult microglia (P28 onwards). Progression of the genetic programme 
from a proliferative focus (early microglia) to a focus on synaptic pruning and neuronal 
maturation (pre-microglia) and finally to a focus on homeostasis and surveillance (adult 
microglia) appears to be controlled by wide-spread changes in the chromatin landscape 
of the cell (Matcovitch-Natan et al. 2016). This study found that MIA with an i.p injection 
of 5mg/kg poly(I:C) at E14.5 resulted in a substantial change in gene expression and a 
premature maturation of the developing microglial cells of offspring (Matcovitch-Natan 
et al. 2016). Although not occurring during gestation, a second study has supported these 
findings by showing that an i.p injection of 330µg/kg LPS at P60 can also accelerate 
microglial maturation at the level of transcription in mice, but only in males, potentially 
the result of differing developmental trajectories of male and female microglia during 
normal development (Hanamsagar et al. 2017). This study hints once more at a potential 
explanation for the sex differences seen in certain neurological disorders like ASD and 
schizophrenia. Another study, also postnatal, has shown that subcutaneous E.Coli 
injection (0.1 × 106 CFU) in rats at P4 can cause a long-lasting alteration in microglia. 




exposure in adulthood, supporting the concept of a ‘two-hit’ hypothesis, whereby early 
exposure to immune insult exasperates the effects of secondary exposure. Minocycline, 
which prevents the activation of microglia, was sufficent to prevent this exaggerated IL-
1β response in the hippocampus (Williamson et al. 2011).  
1.3.7.2 The consequences of MIA on the developing microglia 
 
In a study at E9 a single i.p 20mg/kg poly(I:C) injection increased numbers of microglia 
in both the hippocampus and striatum at P30 as indicated by Iba1 (Ionised calcium-
binding adapter molecule 1) immunostaining of microglia in mice. Furthermore, reduced 
arborisation (branching) of microglia indicated a higher level of microglial activation in 
these regions. This result was not seen in the prefrontal cortex indicative of a regional 
effect of MIA on microglial activation (Juckel et al. 2011). Contrary to this however, 
another study, also at E9 and in mice, found that i.p injection of 8µg/kg LPS induced a 
significant increase in Iba1+ microglia in the forebrain at E18 and P0. It may be the case 
that this upregulation in the forebrain is transient and had already decreased by P30. 
Indeed, Iba1 levels were found to be higher in the forebrain of E18 embryos than P0 pups 
in this study (Le Belle et al. 2014). A further study at E9 found that i.p injection of 
20mg/kg poly(I:C)  increased microglial activity in the hippocampus, thalamus and cortex 
of offspring at P56, also analysed by Iba-1 immunohistochemistry. Interestingly 
minocycline, a broad spectrum tetracycline antibiotic known to inhibit microglial 
activation not only dampened this microglial activation in response to MIA but also 
decreased deficits in social behaviour and prepulse inhibition observed in these mice 
leading these authors to believe that microglial activation may play a key role in 
behavioural deficits associated with schizophrenia (Zhu et al. 2014).  A study by 
Mouihate et al saw no change in the number of microglia in the CC of offspring at P63-
P91 following a 100µg/kg i.p maternal LPS injection in rats at E12 (Mouihate et al. 2017). 




morphology, with microglia displaying an ameboid, more activated morphology in the 
amygdala of offspring at both P7 and P40 following an i.p 50µg/kg maternal LPS 
injection at E12 (O'Loughlin et al. 2017). 
Two studies have investigated the cytokine profile of microglia in response to MIA. In a 
study of microglial activity in the context of ASD Pratt et al. isolated CD11b+ microglial 
cells from the whole brain samples of E16 mouse embryos of mothers treated with i.p 
20mg/kg poly(I:C) injection at E12. The cytokine profiles of these cells were investigated 
by both RT-PCR and ‘Luminex’ cytokine assay. Il-6 mRNA level was found to be 
increased in response to MIA by RT-PCR, however, this result was not significant in the 
cytokine assay. The cytokine assay revealed a significant increase in expression of a 
number of cytokines (Il-1α, granulocyte-macrophage/monocyte colony-stimulating 
factor, macrophage/monocyte colony stimulating factor, IL-4 and IL-9), as well as a 
number of chemokines (eotaxin, lipopolysaccharide-induced CXC chemokine, Regulated 
on Activation, Normal T Cell Expressed and Secreted (RANTES, CCL5) and 
macrophage inflammatory protein 1β), indicating that MIA at E12 drastically alters the 
cytokine profile of microglia (Pratt et al. 2013). A microarray study after i.p 120µg/kg 
LPS treatment at E15.5 also investigated the cytokine profile of microglia in response to 
MIA. Two days later at E17.5, Il-1β, Ccl4, Ccl5, nuclear factor kappa-light-chain-
enhancer of activated B cells (Nfkb) and Stat5b were all upregulated in response to 
maternal LPS infection (Pont-Lezica et al. 2014). Importantly a study by McQuillan et 
al. has suggested that microglia obtained by cell isolation protocols may possess an 
activated phenotype, characterised by increased CD11b and CD40 expression (McQuillan 
et al. 2010). The artefactual effect of this potentially activated phenotype on the cytokine 
profile of microglia after MIA is unknown so further investigation may be necessary. 
 Offspring of rat dams which received a 4mg/kg subcutaneous poly(I:C) injection at E15 




frontotemporal cortex, CC, hippocampus, thalamus, striatum or pons between P90 and 
P104 (Missault et al. 2014). This is in contrast to another study by the same laboratory, 
which saw increased CD11b+ microglia in the hippocampus, CC and thalamus at P180 
at the same dosage and insult timing but with tail vein injection of Poly(I:C). These 
microglia did not show high reactivity to an antibody against ED-1, a marker of activated 
microglia indicating that they may have been in a transitory phase, possibly post-
activation. These immunohistochemical results were region-specific, with no increase in 
intensity of staining or number of microglia in the pons, cortex or striatum (Van den 
Eynde et al. 2014). Another study by Makinson et al. investigated the microglial number 
per gram of brain tissue using flow cytometry following 50µg/kg intrauterine LPS-
induced MIA at E15, and showed a significant increase in microglial number, and TNF-
α+ microglia cell number (Makinson et al. 2017). Delving deeper into the effects of MIA 
on microglial behaviour, a study by Fernández de Cossío et al. investigated the effect of 
MIA on microglia-mediated synaptic pruning in the hippocampus. This study found that 
male offspring of dams treated with i.p 100µg/kg LPS at E15 had an increased spine 
density in the dentate gyrus. This corresponded to decreased CX3CR1 expression by 
microglia which may affect microglial migration and synaptic pruning again pointing to 
an altered microglial phenotype (Fernandez de Cossio et al. 2017). 
Two studies have investigated the effect of MIA on microglia in late gestation. 
Intrauterine E-coli treatment at E17 resulted in an increase in ED-1 staining in the 
cingulum at P8 and P15. This increased ED-1 staining was prevented by treatment with 
anti-inflammatory cytokine IL-10 (Pang et al. 2005). In another study investigating the 
effects of MIA on an EAE model of MS in mice, primary mixed cultures were isolated 
from the whole brains of offspring of dams treated with 120µg/kg i.p injection on E17. 
Cultures isolated from the EAE model offspring showed higher Iba1 staining in response 




potential prenatal susceptibility to MS, or a ‘two-hit’ vulnerability. Flow cytometry 
analysis at P1-P3 showed an increased major histocompatibility complex class II 
(MHCII) expression in microglial cells of MIA offspring in an EAE model than control 
EAE models indicative of exacerbated gliosis (Zager et al. 2015).  
The activation of microglia in response to immune challenge is oftentimes seen as a 
contributing factor to CNS disorders. Indeed, Monji et al. have proposed a microglial 
hypothesis of schizophrenia whereby the release of cytokines and reactive species from 
activated microglia has been proposed as the main culprits in the neurodegeneration, 
white matter damage and decreased neurogenesis observed in schizophrenia (Monji et al. 
2009). This hypothesis, combined with the complex gene expression changes observed 
during microglial development, and the postnatal studies demonstrating the continued 
effects of immune activation on microglial gene expression and cytokine response, 
illustrate that changes in cytokine levels can affect the development and function of 
microglial cells in the long term. They also demonstrate that the effect of MIA on 
microglial cells requires further, more complex, investigation beyond the immediate 
detrimental effects of the activation of these cells on other cells of the CNS.  
1.4 MicroRNAs 
 
MicroRNAs (miRNAs, miRs) are small, non-coding RNAs consisting of 21-23 
nucleotides first identified in 1993 (R.C. Lee et al. 1993). MicroRNAs are negative 
regulators of gene expression, binding to their target mRNA and downregulating it post-
transcriptionally. MicroRNAs have a wide array of biological functions, including a role 
in the regulation of immune system and response to hypoxic-ischemic injury in 
oligodendrocytes (Nahid et al. 2011; Birch et al. 2014; Liu et al. 2017). The convergence 
of this capacity of microRNAs to regulate immune response and their well-documented 




thesis, where the processes of immune response and development intersect in the MIA 
model. 
1.4.1 Structure and function of microRNAs 
 
microRNAs are usually transcribed from the introns of protein coding and non protein 
coding sequences, although transcription from longer, exonic non-coding transcripts, is 
also possible (Rodriguez et al. 2004). Primary miRNA (pri-miRNA) is transcribed from 
these sequences and forms an imperfect hairpin loop, which may contain several miRNA 
transcripts. pri-miRNA is  processed by a microprocessing unit consisting of the 
ribonuclease II enzyme Drosha, and DiGeorge syndrome critical region 8 (DGCR8) to 
produce pre-miRNA (Fitzpatrick et al. 2015). Exportin 5, a member of the Karyopherin 
family, recognises the 3’ tail of pre-miRNA and exports the pre-miRNA to the cytoplasm, 
where it is further processed by dicer, another ribonuclease enzyme to produce a mature 
miRNA (Figure 1.6) (He and Hannon 2004; Y. Wang et al. 2007).  
Mature miRNAs, as a part of the RNA induced silencing complex (RISC) can bind to 
target mRNA at the 3’-UTR resulting in the downregulation of that target mRNA by 
mRNA repression, mRNA degradation or mRNA deadenylation (He and Hannon 2004; 
Eulalio et al. 2009). The type of downregulation which occurs is commonly believed to 
be dependent on sequence complimentarity between the target mRNA and the miRNA. 
It is widely accepted that in order for canonical binding to occur there must be exact 
complementarity between the ‘seed region’, nucleotides 2-7 of the miRNA, and the target 
mRNA sequence. However certain non-canonical instances of binding have been 






Figure 1.6. miRNA synthesis. In the nucleus, miRNA is transcribed by RNA polymerase 
II/III to produce pri-miRNA. Pri-miRNA is cleaved by enzymes Drosha and DGCR8 
before export into the cytoplasm by exportin 5. In the cytoplasm further processing by 
dicer produces a mature miRNA which may bind a target sequence as a part of RISC.  
1.4.2 Nomenclature 
 
MicroRNAs are often referred to by the suffix ‘miR’ followed by a number. MicroRNAs 
discovered earlier generally have lower numbers (for example miR-124 was discovered 
before miR-338). A capitalised ‘R’ references a mature miRNA while use of ‘mir’ relates 
to the immature pre- or pri-miRNAs. Identical mature miRNAs derived from different 
areas of the genome are identified by a number eg -1, -2, -3, while miRNAs derived from 
different sides of the hairpin loop are denoted as -3p or -5p. However this is only the case 
if the miRNAs are present in similar amounts. If multiple forms of the same miRNA exist 
but one is far more abundant than the other the less abundant form may be defined by an 





1.4.3 MicroRNAs and cellular development 
 
Since their discovery in 1993 microRNAs have been repeatedly identified as modulators 
of developmental processes. In the CNS these small, non-coding RNAs are implicated in 
the regulation of neurogenesis, oligodendrogliogenesis, astrogliogenesis and 
microgliogenesis. 
1.4.3.1 MicroRNAs in neurogenesis 
 
Neurogenesis is a stepwise process of NSC proliferation, migration, differentiation and 
maturation in which microRNAs are known to play a role in every step. The expression 
of miR-9, a well characterised microRNA enriched in the CNS, plays an important role 
in proliferation and differentiation. miR-9 induces differentiation of NSCs through the 
modulation of a number of downstream pro-proliferative targets including the nuclear 
receptor TLX, Sirtuin 1 (SIRT1) and Foxg1 (Shibata et al. 2008; Zhao et al. 2009; 
Saunders et al. 2010). In zebrafish miR-9 has been shown to induce neurogenesis by 
repressing hairy-related (her)-5 and her-9, fgf8, fgfr1 and canopyl while in xenopus miR-
9 downregulates Hes-1, resulting the the modulation of WNT signalling (Leucht et al. 
2008; Bonev et al. 2011). Despite this well-characterised role for miR-9 in differentiation 
during neurogenesis, a study by Delaloy et al has shown that miR-9 is upregulated 
following neural induction in human embryonic stem cells and encourages proliferation 
at this early stage (Delaloy et al. 2010). In the Xenopus study identifying Hes-1 as a target 
of miR-9, miR-9 prevented progenitor apoptosis through modulation of the p53 pathway 
through repression of Hes-1 (Bonev et al. 2011). 
miR-137 has also been identified as having a role in differentiation during neurogenesis, 
through modulation of TLX and it’s co-repressor lysine-specific histone demethylase 1 
(LSD1). Like miR-9 miR-137 also has roles in maintaining proliferation, modulating 




Epigenetic modification of miR-137 by MeCP2 and SOX2 modulated hippocampal 
neurogenesis by activating enhancer of zeste homolog 2 (Ezh2) (Szulwach et al. 2010). 
miR-124 is a nervous system specific miRNA known to have pro-neuronal properties. It 
induces neuronal differentiation through modulation of the expression of Small CTD 
Phosphatases 1 (SCP1), present in non-neuronal tissues and recruited by the 
transcriptional repressor element 1-Silencing Transcription factor (REST) to suppress 
neuronal gene expression (Visvanathan et al. 2007). miR-124 also modulates barrier-to-
autointegration factor (BAF) subunit BAF53a, allowing its replacement with BAF53b, a 
neuronal specific subunit during differentiation (Yoo et al. 2009). Sox9, necessary for 
gliogenesis is also a target of miR-124, as is Polypyrimidine tract binding protein 1 
(PTBP1), a repressor of neuronal specific splicing which is replaced by PTBP2 during 
differentiation, and ephrin-B1 (Makeyev et al. 2007; Cheng et al. 2009; Arvanitis et al. 
2010). Like miR-9 and miR-137 miR-124 can also induce proliferation in early 
neurogenic stages through targeting of basic helix-loop-helix transcription factor, 
neurogenic differentiation 1 (NeuroD1) (Liu et al. 2011). Unlike previously discussed 
miRs however it also plays a role in neuronal maturation, targeting CREB expression to 
inhibit the formation of long-term facilitation (LTF), and LIM/homeobox protein 2 to 
facilitate maturation and survival of hippocampal DG neurons (Rajasethupathy et al. 
2009; Sanuki et al. 2011). 
Other microRNAs involved in the maturation of neurons include miR-125b, which targets  
N-Methyl-d-aspartic acid (NMDA) receptor subunit NR2A in association with Fragile X 
mental retardation protein (FMRP) to enhance dendritic spine maturation. miR-128, 
targets regulator of nonsense transcripts 1 (UPF1) and cancer susceptibility candidate 3 
(CASC3), both a part of the nonsense-mediated decay (NMD), to increase dendritic 
length (Chan et al. 2007; Edbauer et al. 2010). miR-132, miR-134 and miR-138 are all 




their targets Rho GTPase activating protein 32 (ARHGAP32), LIM domain kinase 1 
(Limk1) and acyl protein thioesterase 1 (APT1) respectively (Wayman et al. 2008; Siegel 
et al. 2009; Gaughwin et al. 2011). For a complete review of the microRNAs involved in 
neurogenesis see the excellent review by (Lang and Shi 2012). 
1.4.3.2 MicroRNAs in astrogliogenesis 
 
In contrast to the role of microRNAs in neurogenesis far less is known about the role of 
these molecules in astrogliogenesis, with much of the research on microRNAs in 
astrocytes focused on the endosomal release of astrocytic miRNAs and the effect of those 
miRNAs on other cell types. That said a small number of studies have looked at the 
necessity of microRNA expression in astrogliogenesis. In a study utilising adult 
hippocampal stem cells in vitro knockout of dicer, an endoribonuclease necessary for 
microRNA biosynthesis, failed to prevent astrogliogenesis from NSCs (as identified by 
s100b), suggesting miRNAs may not be necessary for adoption of an astrocytic phenotype 
(Pons-Espinal et al. 2017). In contrast a study using primary neuronal stem cells derived 
from embryonic mouse Dicer-null cerebral cortex showed that miRNAs are necessary for 
the generation of both neurons and glia (Andersson et al. 2010). This result was supported 
in an in-vitro conditional knockout model in embryonic stem cells (ESCs), which showed 
that conditional knock out of dicer was sufficient to prevent gliogenesis when 
differentiation was induced using standard protocols. Furthermore this study found that 
reintroduction of Let-7 and miR-125 was sufficient to rescue the glial phenotype in these 
cells (Shenoy et al. 2015). A conditional knockout study using Olig1Cre/+/Dicerflox/flox mice 
to delete dicer expression in the spinal cord saw complete ablation of GFAP, S100b and 
ID3 staining in the triangular region of the spinal cord closest to the floorplate. This 
indicated that miRNAs are necessary for the development of the slit-1+ astrocytes found 
in this region, and that the role of microRNAs in astrogliogenesis may simply be more 




identified miR-31 as necessary for the terminal differentiation of astrocytes. During 
proliferation miR-31 expression is suppressed by Oct4, Sox2, Lin28 and cMyc. During 
differentiation it is activated by STAT3 and Smad1/5/8. The study confirmed that Lin28 
is a target of miR-31, and also noted that the expression of Sox2, Oct4 and cMyc was 
inversely correlated to miR-31 expression (Meares et al. 2018). 
1.4.3.3 MicroRNAs in microgliogenesis 
 
Similar to the situation in astrocytes, much of the research on the role of miRNAs in 
microglia has been focused outside of their role in microgliogenesis, instead focusing on 
maintenance of quiescence and microglial activation in response to immune activation. 
Two studies by Ponomarev et al have identified miR-124 as important in the maintenance 
of quiescence in microglia through targeting of CCAAT/enhancer-binding protein-α 
(C/EBP-α) and it’s downstream effector PU.1 (Ponomarev et al. 2011; Ponomarev et al. 
2013). Another study, also focusing on miR-124, confirmed that overexpression of miR-
124 reduced microglial motility and phagocytosis and suppression induced motility and 
phagocytic phenotypes in zebrafish (Svahn et al. 2016). Although maintenance of 
quiescence and microglial activation is of huge importance in development, and the 
adoption of a quiescent state is a marker of mature microglia in a healthy CNS, it is clear 
that much work remains to be completed in order to establish the role of miRNAs in 
microgliogenesis. 
1.4.3.4 MicroRNAs in Oligodendrogliogenesis 
 
MicroRNAs have been implicated in oligodendrogliogenesis in similar ways to 
neurogenesis, effecting the proliferation, migration, differentiation and maturation of 
oligodendroglial cells. Key microRNAs involved in oligodendrogliogenesis include miR-
9, miR-124, miR-138, miR-338 and miR-146a. The individual roles of these microRNAs 




1.5 Aims and objectives: 
 
The overall aim of this thesis is to investigate the consequences of MIA on the developing 
spinal cords of offspring. This thesis aims to delineate further the temporal and spatial 
specificity of  vulnerability to MIA,  investigate the effect of MIA on the different cell 
populations of the spinal cord, and identify the molecular fingerprint of MIA on spinal 
cord development. 
The overall objectives of this thesis are: 
1. To investigate the consequences of MIA at E12, E14 and E16 at a cellular level, 
using immunofluorescence studies to determine outcomes in the spinal cords of 
offspring both during development (5hr post MIA) and in early postnatal life 
(P14). Specifically, this thesis examines the effects of MIA on the 
oligodendrocytes, astrocytes, microglia and neurons of the cord to give a wide-
angle view of the effects of MIA on the cytoarchitecture of the developing spinal 
cord.  
2. To investigate the consequences of MIA at E12 and E16  using microarray and 
RNA Seq studies to pinpoint differential gene expression in the spinal cords of 
offspring in response to MIA, both during development and in early postnatal life. 
3. To use an in-silico study to further clarify the role of microRNAs in 
oligodendrogliogenesis, and identify miRNA targets in inflammatory pathways 
which may play a role in oligodendroglial response to MIA. 
































2.1 Time mating and maternal immune activation 
 
Time mated, pregnant, Sprague Dawley rats were obtained from the Biological Services 
Unit at University College Cork, Ireland under full ethical approval (DoH license 
B100/4485 with AEEC approval 2012/037). Presence of a vaginal plug confirmed 
pregnancy and was designated as E0. Dams were housed throughout the experiment on a 
12h light/dark cycle (light on 0800h) under a constant temperature of 21± 2̊C and had ad 
libitum access to food and water. To induce maternal immune activation, pregnant dams 
received a single i.p injection of either 50µg/kg or 100µg/kg E.Coli 026.B6 LPS (Sigma-
Aldrich, Ireland) on E12, E14 or E16. Control animals received a single i.p injection of 
100µl of a 0.9% saline injection on E12, E14 or E16. (Figure. 2.1)  
 
Figure 2.1 Schema of the time mating protocol. Dams received an injection of either 
50µg/kg or 100µg/kg LPS on E12, E14 or E16. For embryonic experiments, sacrifice 





2.2 Tissue collection and processing 
 
2.2.1 Tissue collection for embryonic study 
 
Dams assigned to the embryonic study were anesthetised with pentobarbital and 
decapitated 5h post injection. Embryos were harvested by laparotomy and placed in ice-
cold HANKS’ Balanced salt solution (HBSS; Sigma-Aldrich, Ireland). Embryos assigned 
to immunohistochemical studies were submerged whole (E12 embryos) or decapitated 
(E14 and E16 embryos) in 4% paraformaldehyde (PFA) solution overnight (O.N) at 4̊C. 
Fixed embryos were then immersed in 30% sucrose for cryoprotection before snap 
freezing and storage at -80̊C. Embryos assigned to molecular studies were micro-
dissected in ice-cold HBSS to isolate the spinal cord. Isolated cords were stored at -80̊C 
until use. 
2.2.2 Tissue collection for postnatal study 
 
Dams assigned to the postnatal study continued through pregnancy without further 
intervention after injection. P14 pups were sexed, and assigned at random to either 
immunohistochemical or molecular studies. Pups assigned to the immunohistochemical 
studies were anesthetised by i.p injection of pentobarbital and transcardally perfused with 
10mM phosphate buffered saline (PBS) followed by 4% PFA solution. Spinal cords were 
post-fixed in 4% PFA O.N and were then immersed in 30% sucrose for cryoprotection. 
Cords were divided evenly into roughly rostral, middle and caudal tissues for storage at -






2.2.3 Gelation coating of slides 
 
1.5g gelatin was added to 500ml dH2O which was then heated to 60̊C and stirred until 
gelatin was dissolved. 0.25g of chromium (III) potassium sulfate dodecahydrate was 
added to the gelatin solution. When this was dissolved the gelatin solution was cooled to 
~45̊C and racked microscope slides were submerged for 1 min. Excess solution was 
tapped off and slides were placed in slide boxes to dry, and stored at ambient temperature 
prior to use. 
2.2.4 Cryosectioning 
 
Both whole embryos and P14 spinal cords were transversely sectioned at 15µm using a 
cryostat (Lecia Microsystem GmbH, Wetlzar, Germany). Sections of E12, E14 and E16 
embryos were collected on gelatin-coated slides in a non-serial manner and were stored 
at -80̊C until required. The length of the E14 and E16 embryonic spinal cords were 
estimated through complete sectioning of one representative embryo. These data were 
used to establish sectioning boundaries for rostral, middle and caudal tissue (Figure 2.2). 
In P14 samples the total length of the spinal cord was measured in each animal and used 
to establish sectioning boundaries for rostral, middle and caudal tissue. Rostral tissue was 





Figure 2.2 Sectioning protocol for E14 and E16 embryonic tissue. Waste tissue was 







Figure 2.3 Sectioning protocol for postnatal studies. Spinal cords from P14 animals 
were divided into rostral middle and caudal regions as in embryonic studies. The rostral 
cord was then further subdivided into ‘rostral’, ‘middle’, and ‘caudal’ sections with waste 
discarded in between sections to establish sectioning boundaries. 
2.3 Immunohistochemical staining 
 
2.3.1 Immunofluorescent staining 
 
Slides were removed from the -80̊C freezer and dried for 30min at 37̊C. Slides were then 
rehydrated in 10mM PBS (3 x 5 min washes) before incubation in blocking solution (5% 
donkey serum, 0.4% Triton X in 10mM PBS) for 1 h at room temperature (RT). After 1 
h excess blocking solution was removed and slides were incubated in primary antibody 
solution (2.5% donkey serum, 0.1% triton X, primary antibody as required (Table 2.1), 




before incubation in secondary antibody solution (2.5% donkey serum, 0.1% triton X, 
Alexafluor secondary antibody as necessary (Table 2.1), in 10mM PBS) for 2 h at RT for 
all protocols except Reelin staining where incubation was 2.5h at RT.  Slides were rinsed 
with 10mM PBS (4 x 6 min) and incubated with bisbenzimide solution (1:5000) for 3 
min. Slides were rinsed again with 10mM PBS (3 x 10 min) and mounted with 
fluoromount G (Affymetrix/eBiosciences, Cheshire, United Kingdom). See table 2.2 for 
a full list of solutions and Figure 2.4 for a graphical protocol. 
During co-localisation investigations the above methodology was adapted to allow for 
double staining. Following incubation with the first primary antibody and appropriate 
secondary antibody, slides were washed (4x6min) and returned to blocking solution for 
30 min at RT. The staining procedure was then repeated to completion for the desired 
second target.  
 











































































































Table 2.1. Primary and secondary antibody details. Concentrations and catalogue 
numbers of all antibodies used in immunofluoresence protocols. Conc – Concentration, 







Solution Ingredients  
PBS (10X) 80g of NaCl 
2.0g of KCl 
14.4g of Na2HPO4 
2.4g of KH2PO4 
1L Distilled H2O  
Wash Solution 1X (10mM) PBS 
Blocking Solution 5% Donkey Serum 
0.4% Triton X 
10mM PBS as required 
Primary Antibody Solution 2.5% Donkey Serum 
0.1% Triton X 
Primary antibody at desired concentration 
10mM PBS as required 
Secondary Antibody Solution 2.5% Donkey Serum 
0.1% Triton X 
Secondary antibody at 1:200 
concentration 
10mM PBS as required 
Counterstain Bisbenzimide 1:5000 
10mM PBS as required 
 
Table 2.2: Solutions used in immunofluoresence protocols.  
 
2.3.2 Quantification of immunofluorescent staining  
 
All samples were imaged on an Olympus IX83 research inverted microscope using a 
DP80 digital microscope camera (Olympus, Japan). All analysed images were in TIFF 
format, and taken at magnification 20x using the monochrome sensor. Images were post-
coloured where necessary using the Cell Sens Dimensions software (Olympus, Japan). 
All image post-processing and analysis was carried out using the Fiji imagej distribution 
package (Schindelin et al. 2012). Statistical analysis of the numeric output of image 
analysis was competed using Graphpad Prism version 5.0 for Windows (GraphPad 
Software, La Jolla California USA). Representative controls for all staining may be found 




2.3.2.1 Olig2 analysis 
 
In E12 samples, images spanning the entirety of the spinal cord were randomised and the 
number of olig2+ cell nuclei in whole transverse sections of the spinal cord were counted 
using the ‘cell counter’ add-on in Fiji. Rostral, middle and caudal cord were identified 
anatomically as described in section 2.2.4 The average number of olig2+ nuclei for 4, 
non-serial, rostral, middle and caudal slices of the same cord was recorded. In both E14 
and E16 samples representative images of the dorsal, intermediate and ventral white 
matter and dorsal and ventral grey matter were obtained (Fig 2.5). The images were 
randomised and the number of olig2+ nuclei in a known volume of tissue for each region 
was recorded (Fig 2.5), again using the cell counter add-on for Fiji. The average value 
across 4 non-serial sections was recorded for each region in individual animals.  
In postnatal samples representative images of dorsal, intermediate and ventral white 
matter and dorsal and ventral grey matter were obtained (Figure 2.6). The images were 
randomised and the number of Olig2+ nuclei for a known volume of tissue was again 
recorded for each region of each animal (Figure 2.6). The number of Olig2+ nuclei for 






Figure. 2.5 Schematic representation of the sampling strategy in the E14 and E16 
spinal cord. WD – white dorsal, WI – white intermediate, WV – white ventral, GD – 








Figure. 2.6 Schematic representation of the sampling strategy in the P14 spinal cord. 
WD – white dorsal, WI – white intermediate, WV – white ventral, GD – grey dorsal, GV 
– grey ventral. 
2.3.2.2 MBP 
 
The presence of MBP in postnatal samples was analysed by fluorescence intensity 
analysis again using Fiji. The background was subtracted from each image using the 
sliding paraboloid function on Fiji. The image was then duplicated. On one image the 
region of interest (ROI) was selected. These consisted of a 200x200µm region in the 
dorsal white matter (fasciculus gracilis), a 250x250µm region in the intermediate white 
matter (dorsolateral funiculus), and a 150x150µm region in the ventral white matter 
(spanning the anterior cortical spinal and reticulospinal tracts). In the grey matter the 
regions of interest included a 300x150µm region in the substantia gelatinosa, a 
250x250µm region in the dorsal grey matter (~ nucleus intermediolateralis) and a 
250x250µm region in the ventral horn grey matter. The selected ROI was measured and 




autothreshold ‘Triangle’ in the case of the substantia gelatinosa and dorsal horn or ‘Otsu’ 
in the case of all other regions measured. The areas of the ROI reaching threshold were 
selected and the mean grey matter fluorescence intensity measured by redirecting the 





In E12 samples representative images of  whole tranverse sections of the spinal cord were 
obtained. These images were randomised and the number of Iba-1+ cells possessing a 
clear nucleus was counted by eye. The average number of Iba-1+ cells present was 
recorded for four, non-serial sections of each spinal cord in rostral, middle and caudal 
regions. In E16 samples representative images of the dorsal, intermediate and ventral 
white matter and dorsal and ventral grey matter were obtained from rostral, middle and 
caudal regions (see Figure 2.5). These images were randomised and, using the ‘cell-
counter’ add-on in Fiji, the number of iba-1+ cells with a visible nucleus was counted in 
each region for four non-serial sections of each cord. The average for each region was 
recorded. Similarly, in P14 cords, images of the same representative regions were 
obtained (see Figure 2.6). Cells were counted in the same manner and the average 
recorded. 
2.3.2.4 GFAP  
 
GFAP expression was analysed in randomised postnatal samples by fluorescence 
intensity analysis. Randomised images were input into Fiji, the background was 
subtracted from the image using the sliding paraboloid function, and the image was 
duplicated. The ROI was selected on the original image and measured. The area outside 




function. ‘Triangle’ was identified as a suitable threshold for the grey matter regions, 
while ‘moments’ was identified as suitable for white matter analysis. Once the suitable 
threshold was applied to the ROI the areas of the ROI which reached the threshold were 
selected. This selection was applied to the duplicate image, which remained unaltered 
beyond background subtraction, and the average grey matter value in arbitrary units for 
the areas meeting threshold was recorded. These values were recorded for each region of 
interest in 4, non-consecutive, slices of spinal cord for each animal and averaged. Once 
analysis was complete the samples were identified and saline and test compared using 




In E12 samples reelin staining was scored in randomised samples in a semi-quantitative 
manner. In E16 studies reelin fluorescence intensity was analysed in the total grey matter 
of cord slices using Fiji. Randomised greyscale images were input into Fiji and 
duplicated. In this instance the ROI was identified as the whole spinal cord and selected 
and the area was measured. The area outside the ROI was then excluded, and the ROI 
was filtered using a Guassian blur to remove tiny areas of inappropriately high 
fluorescence. The ROI was thresholded using the auto-threshold ‘max entropy’. The area 
of the ROI reaching threshold was then selected, and measured in arbitrary units by 
redirection to the unaltered, duplicate image. The resulting figures underwent two way 
ANOVA in Graphpad prism followed by a bonferonni post hoc analysis. In P14 samples 
representative images of the dorsal horn and the dorsolateral grey matter were 
randomised. The number of cells in the superficial dorsal horn and in the dorsolateral grey 




counter’ add-on in Fiji. The average across the slices was recorded. Reelin co-localisation 
was analysed by observation in the P14 spinal cord. 
2.4 RNA extraction and yield determination 
 
2.4.1 Total RNA extraction 
 
Embryonic spinal cords for RNA extraction were pooled, with six individuals from a 
single litter forming one sample due to small tissue quantities. For postnatal samples, total 
RNA was extracted from the rostral ends of individual postnatal spinal cords. Total RNA 
was extracted using the miRvana miRNA isolation kit (Life Technologies/ Thermofisher, 
Massachusetts, United States) as per manufacturer’s guidelines. Briefly, samples were 
submerged, frozen, in RNAlater-ICE (Thermofisher, Massachusetts, United states) for 
48h at -20ᵒC. On removal, samples were submerged in lysis/binding buffer and 
homogenised before miRNA homogenate additive was added. Acid-Phenol:chloroform 
was used for RNA extraction and the aqueous phase was recovered. 1.25 volumes of 
100% EtOH at RT was added to the retrieved aqueous phase. The lysate/EtOH solution 
was then passed through a glass-fibre spin column and washed. Total RNA was eluted in 
100µl of 95ᵒC nuclease-free H2O. The total RNA was stored at -80ᵒC. 
2.4.2 Quality and yield determination 
 
The concentration of each sample of total RNA was measured using a SpectroStar Nano 
plate reader (BMG Labtech, USA). 2µl of total RNA from each sample was pipetted onto 
a clean evaluation (EV) plate. The exact concentration of RNA was determined with the 
following formula:  
 




where A260 is the maximum wavelength at which DNA and RNA absorb light. The purity 
of the RNA samples was measured using the A260/A280 value where A280 is the maximum 
wavelength at which proteins absorb light. Values ~2.0 (at minimum >1.8) indicated pure 
RNA. The overall quality of the RNA was confirmed through non-denaturing agarose gel 
electrophoresis. 1µg of total RNA sample was separated on the gel and distinct 22S and 
18S bands without smearing indicated good quality RNA. 
 
2.5 RNA expression studies 
 
2.5.1 Microarray expression profiling  
 
RNA extracted from the pooled spinal cords of offspring 5h post treatment of dams with 
either saline or 100µg/kg LPS at either E12 or E16 were sent for microarray analysis by 
Source Bioscience (Nottingham, UK). Each experimental group (E12 saline, E12 LPS, 
E16 saline and E16 LPS) consisted of  3 independent litters (n=3).  Briefly, total RNA 
was quality controlled using both Nanodrop and Aglient bioanalyser technologies before 
fragmentation and hybridisation to an affymetrix Gene Chip Rat Gene 2.0 S.T array. 
Samples were washed and stained, an image was acquired and image analysis completed. 
Analysis of the raw data was completed by Source Bioscience. Raw data underwent 
quantile normalisation to eliminate low-level signals and ensure reproducible analysis. A 
design matrix was set up and a linear model used to summarise the data from each 
condition replicate into a single value. Using moderated t-statistics with empirical Bayes 
shrinkage, array quality weights were produced to check the relative reliability of each 
array. The variance measured how well the expression values from each array followed 
the linear model. The variances in each case were converted to relative weights and use 




the power to detect differential expression (adjusted P-value (adjP) <0.07). Differentially 
expressed genes were annotated with their gene symbol, Entrez ID and gene name. Gene 
symbols were entered into the STRING database of protein-protein interactions to 
identify any potential interactions and pathways of interest (Szklarczyk et al. 2015). A 
review of the literature was completed to identify each gene and the potential function of 
each gene during development. 
2.5.2 RNASeq 
 
RNA samples extracted from the spinal cords of P14 offspring of dams treated with either 
saline or 100µg/kg LPS at either E12 or E16 were sent for RNASeq by Source Bioscience 
(Nottingham, UK). Each experimental group (E12 P14 saline, E12 P14 LPS, E16 P14 
saline and E16 P14 LPS) consisted of  3 animals, 1female and 2 males, from three 
different litters (n=3). Briefly, samples underwent QC upon arrival before library 
preparation using Illumina TruSeq stranded mRNA prep technology. The samples were 
quality controlled using the Aligent bio-analyser to confirm a RNA integrity number (rin) 
>8.0  before pooling and sequencing on the Illumina HiSeq4000 on one lane at 50bp 
single-end read. 
 
2.5.3 RT qPCR ASSAY 
 
 Real-time quantitative PCR (RT qPCR) was carried out to confirm differential expression 
of genes in the E16 P14 100μg/kg LPS treatment group.  
Using a SuperScript™ VILO™ cDNA Synthesis Kit (Thermofisher, Massachusetts, 
United states) cDNA was synthesised from total RNA according to the manufacturer’s 
guidelines. 1µg of total RNA was reverse transcribed in a 20µl reaction volume. 




performed in technical triplicate on a 384 well plate with a 5µl reaction volume per well. 
Each plate contained a positive control and a non-template control to monitor for plate 
contamination and ensure plate continuity. qPCR was carried out on the QuantStudio 7 
Flex Machine (Applied Biosystems) using Taqman Universal  Master Mix II, no UNG 
(biosciences, Ireland) and appropriate Taqman gene assays (Biosciences, Ireland; Table 
2.2). The experiment was designed and the results recorded on the Quantstudio RT-PCR 
software (Applied Biosystems). Briefly, after incubation at 95̊C for 10 minutes 40 cycles 
of PCR were completed. This involved heating the reactions to  95° 15 seconds to enable 
melting before 1 minute at 60̊C for annealing and extension. Threshold values were 
recorded for each reaction well. All probes used were fluorescein amidite (FAM) – 
labelled and results were normalised to the geometric mean of three appropriate, pre-
defined, housekeepers, Ubc, B2M and GAPDH, as identified using the Normfinder add-
in for excel (http://moma.dk/normfinder-software). Data was analysed using the 
comparative cycle threshold (CT) method (2-∆∆cT method) where: 
 
2-∆∆CT =[(CT gene of interest – CT internal control)sample A minus 










Gene symbol Name Assay ID 
Cat Catalase Rn00560930_m1 
Txnip Thioredoxin Interacting Protein  Rn01533891_g1   
Pmvk Phosphomevalonate Kinase  Rn01462515_m1 
Pex11a Peroxisomal Biogenesis Factor 11 Alpha Rn00585152_m1 
Spag7 Sperm Associated Antigen 7  Rn01460477_m1 
Idi1 Isopentenyl-Diphosphate Delta Isomerase 1 Rn00585526_m1 
Pxmp4 Peroxisomal Membrane Protein 4  Rn00597183_m1 
Scara3 Scavenger Receptor Class A Member 3 Rn01762953_m1 
Kif19 Kinesin Family Member 19 Rn01470721_m1 
Fzd9 Frizzled Class Receptor 9  Rn00596271_s1 
Snca Alpha Synuclein  Rn00569821_m1 
S1pr1 Sphingosine-1-Phosphate Receptor 1  Rn02758712_s1 
Mcam Melanoma Cell Adhesion Molecule Rn00576900_m1 
Pla2g3 Phospholipase A2 Group III Rn01442987_m1 
Ppp1r10 Protein Phosphatase 1 Regulatory Subunit 10  Rn00576196_m1 
Emcn Endomucin Rn01521919_m1 
Slco1c1 Solute Carrier Organic Anion Transporter 
Family Member 1C1 
Rn00584891_m1 
Tnfrsf11a TNF Receptor Superfamily Member 11a  Rn04340164_m1 
Sh3bgrl SH3 Domain Binding Glutamate Rich Protein 
Like  
Rn01753977_m1 
Ubc Ubiquitin C Rn01789812_g1 
B2m Beta-2 microglobulin Rn00560865_m1 





Table 2.3: TaqMan®Gene expression assays (Biosciences, Ireland) and ID numbers 
for all genes identified as differentially regulated in RNASeq analysis of P14 spinal cords 
post 100μg/kg LPS treatment at E16 
2.6 Bioinformatic analysis 
 
2.6.1 Literature review 
 
A literature review investigating the current understanding of the role of miRNAs in 
oligodendrogliogenesis was completed. Pubmed 
(http://www.ncbi.nlm.nih.gov/pubmed/) was searched using the advanced search 
function with ‘fields’ set to ‘title/abstract’. Search terms included: 
‘oligodendrogliogenesis’, ‘oligodendrocyte’, ‘development’, “oligodendrocyte 
development”, “white matter”, ‘miRNA’, ‘microRNA’, ‘miR’, ‘miRs’ and “micro 
RNA”. Using the results the miRNAs most commonly associated with 
oligodendrogliogenesis were identified. Of these the six most frequently referenced 
were selected for further analysis.  
2.6.2 miRECORDS 
 
miRecords, an open source resource, amalgamates eleven miRNA-target interaction 
prediction programs. These programs are used to computationally predict interactions 
between miRNA and the genome, most often through seed region complementarity, but 
also using evolutionary conservation, thermostability of the miRNA-mRNA duplex, and 
the presence of an unmatched region among other strategies for prediction. The 
program, available at http://c1.accurascience.com/miRecords/prediction_query.php, was 




miRNA targets predicted by one or more of the miRNA-target interaction prediction 
programs was generated. This was downloaded for further analysis. 
2.6.3 Webgestalt 
 
Enrichment analysis of the miRNA targets identified using miRecords was completed 
using Webgestalt (http://bioinfo.vanderbilt.edu/webgestalt/), a free-to-use, web-based 
gene set analysis toolkit. Gene symbols of previously predicted miRNA targets were 
imported and compared to the entrez protein coding database for rattus norvegicus. 
Gene ontology (GO) analysis was carried out using hypergeometric testing utilising the 
Benjamini- Hochberg (BH) procedure for multiple hypothesis testing to control for false 
discovery rate. P<0.01 was deemed significant enrichment in all instances.  
2.6.4 String analysis 
 
The miR targets contained within GO categories most relevant to the study were 
imported into STRING (http://string-db.org/), an open source database for the analysis 
of protein-protein interactions, to identify pathways potentially targeted by miRNAs 
during oligodendrogliogenesis. Analysis was completed at the highest confidence score 
of interaction. The analysis was first completed with disconnected nodes, (predicted 
targets of the miR that did not interact with another predicted target) removed to 
identify targeted pathways of interest. ‘White nodes’ (computer-generated nodes 
representing proteins that were not present in the predicted target list but serve as 
connection points for multiple predicted targets) were then introduced to counteract the 
removal of relevant pathways due to lack of immediate connection between identified 
nodes in that pathway. Pathway-related filtering of predicted targets served to reduce 






Figure 2.7 Schematic representation of study methodology. Arrows indicate the 




























Chapter 3. The effect of MIA on the 





3.1 Chapter Abstract  
 
CNS white matter has been recognised as being particularly vulnerable to the effects of 
inflammation for  a number of years, resulting in devastating conditions such as cerebral 
palsy and periventricular leukomalacia.  
This chapter investigates the immediate effects of MIA on the white matter of the 
developing spinal cord at E12 and E16 as well as the effects of MIA at these time points 
at P14 using immunofluorescence studies of the pan-oligodendrocyte marker Olig2 and 
the myelin marker MBP. 
MIA with 100µg/kg LPS at E12 was found to have no measurable effect on Olig2+ cell 
number in the spinal cord 5h post injection. In contrast MIA at E16 was found to 
decrease the number of Olig2+ cell nuclei in the spinal cord 5h post injection. At P14 
the number of Olig2+ cell nuclei was decreased in the ventral grey matter of the cord 
following MIA at E12 suggesting a delayed effect of MIA at this time point. Conversely 
no change in the number of Olig2+ cell nuclei was seen in the P14 spinal cord after 
MIA at E16 suggesting recovery from the immediate effect of MIA at E16. There was 
no change in MBP expression in the P14 spinal cord following MIA at E12 or E16. 
These results indicate that E16 may be a specific period of early vulnerability of white 
matter to MIA, and that the spinal cord may be able to compensate in some way for 
these gross early changes. The results also suggest that MIA at E12 may result in 









It is understood that the white matter of the CNS is particularly vulnerable to 
inflammation, and that the developing oligodendrocyte specifically is extremely 
susceptible to damage (Volpe et al. 2011). Inflammation during gestation has been well 
documented as resulting in devastating disorders such as PVL and CP. Retrospective 
studies in humans, as well as work in animal models has suggested that gestational 
inflammation may also be linked to changes in white matter related to 
neurodevelopmental disorders such as autism and neuropsychiatric disorders such as 
schizophrenia. Such disorders are believed to have, at least to some extent, a 
developmental origin (Brown et al. 2004b; Buka et al. 2008; Brown 2012; Fatemi et al. 
2012; Makinson et al. 2017). This chapter investigates the effect of MIA at E12and E16 
on white matter development in the spinal cord, focusing specifically on the cellular 
consequences of MIA through immunofluorescence studies of Olig2 and MBP. 
Olig2 is a basic helix-loop-helix transcription factor expressed by different cells of the 
CNS in a time dependent manner. Olig2 is a master regulator, and is expressed by all 
oligodendrocyte progenitor cells. It is therefore considered a key marker of these cells 
during development. Use of Olig2 as a marker is particularly advantageous to the study 
of oligodendrocyte proliferation and migration during development due to its distinct 
nuclear expression. 
As Olig2 is a key regulator of the oligodendrocyte lineage, developmental expression of 
the transcription factor is synonymous with oligodendrocyte emergence and migration, 
which is well characterised in the spinal cord. However, it is important to note that before 
Olig2 expression in OL progenitors begins, Olig2 is expressed by developing MNs. Both 
MNs and the vast majority of OLs in the spinal cord arise from a specific region of the 




an MN to OL switch, which is mediated by the temporal expression of sulfatase 1 (Sulf1) 
which activates SHH expression and subsequent OL proliferation around E12.5 in mice 
or E14 in rats (Timsit et al. 1995; Touahri et al. 2012). 
Ventrally derived Olig2 positive oligodendrocytes arise in the pMN and migrate laterally 
and dorsally to populate the spinal cord during development. These OLs account for 
roughly 85% of the OL population in the spinal cord. The remaining 15% of OLs are 
dorsally derived and also express Olig2. Unlike their ventrally derived counterparts, 
specification of dorsal OLs is Shh-independent, with dorsally derived OL specification 
relying on the expression FGF and other local factors. Dorsally derived OLs emerge in 
mice from E15 (~E16.5 in rats) (Fogarty et al. 2005; Richardson et al. 2006). 
In contrast to Olig2 MBP expression is more diffuse and begins much later in 
development. Studies utilising MBP in this chapter allow investigation of the effect of 
MIA on myelination in the developing spinal cord. 
MBP is the second most abundant component of CNS myelin, comprising 30% of all 
myelin proteins (Doyle 1978; Moscarello 1997). It is the only myelin protein essential to 
CNS myelin formation (Moscarello 1997). Shiver mutants, a naturally occurring MBP 
mutant in which most of the gene is deleted, show an almost complete lack of compact 
myelin (Readhead et al. 1990). Similarly the Long Evans shaker rat, which possesses a 
mutation causing aberrant MBP transcription, also lacks compact myelin (Carre et al. 
2002). MBP is a multifunctional protein with roles in cell signalling, cytoskeletal 
dynamics, and regulation of other myelin gene expression (Readhead et al. 1990; Dyer et 
al. 1995; Staugaitis et al. 1996). MBP has four major isoforms in humans, 21.5, 20.2, 
18.5, and 17.2 kilodalton (kDa), and 6 known isoforms in mice 21.5, 20.2, 18.5, 17.24, 




common isoform in mice and rats is 14 kDa (Boggs 2006). Some isoforms of MBP can 
enter the nucleus and can therefore alter transcription. 
MBP expression in the rostral spinal cord of the immature rat begins at P1, in the ventral 
funiculus. MBP expression spreads in a mosaic fashion thereafter, appearing in the 
fasciculus cuneatus and ventro-lateral funiculus at P2, and the fasciculus gracilis and 
dorso-lateral funiculus between P3 and P4. MBP first appears in the cortical spinal tract 
at P11 and the Lissauer tract as late as P14. MBP expression in the grey matter begins 
between P11 and P14 (Schwab and Schnell 1989). Temporal and spatial differences in 
MBP isoform expression have been recorded in the immature rat. The 18.5 kDa and 14 
kDa isoforms are reportedly restricted to the plasma membrane while the 21.5 kDa and 
17kDa isoforms may enter the cytosol and nucleus (Allinquant et al. 1991). Furthermore 
the 14 kDa isoform is highly expressed during active myelination becoming the most 
abundant isoform in the adult. Expression of the 14.0-kDa and 18.5-kDa MBP isoforms 
occurs approximately one week earlier in the cerebellum and spinal cord than in the 
cerebrum (Akiyama et al. 2002). 
This chapter aims to investigate the effect of MIA on the white matter of the developing 
spinal cord in a comprehensive manner. Firstly, the study examines the effect of MIA on 
the development of oligodendrocytes themselves, by way of olig2 immunofluorescence. 
Careful regional investigation allowed for investigation of the effect of MIA on more 
subtle parameters such as oligodendrocyte positioning in the developing spinal cord, as 
well as more robust measures such as oligodendrocyte cell number. Secondly the study 
investigates the potential effects of MIA on a function of these cells, namely myelination 
of the spinal cord, by analysing MBP expression in postnatal animals. It should be noted 
that some of the microscopic images contained within this thesis have been brightened 





3.3 Chapter aims 
 
The objective of this study was: 
1. To investigate the immediate early effects of maternal LPS injection at either E12 
or E16 on oligodendrocyte emergence and migration in the embryonic rat spinal 
cord 
2. To investigate the effects of maternal LPS injection at either E12 or E16 on 
oligodendrocytes of the P14 rat spinal cord 
3. To examine the postnatal effects of maternal LPS injection at E12 or E16 on MBP 








3.4.1 Characterisation of Olig2+ cell distribution in the embryonic spinal cord 
during normal development at E12 and E16; and following MIA at E12 and 
E16 
 
3.4.1.1 Olig2+ cell distribution in the E12 spinal cord in normal development, and 
post MIA with 100µg/kg LPS 
 
During normal development Olig2+ cell nuclei are expressed in the rostral, middle, and 
caudal regions of the spinal cord at E12. In the rostral E12 cord olig2+ nuclei are largely 
restricted to the pMN of the VZ from which they arise (Figure 3.1 (A)). Olig2+ nuclei are 
expressed in higher numbers in the intermediate E12 cord, and are not restricted to the 
pMN, occupying much of the ventral spinal cord although higher numbers are still visible 
in the VZ (Figure 3.1 (B)). Olig2+ cell nuclei numbers were highest in the caudal spinal 
cord, occupying the entirety of the ventral spinal cord (Figure 3.1 (C)).  
Following MIA at E12 Olig2+ cell nuclei number per unit volume was examined in whole 
cord slices. No change in the number of Olig2+ cell nuclei was identified in rostral, 
middle or caudal cord sections 5h after MIA with 100µg/kg LPS at E12 (Figure 3.2, 







Figure 3.1 Characterisation of Olig2+ cell distribution in the E12 spinal cord. At E12 
small numbers of Olig2+ cells are visible in the VZ of the ventral spinal cord at rostral 
levels (A, arrow). Olig2+ cell number increases in the VZ and surrounding ventral cord 
at intermediate level (B, arrow). At the caudal level of the E12 spinal cord large numbers 
of Olig2+ cells are present throughout the ventral spinal cord (C, arrows). 
 
 
Figure 3.2 Olig2+ cell number is not decreased in the E12 spinal cord 5h post MIA 
with 100μg/kg LPS (P>0.05 in all instances). A statistical analyses was performed using 




of variance (ANOVA) and groups were compared using Bonferroni multiple comparison 
post hoc analysis.  (N= 6 Saline, N=5 LPS)  
 
3.4.1.2 Olig2+ cell distribution in the E16 spinal cord in normal development, and 
post MIA with 100µg/kg LPS 
 
During normal development Olig2+ cell nuclei are present in the rostral, middle, and 
caudal regions of the spinal cord at E16. In the rostral E16 spinal cord olig2+ cells have 
migrated out of the pMN and the VZ to occupy the whole spinal cord. Olig2+ cell nuclei 
are visible in large numbers in the intermediate grey and white matter as well as the 
ventral grey and white matter (Figure 3.3 (B)). Smaller numbers of Olig2+ nuclei are 
visible in the dorsal grey and white matter (Figure 3.3 (A)). In the caudal spinal cord 
Olig2+ cell nuclei are still largely restricted to the VZ although migration is underway 
and a number of olig2+ nuclei are visible in the dorsal grey matter (Figure 3.3 (C, D)). 
Following MIA at E16 with 100µg/kg LPS Olig2+ cell number per unit volume was 
examined in five distinct regions of the spinal cord and compared to control animals. 
These regions included the dorsal and ventral grey matter and the dorsal, ventral and 
intermediate white matter. Significantly fewer Olig2+ nuclei were observed in the dorsal 
grey matter (P<0.001), ventral grey matter (P<0.01), ventral white matter (P<0.01) and 
intermediate white matter (P<0.001) of the rostral spinal cord of offspring at E16 
following MIA with 100µg/kg LPS 5h previously (Figure 3.4 (A-D)). With the exception 
of the ventral grey matter, where the number of Olig2+ cell nuclei decreased in middle 
regions of the spinal cord (P<0.05) (Figure 3.4 (B)), these decreases were not observed 
in middle and caudal regions of the spinal cord. No decrease in the number of Olig2+ cell 




the same conditions (Figure 3.4(E)). The dorsal white matter of the caudal cord was not 
examinable at this age. 
In addition to the 100µg/kg LPS study at E16, a preliminary study using a single litter, 
investigating the effect of MIA at E16 with 50µg/kg LPS on the spinal cords of offspring 
after 5h was also completed. This study saw no significant difference in the number of 






Figure 3.3 Characterisation of Olig2+ cell distribution in the E16 spinal cord. At E16 
Olig2+ cells have migrated out of the pMN domain and the VZ to populate the rostral 
spinal cord (A, B). Olig2+ cells can be found in the ventral grey and white matter and 
intermediate grey and white matter (B). Smaller numbers can be observed in the dorsal 
grey and white matter as migration is ongoing (A). In the caudal spinal cord Olig2+ cells 




(C,D). Very few cells are present in the white matter of the caudal cord at this time. GM 

























Figure 3.4 Olig2+ cell number is decreased in the dorsal grey matter (A, P<0.001), 
ventral grey matter (B, P<0.01), ventral white matter (C, P<0.01) and the 
intermediate white matter (D, P<0.001) of the rostral region of the E16 spinal cord 
5h post MIA with 100μg/kg LPS. With the exception of the ventral grey matter where 
olig2+ cell number decreased in  middle regions of spinal cord (B, P<0.05)  these effects 
were not observed in the middle and caudal regions of the spinal cord. No decrease in the 




Olig2+ cell number was not decreased in the E16 spinal cord 5h post MIA with 50µg/kg 
LPS (P>0.05). Statistical analyses was performed using Graphpad prism 5. The 
differences between groups were determined by one-way analysis of variance (ANOVA) 
and groups were compared using Bonferroni multiple comparison post hoc analysis. (N= 
6 Saline, N=5 LPS, * =P<0.05, ** = P<0.01, ***= P<0.001) 
 
3.4.2 Characterisation of Olig2+ cell distribution in the postnatal spinal cord 
during normal development; and following MIA at E12 and E16 
 
3.4.2.1 Olig2+ cell distribution in the P14 spinal cord during normal development 
 
Olig2+ cell distribution was examined in the rostral region of the spinal cord at P14. By 
P14 Olig2+ cell nuclei have migrated throughout the rostral cord occupying the grey and 
white matter in their entirety (Figure 3.5). 
 
Figure 3.5 Characterisation of Olig2+ cell distribution in the P14 spinal cord.  By 





3.4.2.2 Olig2+ cell number in the P14 spinal cord following MIA with 100µg/kg LPS 
on E12 or E16 
 
Olig2+ cell number per unit volume was examined at P14 in the rostral spinal cord of 
offspring of dams exposed to MIA (100µg/kg LPS) at E12. Olig2+ cell number was 
examined in four regions, the dorsal and ventral grey matter and the intermediate and 
ventral white matter. The number of olig2+ cell nuclei was found to be decreased in the 
ventral grey matter of P14 offspring spinal cord after MIA at E12 (P<0.01) (Figure 3.6 
(A)). No decreases were observed in the dorsal grey matter or the intermediate and ventral 
white matter (P>0.05 in all instances) (Figure 3.6 (A,B)). The number of Olig2+ nuclei 
in the dorsal white matter was not examinable in a statistically robust way in these 
samples. 
Olig2+ cell nuclei number per unit volume was also examined at P14 in the rostral spinal 
cord of offspring of dams exposed to the same dose of LPS at E16. Olig2+ cell number 
was examined in the same 4 regions, the dorsal and ventral grey matter and the 
intermediate and ventral white matter. Olig2+ cell number was unchanged in the dorsal 
and ventral grey matter (Figure 3.7 (A)) and in the intermediate and ventral white matter 
(Figure 3.7(B)) of the rostral P14 spinal cord of offspring following MIA with 100μg/kg 








Figure 3.6 Olig2+ cell number is decreased in the ventral grey matter of the rostral 
spinal cord of P14 offspring following MIA with 100μg/kg LPS at E12 (A, P<0.01) . 
Olig2+ cell number was unchanged in the dorsal grey matter and in the intermediate and 
ventral white matter (A,B, P>0.05 in all instances) The differences between groups were 
determined by one-way analysis of variance (ANOVA) and groups were compared using 
Bonferroni multiple comparison post hoc analysis. GM – Grey matter, WM – White 
matter. (N =6 Saline, N=5 LPS, * =P<0.05, ** = P<0.01, ***= P<0.001) 
 
Figure 3.7 Olig2+ cell number was unchanged in the dorsal and ventral grey matter 
(A) and in the intermediate and ventral white matter (B) of the rostral P14 spinal 
cord of offspring following MIA with 100μg/kg LPS at E16 (P>0.05 in all instances). 
The differences between groups were determined by one-way analysis of variance 
(ANOVA) and groups were compared using Bonferroni multiple comparison post hoc 





3.4.3 Characterisation of MBP expression in the postnatal spinal cord during 
normal development; and following MIA at E12 and E16 
 
3.4.3.1  MBP expression in the P14 spinal cord during normal development 
 
MBP expression was examined in the rostral region of the spinal cord at P14 by mean 
fluorescence intensity analysis. At P14 MBP is expressed throughout the spinal cord 
(Figure 3.8 (A)). MBP+ longitudinal fibres are visible in the dorsal horn, traversing the 
characteristically myelin-devoid  substantia gelatinosa  (Figure 3.8 (B)). Bundles of 
MBP+ axons are evident in the dorsal grey matter (Figure 3.8 (C)). MBP is expressed 
throughout the white matter (although still at lower levels in the cortical spinal tract) 





Figure 3.8 Characterisation of MBP expression in the P14 spinal cord. MBP is 
expressed throughout the rostral P14 spinal cord (A). MBP+ longitudinal (B) and 




the white matter of the spinal cord (D) as well as in the ventral grey matter (E). MBP – 
myelin basic protein. Scale bar 200µm (A), 50µm (B-E) 
 
3.4.3.2 MBP expression in the P14 spinal cord following MIA with 100µg/kg LPS on 
E12 or E16 
 
At E12, mean fluorescence intensity of MBP was unchanged in the dorsal white matter, 
intermediate white matter and ventral white matter of the P14 spinal cord of offspring 
following MIA. Mean fluorescence intensity of MBP was  unchanged in the longitudinal 
and transverse fibres of the grey matter, as well as the ventral grey matter of the P14 
spinal cord (Figure 3.9, P>0.05 in all instances) 
Mean fluorescence intensity of MBP was also unchanged in the same regions of the P14 
spinal cord of offspring following MIA with 100µg/kg LPS on E16 (Figure 3.10, P>0.05 
in all instances) 
 
Figure 3.9 MBP mean fluorescence intensity was unchanged in grey matter (A) and 
white matter (B) of the rostral P14 spinal cord of offspring following MIA with 
100μg/kg LPS at E12 (P>0.05 in all instances). The differences between groups were 
determined by one-way analysis of variance (ANOVA) and groups were compared using 




matter, LF – longitudinal fibres, TF – transverse fibres, AU – arbitrary units. (N= 6 Saline, 
N=6 LPS except dorsal WM where N=5) 
 
Figure 3.10 MBP mean fluorescence intensity was unchanged in grey matter (A) and 
white matter (B) of the rostral P14 spinal cord of offspring following MIA with 
100μg/kg LPS at E16 (P>0.05 in all instances). The differences between groups were 
determined by one-way analysis of variance (ANOVA) and groups were compared using 
Bonferroni multiple comparison post hoc analysis.  GM – Grey matter, WM – white 
matter, LF – longitudinal fibres, TF – transverse fibres, AU – arbitrary units. (N= 6 Saline, 
N=6 LPS) 
 















 E12 E16 
5H - ↓ 
P14 ↓ - 
 
Table 3.1 Summary table of the results of embryonic and postnatal Olig2 
investigation. Olig2+ cell number was not decreased in the E12 offspring spinal cord 5h 
after maternal injection with 100µg/kg LPS. Olig2+ cell number was decreased in the 




conditions. Olig2+ cell number was decreased in the dorsal and ventral grey matter and 
intermediate and ventral white matter of the rostral spinal cord of offspring 5h after 
100µg/kg maternal LPS injection at E16. Olig2+ cell number was not decreased in the 
rostral spinal cord under the same conditions at P14. E – embryonic day, P – postnatal 
day 
 















 E12 E16 
P14 - - 
 
Table 3.2 Summary table of the results of the postnatal MBP investigation. MBP 
mean fluorescence intensity was unchanged in the rostral P14 spinal cords of offspring 
following 100µg/kg maternal LPS injection on either E12 or E16. E – embryonic day, P 














It has been established that oligodendrocytes are particularly vulnerable to the effects of 
inflammation during development, resulting in devastating disorders like PVL and CP 
(Volpe et al. 2011). In investigating the effect of MIA on oligodendrocyte progenitors 
during key gestational windows this study has demonstrated once again the susceptibility 
of these cells to inflammation in the form of MIA. This study has also demonstrated that 
the effects of MIA on oligodendrocytes are temporally and spatially dependent. 
The first study investigated the early effect of MIA induced by a single i.p 100µg/kg LPS 
injection on Olig2+ cell number and migration in the E16 spinal cord of offspring. 
Previous studies in our own laboratory and others have indicated that changes in gene 
expression are evident and measurable as early as 4h post MIA (Garbett et al. 2012; 
Oskvig et al. 2012; Park et al. 2018), O’Loughlin EK unpublished data.  This study 
identified a decrease in Olig2+ cell number per unit volume in four of the five regions of 
interest, specifically the dorsal and ventral grey matter and the intermediate and ventral 
white matter, 5h post MIA by LPS injection (Figure 3.4). Interestingly, these decreases 
were only evident in the rostral spinal cord of offspring, and were not observed in the 
middle and caudal regions with the notable exception of the ventral grey matter of middle 
spinal cord in which the decrease in Olig2+ cells were also noted. Decreases in Olig2+ 
cell number in the ventral grey matter of the rostral spinal cord were among the most 
statistically striking (P<0.0001). This is perhaps to be expected as the region of interest 
included the pMN, the region of the VZ from which olig2+ cells arise, and surrounding 
VZ. Newly born Olig2+ cells populate the VZ before migrating further dorsolaterally. 
The noted decrease in Olig2+ cell number in the ventral grey matter of the middle spinal 
cord region suggests that MIA can also affect the number of olig2+ cell nuclei in the 




inclusion of the pMN and surrounding VZ in that area, as olig2+ cell nuclei are still 
largely restricted to these regions in middle samples at E16. This effect of MIA is lost in 
the less developmentally mature caudal cord. 
The development of the spinal cord has been well characterised previously and displays 
a distinct rostro-caudal gradient, with the rostral spinal cord being the most 
developmentally mature. The spinal cord becomes progressively less mature as one 
investigates middle and caudal spinal cord (Schwab and Schnell 1989; Hajihosseini et al. 
1997; Nakayama et al. 1999).  The loss of the effect of MIA on Olig2 expressing cells 
identified in the E16 spinal cord as we move down the rostro-caudal axis demonstrates 
how precise the window of developmental vulnerability to MIA truly is, with MIA 
effecting only the more mature rostral tissue at E16.  
Previous studies have also investigated the effect of MIA around the E16 time point on 
oligodendrocyte development. A large study by Fatemi and colleagues identified 
decreases in white matter markers such as MBP, MOBP, MOG, MAL and PLP1 in the 
hippocampus of P0 offspring following MIA with a sublethal dose of H1N1 at E16 in 
mice (Fatemi et al. 2009a). An E15 study in rats meanwhile saw dams receive a 4mg/kg 
injection of Poly(I:C) and identified decreases in MBP and Rhombex29 that were 
measurable in the prefrontal cortex at P120 (Farrelly et al. 2015). A further study in E15 
mice saw decreases in MBP levels in the corpus callosum of offspring 28 weeks 
postnatally following a 50µg/kg LPS injection to induce MIA. The same study found that 
this was not true of the anterior commissure where no change in MBP levels was observed 
at the 28 week time point, another indication of the spatial dependence of the effects of 
MIA on white matter development (Makinson et al. 2017).  
Although variables such as time, type and dosage of immune insult as well as location of 




around the E16 time point has an effect on white matter development. This study is the 
first to investigate the early effects of MIA on white matter development, utilising the 5h 
time point, and is the only study in the literature to have investigated these effects using 
the marker Olig2 at this gestational point. This study suggests that E16 presents a specific 
window of vulnerability during which the emergence and subsequent migration of OL 
progenitors may be hindered by MIA, and that this effect is spatially dependent in the 
spinal cord. 
The embryonic study also investigated the early effects of MIA at E12 at the 5h time 
point. The study again utilised a single i.p injection of 100µg/kg LPS to induce MIA. This 
study found no significant difference in the number of olig2+ cell nuclei per unit volume 
in whole spinal cord sections 5 h after MIA at E12 (Figure 3.2).  
Just one study in the literature has investigated the effect of MIA on white matter at E12 
previously. In that study the authors used the same dose (100µg/kg LPS) to induce MIA 
as in this study, but only observed effects in the corpus callosum. They found that NG2 
and MBP were increased at P2 and P63—91 respectively, indicative of the very different, 
yet seemingly still susceptible cellular and molecular environment at E12 (Mouihate et 
al. 2017). It may be the case that Olig2 expression is unchanged at this time point in the 
E12 spinal cord. Indeed, a study at E9.5 in mice identified a transient decrease in MBP 
expression in the hippocampus of offspring following a 60mg/kg poly(I:C) injection, but 
no change in the level of Olig2 expression (Manabu Makinodan et al. 2008). 
The study of Olig2 expression in the E12 spinal cord is complicated by the rostro-caudal 
gradient of cord development. This study identified larger numbers of olig2+ cell nuclei 
in the middle and caudal sections of the E12 cord than in the developmentally more 
mature rostral sections, this was potentially due to observation of the MN to OL switch 




the VZ responsible for producing 85% of spinal cord oligodendrocytes, contains olig2+ 
motor neuron precursors. Before oligodendrocyte production can begin the region must 
undergo an MN to OL switch. This appears to be regulated by the temporal expression of 
sulf1 which activates the SHH expression necessary for ventral OL proliferation at around 
E12.5 in mice (Touahri et al. 2012). This timing is consistent with the observed higher 
numbers of caudal oligodendrocytes in this study, although this cannot be verified without 
co-staining with a marker of early motor neurons. 
The co-expression of Olig2 by two different cell types identified in this study in different 
regions of the same tissue at the E12 time point indicates that Olig2 may not be an 
effective marker for the investigation of the effect of MIA on white matter development 
at this time point. Future work could utilise markers such as NG2 or PDGFRα to mark 
progenitor cells, or a combination of olig2 and SOX10 to mark all oligodendrocytes in 
order to mitigate this issue. Despite this it is clear from the literature that further 
investigation of the effects of MIA at this early time point in development are needed to 
clarify how vulnerable the white matter is to MIA at this time. 
To further the investigation into the effects of 100µg/kg maternal LPS injection at E12 or 
E16 on the development of the white matter of the spinal cord of offspring, the prolonged 
effect of MIA on the P14 offspring spinal cord was investigated. In these experiments 
dams received the same single i.p injection of LPS or saline that dams in embryonic 
experiments did but were allowed to give birth naturally, with pups subsequently 
sacrificed at P14.  
In the E16 study at the 5h time point there was a significant decrease in the number of 
Olig2+ cell number per unit volume in the dorsal and ventral grey matter and the 
intermediate and ventral white matter of the rostral spinal cord following 100µg/kg LPS 




of Olig2+ nuclei in the rostral P14 spinal cord in any of the four regions examined (P>0.05 
in all instances) (Figure 3.7). 
As previously outlined, the existing literature suggests that during the gestational period 
around E16 white matter is particularly vulnerable to the effects of MIA. Multiple studies 
have shown decreases in a number of white matter markers, most notably MBP (Fatemi 
et al. 2009a; Farrelly et al. 2015; Makinson et al. 2017), but also MAG, MAL, MOBP, 
MOG, (all (Fatemi et al. 2009a)) CNP (Makinson et al. 2017) and Rhombex29 (Farrelly 
et al. 2015). Many of these decreases are persistent, with one mouse study at E15 showing 
a decrease in MBP that was still present in the corpus callosum at P196, twenty-eight 
weeks after birth, following a 50µg/kg LPS injection (Makinson et al. 2017). Notably, a 
human influenza study at E16 in mice showed decreases in the white matter markers 
MBP, MAG, MAL, MOBP MOG and PLP1 in the hippocampus and cerebellum that were 
still present at P14 (Fatemi et al. 2009a). No studies in the literature have investigated the 
effects of MIA at E16 using Olig2. It may be the case that changes are simply more subtle 
than a change to gross Olig2+ cell number. 
The unchanged Olig2+ cell number in this postnatal study following MIA at E16 may be 
in line with existing literature, which suggests that programmed cell death, or apoptosis 
of oligodendrocyte cells, is a normal part of the developmental process (Caprariello et al. 
2015). It may be the case that this programmed apoptosis is responsible for realigning the 
number of olig2+ cells in controls and MIA exposed spinal cords. If so, it may mask the 
early decrease observed in oligodendrocyte cell number and result in the unchanged 
number of Olig2+ cell nuclei observed at P14. An unchanged cell number at P14 does not 
preclude more subtle change such as those recorded in other studies of individual white 
matter markers, indeed the early decrease in Olig2+ cell number at 5h, and subsequent 
recovery at P14, may provide an interesting clue as to the mechanisms underlying some 




Despite unchanged Olig2+ cell number at the 5h time point following 100µg/kg LPS 
injection at E12, a decrease in the Olig2+ cell number per unit volume was observed in 
the ventral grey matter of the rostral spinal cord at P14 following E12 maternal LPS 
injection (P<0.01, Figure 3.6). This seemingly delayed effect of MIA on oligodendroglial 
cell number suggests a different mechanism by which the LPS is effecting the Olig2+ 
cells, perhaps indirectly or further upstream of the oligodendrocyte itself, perhaps at the 
level of progenitor. 
This study also investigated the mean fluorescence intensity of MBP following MIA at 
E12 and E16 to further elucidate the effect of MIA on the white matter of the postnatal 
spinal cord. No significant change in MBP expression in the spinal cords of offspring was 
observed following MIA at E12 or E16 (Figure 3.9, 3.10). This result suggests the 
decreased number of Olig2+ cell nuclei in the ventral grey matter of the P14 rostral spinal 
cord following MIA at E12 is likely not linked to changes in MBP expression. This result 
is also contrary to the only study which has investigated the effect of MIA at E12 in which 
MBP was shown to increase at P63-90 following MIA with 100µg/kg LPS although this 
study was performed in the corpus callosum and spatial differences may apply (Mouihate 
et al. 2017). Interestingly another study, consisting of three consecutive injections of 
1.0mg/kg at E9, E13 and E17 in rats showed decreased MBP expression in the corpus 
callosum at P56 (K. Kim et al. 2014).  
This study has identified E16 as a gestational period of vulnerability in white matter 
development. The decrease in the number of Olig2+ cells as early as 5h after LPS 
injection suggests a rapid effect on the emergence and subsequent migration of Olig2+ 
cells in the spinal cord. The apparent restriction of this change to the rostral spinal cord 
illustrates the spatial dependence of the cellular effects of MIA even in a single region 
like the spinal cord, and the complexity of the cellular consequences of MIA. However, 




where no decrease in the number of olig2+ nuclei was observed in the rostral spinal cord 
of offspring. As previously mentioned this may be due to developmental apoptosis 
masking the effect, or simply a recovery. Olig2+ cell number may not be the best 
measurement of the effect of MIA on oligodendrocytes postnatally when migration is 
complete, apoptosis has occurred, and oligodendrocytes are mature and myelinating. This 
is addressed in the subsequent immunofluorescent study of the effect of MIA on MBP 
expression at P14, arguably a much more sensitive reading of the more subtle effects of 
MIA on the postnatal oligodendrocyte. However, no changes in MBP expression were 
observed by fluorescence intensity analysis at P14 following MIA at either E12 or 
E16.This again, may be due to recovery of the oligodendrocytes or compensation for early 
changes in oligodendrocyte number by other oligodendrocytes during the myelination 
process. Regardless, the identification of an immediate effect of MIA on developing 
oligodendrocyte number provides an important clue as to the mechanisms underlying the 
effect of MIA on white matter. Future research may address this with careful regional 
analysis of further white matter markers at embryonic stages, and other markers of 
myelination at P14.  
The apparent failure of maternal LPS injection to produce an immediate effect on the 
number of olig2+ cells in the E12 cord is a clear example of the importance of the 
gestational timing of an inflammatory insult to the effect of that insult. While E16 appears 
to be a gestational window of immediate vulnerability for oligodendrocytes, at least in 
the more rostral cord, the E12 spinal cord was seemingly unaffected 5h after LPS 
injection. This contrast between the E12 and E16 gestational windows continued 
postnatally where a decrease in the number of Olig2+ cell nuclei in the ventral grey matter 
of the rostral P14 cord was visible following E12 maternal LPS injection but not E16, 
indicative of a delayed response to injection at E12 which is distinctly different. 




of this delayed response. Future work will further delineate the cellular and molecular 
mechanisms underlying this delay. It may also be prudent to look at the effect of MIA on 
olig2+ cell number at the 5h time point following MIA at E17/E18, specifically in the 
middle and caudal spinal cord regions which were mostly unaffected by MIA at E16. This 
thesis however aims to investigate the effect of MIA across multiple cell populations, and 































Chapter 4. The effect of MIA on the 















4.1 Chapter Abstract 
 
Microglia and astrocytes are key cells in the structure and function of the CNS, with roles 
in immune response, synaptic pruning and maintenance and osmoregulation.  
 This chapter investigates the effect of MIA at E12, E14 and E16 on the microglia and 
astrocytes of the developing spinal cord through immunofluorescence studies of Iba-1 
and GFAP respectively. It focuses on the consequences of MIA on these cells themselves, 
rather than the downstream consequences of the activation of these cells on other cells of 
the CNS. 
MIA with 100µg/kg LPS at E16 was found to decrease the number of Iba-1+ cells in the 
spinal cord 5h post injection. This decrease was not observed at P14. MIA at E12 did not 
change the number of Iba-1+ cells in the spinal cord 5h post injection or at P14. A 
preliminary study using a single litter suggested the MIA at E14 may reduce the number 
of Iba-1+ cells 5hr post injection. GFAP expression was found to be unchanged at P14 
following MIA at either E12 or E16. 
These results suggest that E16 is a specific period of early vulnerability in the microglia 












Astrocytes and microglia are the key players in the normal function of the CNS. 
Responsible for processes such as water and ion balance, synapse formation and 
phagocytosis, they are often the cells at the forefront of CNS response to inflammatory 
insult. Astrogliosis and microglial activation are necessary cellular behaviours for 
immune system function. However, these inflammatory processes can result in the release 
of cytokines, chemokines and other intercellular signalling factors which may damage or 
otherwise change the developing CNS. 
Iba-1 is a 17kDa EF hand calcium binding protein. In the CNS Iba-1 is expressed 
specifically by microglial cells, the resident immune cells of the central nervous system 
(Imai et al. 1996; Ito et al. 1998). The gene encoding the Iba-1 protein, Allograft 
inflammatory factor 1 (AIF-1) is located in the MHCIII region of human chromosome 6 
(Imai et al. 1996). Iba-1 is also expressed by circulating macrophages (which may be 
detected in the CNS during development), meningeal macrophages, circumventricular 
organ macrophages, and macrophages of the choroid plexus. Despite this, microglia 
remain the majority of the Iba-1 positive cells in the CNS (Perry and Teeling 2013).  
Research by our laboratory and others has shown that Iba-1 levels rise in the CNS in 
response to nerve injury, IL-1b induced inflammation and LPS administration (S.C. Lee 
et al. 1993; Ito et al. 1998; Cai et al. 2000; O'Loughlin et al. 2017). This increase in Iba-
1 in response to inflammatory factors identifies Iba-1 as a marker not only of CNS 
resident immune cells, but also as an effective measure of the activation of these immune 
cells in response to immune activation. 
Microglia, unlike macroglia, originate outside the CNS, and arise from CD45+ cKit- 
erythromyeloid progenitors in the yolk sac. The CX3CR1+ sub-population of these 




sole source of all microglia following blood brain barrier formation (Ajami et al. 2007; 
Ginhoux et al. 2010; Schulz et al. 2012; Kierdorf et al. 2013; Gomez Perdiguero et al. 
2015). Microglia are believed to have several routes of entry into the CNS, including via 
the peripheral vasculature, the meninges, the choroid plexus, the ventricles and central 
canal, and, in later development, via the CNS blood vessels (Boya et al. 1991; Navascues 
et al. 2000; Monier et al. 2007; Rigato et al. 2011; Cunningham et al. 2013). Once present 
in the CNS, microglia migrate to their final destination where they mature and self-renew 
into adult life (Ajami et al. 2007).  
In the human spinal cord, the presence of microglia can be identified by week 9 of 
gestation (Rezaie et al. 1999). These cells are present largely in the ependymal layer and 
are associated with developing GFAP+ RGCs in the region. Microglial influx into the 
spinal cord via the developing white matter  is highest in the dorsal and ventral white 
matter (Rezaie et al. 1999). In a study by Rigato et al. microglia have been shown to begin 
to invade the parenchyma of the mouse spinal cord at E11.5, reaching the spinal cord 
through the peripheral vasculature. Over the course of development microglia were 
shown to aggregate close to the central terminals of dorsal root ganglia neurons 
undergoing developmental apoptosis (E12.5) and within the lateral motor columns where 
motor neurons were undergoing developmental apoptosis (E13.5). Microglia were shown 
to interact with GFAP+ cells and growing capillaries of the parenchyma at E13.5, and 
were randomly distributed within the parenchyma by E15.5 (Rigato et al. 2011).  
Glial fibrillary acid protein (GFAP) is a type III intermediate filament protein found in 
astrocytes and ependymal cells of the CNS (Jacque et al. 1978; Roessmann et al. 1980; 
Reeves et al. 1989). GFAP has been mapped to human chromosome 17q2 (Bongcam-
Rudloff et al. 1991). The function of GFAP in astrocytes appears to be diverse. GFAP 
has been demonstrated to add structural support to astrocytes themselves as well as to 




functionally impaired in GFAP knockout studies (Liedtke et al. 1996; Gomes et al. 1999; 
Gimenez et al. 2000). GFAP knock out is also known to have a detrimental effect on 
oligodendrocytes resulting in white matter destruction and impaired myelination (Liedtke 
et al. 1996; Gimenez et al. 2000). GFAP is also known to play a role in mitosis, with 
phosphorylated GFAP present in the cleavage furrow of cells (Sekimata et al. 1996; 
Kawajiri et al. 2003). GFAP is intimately involved in cell-cell communication processes, 
specifically astrocyte-neuron communication (Weinstein et al. 1991). GFAP, although 
preferentially expressed in white matter astrocytes, is an effective marker of both fibrous 
and reactive astrocytes allowing for a broad study of the effects of MIA on the astrocytic 
populations of the postnatal spinal cord (Bignami et al. 1972; Cahoy et al. 2008). 
In the spinal cord, the neurogenic to astrocytogenic switch is reported to occur at E12.5 
in mice (Deneen et al. 2006). Upon specification astrocyte progenitor cells undergo 
migration from the VZ to the intermediate zone where they undergo proliferation (Ge et 
al. 2012). On reaching their final location, astrocytes mature and become functional 
during the postnatal stages of development. Astrocytes, including those in the spinal cord, 
appear to be a diverse cell type with a number of subtypes (Hochstim et al. 2008; Tsai et 
al. 2012). In the spinal cord, Hochstim et al. identified three positionally distinct types of 
white matter astrocyte which can also be defined by their relative expression of Reelin 
and Slit1 (Reelin+ Slit1-, Reelin- Slit1+ or Reelin+ Slit1+). These subtypes arise from 
homeobox domains expressing Pax6 and Nkx6.1 respectively, which work in a 
combinatorial manner to specify subtype localisation in the spinal cord white matter 
(Hochstim et al. 2008). 
This chapter investigates the effects of MIA on microglia and astrocyte expression in the 
embryonic and postnatal spinal cords of offspring using a mixture of cell counting 
techniques and fluorescence intensity analysis. Comment is made on the microglial 




potential consequences of MIA directly on these cell types is addressed. . It should be 
noted that some of the microscopic images contained within this chapter have been 





















4.3 Chapter aims 
 
The objective of this study was: 
1. To investigate the early effects of maternal LPS injection at either E12, E14 or 
E16 on microglial colonisation of the embryonic rat spinal cord and to investigate 
the effect of LPS injection on subsequent microglial distribution in the embryonic 
rat spinal cord. 
2. To investigate the effects of LPS injection at either E12 or E16 on the microglia 
of the P14 rat spinal cord 
3. To investigate the effects of maternal LPS injection at either E12 or E16 on the 


















4.4.1 Characterisation of Iba-1+ cell distribution in the embryonic spinal cord 
during normal development at E12, E14 and E16; and following MIA at E12 
and E16 
 
4.4.1.1 Iba-1+ cell distribution in the E12 spinal cord in normal development and 
post MIA  with 100µg/kg LPS 
 
At E12 Iba-1+ cells are sparsely present in the rostral, middle and caudal spinal cord 
[Figure 4.1, A and Figure 4.2 (<10 Iba-1+ cells per whole cord slice in all instances)]. 
Higher numbers of Iba-1+ cells are present per unit volume in the more developmentally 
mature rostral spinal cord, with progressively lower numbers present in the middle and 
caudal spinal cord (Figure 4.2). Iba-1+ cells can be observed in the tissues surrounding 
the E12 spinal cord and on the pial surface (Figure 4.1, B). These cells, and those found 
within the parenchyma of the spinal cord, are largely amoeboid in shape (Figure 4.1, C). 
Following MIA with 100µg/kg LPS Iba-1+ cell number per unit volume was examined 
in whole cord slices of the E12 rostral, middle and caudal spinal cord. No change in the 
number of Iba-1+ cells was observed in the spinal cords of offspring 5hr after MIA when 





Figure 4.1 Characterisation of Iba-1+ cell distribution in the E12 Spinal cord. Iba-
1+ cells are expressed sparsely in the E12 middle spinal cord (A). Iba-1+ cells can be 
observed in the pial tissues surrounding the spinal cord (B, arrows). Iba-1+ cells present 
in the E12 spinal cord are largely ameboid in shape (C, arrows). D = dorsal, V = ventral, 





Figure 4.2 Iba-1+ cell number per unit volume was not altered in the rostral, middle 
or caudal spinal cord 5h after 100µg/kg maternal LPS injection at E12. The 
differences between groups were determined by one-way analysis of variance (ANOVA) 
and groups were compared using Bonferroni multiple comparison post hoc analysis.  
P>0.05 in all instances. (N= 6 Saline, N=6 LPS) 
 
4.4.1.2 Iba-1+ cell distribution in the E14 spinal cord in normal development and 
post MIA with 50µg/kg LPS 
 
At E14 Iba-1+ cells are present throughout the rostral, middle and caudal regions of the 
spinal cord. As in the E12 spinal cord, higher numbers of Iba-1+ cells are present per unit 
volume in the more developmentally mature rostral spinal cord with successively lower 
numbers in the middle and caudal spinal cord (Figure 4.4 A-D). Iba-1+ cells are most 
dense in the presumptive white mater of the rostral E14 spinal cord and along the pial 
layer (Figure 4.3, A, C, Figure 4.4 A-D). Iba-1+ cells are present in the central canal (CC) 
of the E14 rat spinal cord (Figure 4.3, B). The morphology of Iba-1+ cells in the E14 cord 




of cells (Figure 4.3, A, arrow), however amoeboid cells remain present (Figure 4.3, A, 
asterisks). 
Following MIA with 50µg/kg LPS Iba-1+ cell number per unit volume was examined in 
the dorsal and ventral grey and white matter of the rostral, middle and caudal regions of 
the E14 spinal cord. The number of Iba-1+ cells per unit volume was decreased 5h after 
MIA in the dorsal grey matter of the rostral spinal cord (Figure 4.4, A, P<0.05), the dorsal 
white matter of the rostral and caudal spinal cord (Figure 4.4, B, P<0.01 and P<0.05 
respectively), and the ventral white matter of the rostral spinal cord (Figure 4.4, D, 
P<0.05). The number of Iba-1+ cells remained unchanged in all other instances when 







Figure 4.3 Characterisation of Iba-1+ cell distribution in the E14 spinal cord. Iba1+ 
cells have colonised the parenchyma of the spinal cord by E14 and possess a more 
ramified phenotype although amoeboid Iba-1+ cells remain present (A, arrows). Iba-1+ 
cells can be identified in the presumptive white matter (C) and in the central canal (B). D 
= dorsal, V= ventral, SC = spinal cord, CC = central canal, magnification = 20x (A, C), 





Figure 4.4 Iba-1 expression is decreased at E14 5h post maternal injection with 
50ug/kg LPS in the dorsal grey matter of the rostral spinal cord (P<0.05, A), the dorsal 
white matter of the rostral and caudal spinal cord (P<0.01 and P<0.05 respectively, C), 
and the ventral white matter of the rostral spinal cord (P<0.05, D). There were no changes 
in Iba-1 expression in the ventral grey matter of the spinal cord (B). The differences 
between groups were determined by one-way analysis of variance (ANOVA) and groups 
were compared using Bonferroni multiple comparison post hoc analysis. (N=5 saline, 
N=6 LPS, single litter experiment.) 
 
4.4.1.3 Iba-1+ cell distribution in the E16 spinal cord in normal development and 
post MIA  with 100µg/kg LPS 
 
At E16 Iba-1+ cells are present throughout the rostral, middle and caudal regions of the 
spinal cord. Once again, the number of Iba-1+ cells per unit volume follows the rostro-
caudal gradient of spinal cord development, with more cells present in the rostral spinal 
cord and successively fewer in the middle and caudal spinal cord (Figure 4.6). Iba-1+ 




processes (Figure 4.5, A). Localised regions of microglial activation can be observed in 
some individuals in the E16 spinal cord as illustrated by an amoeboid phenotype (Figure 
4.5, C). In the caudal region Iba-1+ cells can still be observed in the CC of some E16 
spinal cord sections (Figure 4.5, B). These cells have largely migrated out of the CC in 
more rostral regions (Figure 4.5 A). 
5h post MIA at E16 with 100µg/kg LPS Iba-1+ cell number per unit volume was 
examined in the dorsal and ventral grey and white matter of the rostral, middle and caudal 
spinal cord. The number of Iba-1+ cells per unit volume decreased in the dorsal grey 
matter of rostral and middle spinal cord (Figure 4.6, A, P<0.001 and P<0.05 respectively), 
the dorsal white matter of rostral and middle spinal cord (Figure 4.6, B, P<0.01), the 
ventral grey matter of rostral, middle and caudal regions of the spinal cord (Figure 4.6, 
C, P<0.001), and the ventral white matter of rostral, middle and caudal regions of the 






Figure 4.5 Characterisation of Iba-1+ cell distribution in the E16 spinal cord. At E16 
the majority of Iba-1+ cells in the rostral spinal cord display a ramified morphology 
(A,arrows). In the caudal cord Iba-1+ cells continue to be observed in the central canal 
(B, arrow). Evidence of localised microglial activation as identified by amoeboid-like 
morphology of motile, phagocytic microglia, can be seen in some samples (C, arrow). D 
= dorsal, V = ventral, SC = spinal cord, CC = central canal, magnification = 20x, scale 





Figure 4.6 Iba-1+ cell number per unit volume is significantly decreased in the E16 
spinal cord 5h post MIA with 100ug/kg LPS in the dorsal grey matter of the rostral and 
middle spinal cord (P<0.001 and P<0.05 respectively, A), the dorsal white matter of the 
rostral and middle spinal cord (P<0.01, B), the ventral grey matter of the rostral middle 
and caudal spinal cord (P<0.001, C), and the ventral white matter of the rostral and middle 
and caudal spinal cord (P<0.001 rostral and middle cord, P<0.05 caudal cord, D). The 
differences between groups were determined by one-way analysis of variance (ANOVA) 
and groups were compared using Bonferroni multiple comparison post hoc analysis.  









4.4.2 Characterisation of Iba-1+ cell distribution in the rostral P14 spinal 
during normal postnatal development; and following MIA at E12 and E16 
 
4.4.2.1 Iba-1+ cell distribution in the P14 spinal cord during normal postnatal 
development 
 
At P14 Iba-1+ cells have populated the grey and white matter of the rostral spinal cord in 
its entirety (Figure 4.7, A). These cells display the ramified morphology of mature 
microglial cells (Figure 4.7, B) and display an activated, amoeboid-like phenotype in 
response to localised inflammation (Figure 4.7, C). 
 
Figure 4.7 Characterisation of Iba-1+ cell distribution in the P14 spinal cord. By P14 
Iba-1+ cells have populated both the grey and white matter (A). Microglia display the 




activation are visible in some samples (C, arrow). Magnification = 20x, scale bar = 200µm 
(A), scale bar = 20µm (B), scale bar = 50 µm (C) 
 
4.4.2.2 Iba-1+cell number in the P14 spinal cord following MIA with 100µg/kg LPS 
on E12 or E16 
 
At P14 the number of Iba-1+ cells per unit volume was unchanged in the dorsal and 
ventral grey matter and the intermediate and ventral white matter of the rostral spinal cord 
following MIA with 100µg/kg LPS at E12. Iba-1+ cell number was not counted in the 
dorsal white matter of these sections due to tissue damage during processing (Figure 4.8 
A, B, P>0.05 in all instances). 
The number of Iba-1+ cells per unit volume was also unchanged in these regions at P14 
following MIA with 100µg/kg LPS at E16. Again, Iba-1+ cell number was not counted 
in the dorsal white matter of these sections due to tissue damage during processing (Figure 
4.9 A, B, P>0.05 in all instances). 
 
Figure 4.8 Iba-1+ cell number is unaltered in the dorsal and ventral grey matter (A), 
and the intermediate and ventral white matter (B), of the rostral P14 spinal cord 
following maternal 100µg/kg LPS injection at E12. The differences between groups 




using Bonferroni multiple comparison post hoc analysis.  P>0.05 in all instances. (N=6 
Saline, N=5 LPS) 
 
Figure 4.9 Iba-1+ cell number is unaltered in the dorsal and ventral grey matter (A), 
and the intermediate and ventral white matter (B), of the rostral P14 spinal cord 
following maternal 100µg/kg LPS injection at E16. The differences between groups 
were determined by one-way analysis of variance (ANOVA) and groups were compared 
using Bonferroni multiple comparison post hoc analysis. P>0.05 in all instances. (N=6 
Saline and LPS) 
 
4.4.3 Characterisation of GFAP expression in the rostral P14 spinal cord 
during normal postnatal development; and following MIA at E12 and E16 
 
4.4.3.1 GFAP expression in the P14 spinal cord during normal postnatal 
development 
 
At P14 GFAP+ cells have populated the entirety of the grey and white matter of the spinal 
cord (Figure 4.10, A). In the grey matter GFAP+ cells displayed the stellate shape of 
protoplasmic astrocytes (Figure 4.10, B, arrow). Astrocytes of the white matter were 






Figure 4.10 Characterisation of GFAP expression in the P14 spinal cord. By P14 
GFAP is expressed in both the protoplasmic astrocytes of the grey matter (B, arrow) and 
the fibrous astrocytes of the white matter, the processes of which extend into the cord (C 
and D, arrows). GM = grey matter WM = white matter, magnification = 20x, scale bar = 








4.4.3.2 GFAP expression in the P14 spinal cord following MIA with 100µg/kg LPS 
on E12 or E16 
 
At P14 GFAP expression was examined using fluorescence intensity analysis in the 
dorsal, intermediate and ventral white matter, and the dorsal and ventral grey matter, of 
the rostral spinal cord. There was no significant difference in GFAP fluorescence intensity 
following MIA with 100µg/kg LPS at E12 (Figure 4.11, A and B, P>0.05 in all instances). 
GFAP expression was also examined in these regions of the P14 spinal cord following 
MIA with 100µg/kg LPS at E16. Once again there was no significant difference in GFAP 
fluorescence intensity following MIA with 100µg/kg LPS (Figure 4.12, A and B, P>0.05 
in all instances).  
 
 
Figure 4.11 GFAP fluorescence intensity is unaltered in the dorsal and ventral grey 
matter (A) and the dorsal, intermediate and ventral white matter (B) of the rostral 
P14 spinal cord following MIA with 100µg/kg LPS at E12. The differences between 
groups were determined by one-way analysis of variance (ANOVA) and groups were 
compared using Bonferroni multiple comparison post hoc analysis. P>0.05 in all 





Figure 4.12 GFAP fluorescence intensity is unaltered in the dorsal and ventral grey 
matter (A) and the dorsal, intermediate and ventral white matter (B) of the rostral 
P14 spinal cord following MIA with 100µg/kg LPS at E16. The differences between 
groups were determined by one-way analysis of variance (ANOVA) and groups were 
compared using Bonferroni multiple comparison post hoc analysis.  P>0.05 in all 



















 E12 E14 E16 
5H - ↓* ↓ 
P14 - N/A - 
 
Table 4.1 Summary table of the results of the embryonic and postnatal Iba-1 
investigation. Iba-1+ cell number per unit volume was unchanged in the spinal cord of 
E12 embryos 5h post maternal 100µg/kg LPS injection. Iba-1+ cell number was also 
unchanged in the spinal cord of offspring at P14 following MIA at E12 with the same 




matter of the rostral spinal cord, the dorsal white matter of the rostral and caudal spinal 
cord and the ventral white matter of the rostral spinal cord of E14 embryos 5h post MIA 
with 50µg/kg LPS. The P14 time point was not examined. The number of Iba-1+ cells 
per unit volume decreased in the dorsal grey matter of rostral and middle regions, the 
dorsal white matter of rostral and middle regions, the ventral grey matter of rostral, middle 
and caudal regions and the ventral white matter of rostral, middle and caudal regions of 
the E16 embryonic spinal cord 5h post MIA with 100µg/kg LPS. Iba-1+ cell number was 
unchanged in the spinal cord of offspring at P14 following MIA at E16 with the same 
LPS dosage.  
 
GFAP 















 E12 E16 
5H N/A N/A 
P14 - - 
 
Table 4.2 Summary table of the results of  postnatal GFAP investigation. GFAP 
expression as measured through fluorescence intensity analysis, was unchanged in the 
rostral P14 spinal cord of offspring following MIA with 100µg/kg LPS at either E12 or 










Microglia and astrocytes are oftentimes the glial cells at the centre of the CNS response 
to inflammation. Microglia are the immune cells of the CNS, responding to threat through 
antigen presentation, cytokine activation and phagocytosis. Once believed to be simple 
structural support cells, astrocytes are now known to play vital roles in homeostasis of 
extracellular fluid and ion balance, regulation of blood flow, and synapse formation and 
maintenance. Astrogliosis in response to inflammation or injury results in the 
accumulation of astrocytes in the affected area and the formation of a glial scar. This 
study has characterised the distribution of microglia and astrocytes during embryonic and 
postnatal development through examination of the expression of microglial and astrocyte-
associated markers. It has also investigated the effect of MIA on the distribution of these 
cells and the expression of these markers.  
Characterisation of the E16 spinal cord revealed that larger numbers of Iba-1+ cells were 
present in the dorsal and ventral white matter of animals than in the grey matter (Figure 
4.6). This echoes a study by Rezaie et al. in the developing human spinal cord which 
suggested that the influx of microglia into the spinal cord is largely via the developing 
dorsal and ventral white matter (Rezaie et al. 1999). The number of Iba-1+ cells decreased 
in both grey and white matter in line with the rostro-caudal gradient of development, with 
more Iba-1+ cells present in the more developmentally mature rostral spinal cord and 
progressively fewer in the more immature middle and caudal spinal cord. 
Utilising this understanding of normal development, an investigation was carried out into 
the potential early effects of MIA on the microglia of the developing rat spinal cord. 
Previous research in our own laboratory and in others has suggested that changes in gene 
expression following MIA are observable as early as 4h after the insult (Garbett et al. 




found that MIA with 100µg/kg LPS at E16 resulted in a decrease in Iba-1+ cell number 
in the spinal cords of embryos 5 hours later. These decreases were most severe in the 
ventral grey and white matter where they were observable in rostral, middle and caudal 
spinal cord regions. In the dorsal grey and white matter decreases were observed in the 
rostral and middle parts of the spinal cord but not in the caudal spinal cord. These findings 
suggest that there may be a regional specificity to the effects of MIA on Iba-1+ cell 
number in the developing spinal cord, with larger decreases in the dorsal spinal cord than 
in the ventral, and that such effects are preferentially observed in the more mature spinal 
cord (Figure 4.6). 
Decreases in the number of microglia in response to immune activation appear 
counterintuitive at first glance. However, it may be the case that MIA at E16 causes a 
delay in microglial colonisation of the spinal cord resulting in the decreased cell numbers 
observed. A study characterising the colonisation of the mouse spinal cord by microglia 
has suggested that colonisation begins at E11.5 (~E13 in the rat) and that microglia are 
distributed throughout the parenchyma by E15.5 (~E17 in the rat) (Rigato et al. 2011). 
Further research confirming that this is also the case in rats, as well as Iba-1+ cell counts 
in the tissues surrounding the spinal cord to investigate whether Iba-1+ cells simply have 
not infiltrated the cord, may shed further light on these findings. 
At P14 no alteration in the number of Iba-1+ cells was observed in the rostral spinal cord 
following MIA at E16 suggesting that the effects observed at the 5h time point may have 
been transitory in nature (Figure 4.9). Other studies investigating the effects of MIA on 
microglia in the CNS have produced mixed results. A study at E15 in rats using 4mg/kg 
poly(I:C) as the immune insult identified no changes in Iba-1 expression or CD11b 
expression in the frontotemporal cortex, corpus callosum, dorsal hippocampus, thalamus, 
striatum or pons between P90 and P104 (Missault et al. 2014). In contrast however, 




in CD11b in the hippocampus, thalamus and corpus callosum of offspring at P180 (Van 
den Eynde et al. 2014). A study at E15 in mice using 50µg/kg LPS saw an increase in the 
number of   CD45intCD11b+ cells in whole brain samples at 28 weeks (P196) (Makinson 
et al. 2017). Another mouse study, again at E15 but this time using 100µg/kg LPS saw a 
decrease in CXCR3 expression in the dorsal hippocampus at P15 (Fernandez de Cossio 
et al. 2016). A study utilising e-coli as the immune challenge at E17 in rats saw an 
increase in ED-1 in the cingulum of offspring at P8 which persisted to P15 (Pang et al. 
2005).  
The mixed results observed in the literature as well as the findings in this study suggest 
that further investigation into the effects of MIA on microglial cells in the CNS is 
necessary. From the results, it appears that the effects of MIA are dependent on the insult 
time, the time at which the effect of the insult is investigated, and the region of the CNS 
examined. Some of the studies, including this one, have suggested transience in the effect 
of MIA on microglia. A study at E14.5 in mice, using 5 mg/kg poly(I:C) identified global 
changes in gene expression in microglia consistent with the adoption of a more 
developmentally mature microglial phenotype following MIA (Matcovitch-Natan et al. 
2016). The authors have suggested that it is the adoption of a mature phenotype that 
results in the transience in effect observed in some studies, as this early maturation 
resulting from the insult is masked following the timely maturation of unaffected 
microglial cells.  
This study also examined the effect of MIA on microglia at E12. The E12 spinal cord, 
like the E16 spinal cord had higher numbers of Iba-1+ cells in the rostral spinal cord, with 
progressively fewer cells in the middle and caudal spinal cord samples (Figure 4.2). The 
number of Iba-1+ cells in the cord is sparse at E12, with <10 cells per cord in the examined 
rostral regions. This low level of expression may be because microglial colonisation of 




at E11.5, or E13 in rats, predating the intervention in this rat study (Rigato et al. 2011). 
Iba-1 expression is not limited to microglial cells in the CNS, although they compose the 
majority of Iba-1+ cells, and has been documented in circulating macrophages, meningeal 
macrophages, circumventricular organ macrophages, and macrophages of the choroid 
plexus (Perry and Teeling 2013). If, indeed, microglial colonisation has not yet occurred 
it is likely that the Iba-1+ cells in the E12 study belong to one of these populations. It is 
also possible that the Iba-1+ cells comprise both these macrophages and the newly present 
microglia as the precision of time-mating is sometimes uncertain in these studies. 
In this study, MIA with 100µg/kg LPS at E12 appeared to have no effect on Iba-1+ cell 
number in the spinal cord of offspring 5h later, or in fact at P14 (Figure 4.2, 4.8) . Just 
one study has investigated the effect of MIA at E12 on the CNS microglia, finding no 
change in Iba-1 expression in the corpus callosum between P63 and P91 following 
100µg/kg LPS administration at E12 in rats (Mouihate et al. 2017). It may be the case 
that E12 is simply too early a time point to study the effect of MIA on microglia in the 
spinal cord.  
A preliminary study in a single litter group at E14 showed some intriguing results. At E14 
microglia have colonised most of the spinal cord, however large numbers of Iba-1+ cells 
are still observed in the presumptive white matter and the central canal, both proposed 
routes of entry into the spinal cord during microglial colonisation (Rezaie and Male 1999; 
Rezaie et al. 1999). Particularly high numbers of Iba-1+ cells are observed in the region 
of the dorsal horn (Figure 4.3). This is in line with a study by Rigato et al. characterising 
the microglial colonisation of the mouse spinal cord which showed that at E12.5 in the 
mouse (E14 in the rat) microglia aggregated close to the central terminals of dorsal root 
ganglia neurons undergoing developmental apoptosis. In the preliminary MIA study 
using the lower dose of 50µg/kg LPS Iba-1+ cell number was shown to be decreased in 




cord, and the ventral white matter of the rostral spinal cord 5h after injection (Figure 4.4). 
These preliminary data suggest that E14 in the rat, and at equivalent times in other 
rodents, may be a developmental window during which microglia are particularly 
vulnerable to MIA, perhaps due to the levels of phagocytic activity occurring at this time 
of development. Inter-litter variability is a known confounding factor in rodent studies 
and what is true of a single litter may not be true across multiple litters with larger genetic 
variability. Further study using multiple litters is necessary, however, this preliminary 
data does raise an interesting starting point for further research. 
The second part of this chapter investigated the effect of MIA on astrocytes. As this study 
used GFAP as a marker of astrocytes, embryonic study was not completed. In the embryo 
GFAP is a marker of radial glial cells and is therefore unsuitable for the study of 
astrocytes alone. 
In this study MIA at E12 or E16 appeared to have no effect on the astrocytes of the 
postnatal spinal cord at P14, as measured by GFAP fluorescence intensity analysis 
(Figure 4.11, 4.12). A number of studies have investigated the effect of MIA on 
astrocytes, although none have looked at the effects of MIA at E12 or E16 in rats to date. 
An E9 study in mice, utilising a sublethal dose of the influenza virus saw a whole brain 
increase in the level of GFAP expression at P0 (Fatemi et al. 2005a). It is important to 
note however, that during early development GFAP is a marker of radial glial cells, and 
this result could be indicative of a change in these cells rather than in astrocytes. Another 
study by the same group using the same insult conditions at E16 saw an increase in GFAP 
in the hippocampus at P56 (Fatemi et al. 2009b). Interestingly, a third study at E18, again 
in mice, and the only existing study to date to investigate the effects of MIA on astrocytes 
at the survival time point P14, saw no change in the expression of GFAP in the cortex, 
cerebellum or hippocampus following influenza-induced MIA (Fatemi et al. 2008b). The 




study, with regards the gestational timing of insult, and might suggest that the E16 insult 
may be too late to alter GFAP expression in the rat. However this is contradicted by two 
other studies completed in rats. The first used repeated injection of 500µg/kg LPS at E18 
and E19 and showed increased GFAP in the cortex and hippocampus at P8 (Cai et al. 
2000). While the second study used repeated injections of 300µg/kg LPS at E19 and E20, 
which showed increased GFAP expression in the internal and external capsule at P7 
(Rousset et al. 2006). It may be the case that E16 in the rat is simply not a period of 
astroglial vulnerability.  
There is very limited existing research which has investigated the effect of MIA on GFAP 
expression in the spinal cord, and it may be that alterations in astrocytic expression and 
function in the cord are more subtle than analysis by GFAP fluorescence intensity allow. 
Hochstim et al have identified a number of positionally distinct astrocytic subtypes in the 
spinal cord and future investigations could investigate the effect of MIA on these groups 
(Hochstim et al. 2008). 
The data contained within this chapter have once again suggested that E16 is an 
intrinsically vulnerable period during spinal cord development, with MIA at E16 altering 
microglial presence in the cords of offspring 5h post treatment. Like in the case of 
oligodendrocytes, this loss is undetectable at P14 following E16 treatment. No change, 
immediate or postnatal, was detected in offspring of animals treated at E12. Interestingly 
E14 appeared to be a timepoint of microglial vulnerability at E14 in the spinal cord in a 
preliminary study and this requires further study, however this is beyond the scope of the 
current research. No change in GFAP expression was detected at P14 following MIA with 
100µg/kg LPS at E12 or E16, and other methods of astroglial analysis may serve to better 
















Chapter 5. The effect of Maternal 
Immune Activation on Reelin 














5.1 Chapter Abstract 
 
Reelin is an extracellular matrix glycoprotein with an established role in cell migration 
and positioning during development, and cell-cell communication and synaptic structural 
integrity in the adult.  
This chapter investigates the effect of MIA at E12 and E16 on reelin expression 
embryonically, 5hr after insult, as well as at P14 using immunofluorescence studies to 
analyse reelin fluorescence intensity and count reelin+ cells. This chapter also 
investigates the co-localisation of reelin with specific cell populations. 
Reelin expression was decreased 5h post MIA with 100µg/kg LPS at E16 in the rostral, 
middle and caudal cord of offspring. Semi-quantitative analysis of reelin expression at 
E12 5h post MIA also suggested decreased expression. No change was observed in the 
number of reelin+ cells in the dorsal horn or medio-lateral grey matter at P14 following 
MIA at E12 or E16. In the co-localisation experiment reelin expression was found to co-
localise with NeuN expression in neurons but not with markers of oligodendrocytes or 
microglia. 
These results suggest E16 and potentially E12 are periods of early vulnerability of 
Reelin+ cells to MIA, but that the spinal cord may be able to compensate for these early 













First identified in the 1950’s reelin is an extracellular matrix glycoprotein coded for by 
the RELN gene. Mutation of this gene is responsible for the characteristic reeling gait, 
poor balance, and mobility issuses of the ‘reeler’ mouse, a naturally occurring mutant in 
which the gene was first identified (Falconer 1951; D'Arcangelo et al. 1995). These mice 
display striking cytoarchitectural anomalies including widespread disruption of 
lamination in the CNS, heterotopia (ectopic tissue presence), lissencephaly (lack of 
development of gyri and sulci of the brain) and polymicrogyria (the development of an 
unusually high number of small gyri) (Hamburgh 1963). 
Synthesised from a large 3460 amino acid precursor protein, reelin has a molecular weight 
of 388kDa. The protein consists of a 27 amino acid signalling peptide at the N-terminus, 
the reeler domain, 8 ‘reelin’ repeats, each one made up of an EGF-like domain and a 
BNR/Asp-box repeat, and a conserved N-terminus of 32 amino acids (Royaux et al. 
1997). Reelin is cleaved in two locations, the N-t and C-t sites between the second and 
third and sixth and seventh reelin repeats producing three fragments (Lambert de Rouvroit 
et al. 1999).  
In the canonical pathway reelin has two known receptors, the very low density lipoprotein 
receptor (VLDLR) and the apolipoprotein E receptor two (ApoER2) (Trommsdorff et al. 
1998). ApoE is a known antagonist of reelin signalling. Receptor binding in the presence 
of calcium results in oligomerisation of the lipoprotein receptors. The NPxY motif of the 
cytoplasmic tail serves as the docking site for disabled-1 (dab-1) via its phosphotyrosine 
kinase domain (Hoe et al. 2006). Dab-1 is phosphorylated by Fyn kinase, and to a lesser 
extent Src and Yes(Arnaud et al. 2003). Phosphorylated dab further activates the PI3K, 
Crk, Crk-like and Lis1 pathways in the embryonic neuron to modify cell migration and 




phosophorylated Dab-1 interacts with the serine family kinases (SFKs) to phosphorylate 
NMDARs resulting in CAMP responsive element binding protein-1 (CREB-1) activation 
and downstream processes such as dendritic spine formation and modification of synaptic 
plasticity (Figure 5.1) (Sinagra et al. 2005).  
 
 
Figure 5.1. Reelin signalling. Reelin, released from cells such as the Cajal-retzius 
neurons of the cortex, activates its receptors VLDL and ApoER2 resulting in the binding 
of, and phosphorylation of, Dab-1. Phosphorylated Dab-1 activates downstream 
signalling pathways such as the PI3K, Crk, Crk-like and Lis1 pathways, modifying cell 
migration, and the organisation of structural lamination in the cortex. In the postnatal 
neuron, shown on the right hand side of the image, phosphorylated dab-1 phosphorylates 
the NMDAR via SFKs resulting in the activation of CREB-1, dendritic spine formation 





Reelin is probably best known for its role in the correct lamination of the cerebral cortex 
during mammalian development. It is secreted by the cajal-retzius neurons of the 
marginal, or outermost layer, of the cortex where neuronal migration halts, and plays a 
role in the formation of the well-characterised inside-out pattern of cellular organisation 
whereby the innermost neurons of the cortex are born first with younger neurons 
sequentially occupying layers II-VI (Franco et al. 2011). This cortical lamination is 
disrupted in the reeler mouse as well as in animals in which reelin signalling has been 
impaired (Hamburgh 1963; Franco et al. 2011). Conditional knockout of reelin in two 
month old animals resulted in normal cortical formation indicating that this role in gross 
lamination is specific to development (Lane-Donovan et al. 2015). 
Reelin is also known to play a role in cerebellar development, where it is expressed in 
cells of the rhombic lip migratory stream, the nuclear transitory zone and in the external 
granular layer (Fink et al. 2006). It is also expressed by some cells in the internal granular 
layer and in the deep cerebellar nuclei (Miyata et al. 2010). In the cerebellum reelin 
appears to function in the detachment of purkinje cells from the radial glial scaffolds 
along which they migrate, indicative of a role in cell positioning similar to that in the 
cortex (Larouche et al. 2008; Miyata et al. 2010). Reelin is also known to be expressed 
in the brainstem and optic tectum, among other regions, and is likely to participate in cell 
migration and positioning throughout the CNS (Di Donato et al. 2018). 
Reelin expression in the spinal cord has been particularly well-characterised. Beginning 
around E9.5 in the mouse reelin expression is restricted to a subset of neurons in the 
ventral and intermediate spinal cord (Ikeda and Terashima 1997). By E11.5 reelin is 
expressed medially and dorsally (Ikeda and Terashima 1997). Between E11.5 and E12.5 
reelin is still expressed in the ventral and intermediate cord but is excluded from Somatic 
motor neurons (SMNs) and  the cholinergic preganglionic neurons which run from the 




associated with the V1 and V2 interneurons at this time in development and it has been 
suggested that these cells may be the source of reelin (Yip et al. 2004b). Between E13.5 
and E14.5 reelin expression appears in a band of cells in the superficial dorsal horn and 
in the dorsolateral VZ (Kubasak et al. 2004). Reelin+ cells of the dorsal horn are largely 
Lmx1b+ suggesting they are glutamatergic in nature (Yvone et al. 2020). Prenatally reelin 
expression is maintained in the intermediate grey matter, in the superficial dorsal horn 
and in a subset of the white matter astrocytes located in the ventral cord (Ikeda and 
Terashima 1997; Kubasak et al. 2004; Hochstim et al. 2008).  
Reelin is known to facilitate the migration of sympathetic preganglionic neurons (SPNs), 
parasympathetic preganglionic neurons (PPNs) and SMNs in the spinal cord(Yip et al. 
2000; Yip et al. 2003; Kubasak et al. 2004; Palmesino et al. 2010). Reeler mice, as well 
as VLDLR/ApoE2R K.O’s and dab-1 K.O’s display defects in the tangential migration 
of these cells as well as aberrant migration of cells outside the spinal cord in the case of 
SPNs, illustrating the importance of reelin for both normal cell migration and as a stop 
signal (Yip et al. 2000; Yip et al. 2003; Chai et al. 2009). 
Reelin is frequently considered a stop-signal in neuronal migration during development, 
expressed by cells of the marginal layer of the cortex and the outer layers of the 
cerebellum to prevent migration beyond designated stop points. However, receptor 
knockout studies have indicated that this may not be entirely true (Chai et al. 2009). While 
activation of the VLDL receptor does appear to negatively regulate migration, studies 
indicate that activation of the ApoE2 receptor is necessary for granular cell migration in 
the cortex suggesting that reelin modulates cell positioning through two different 
mechanisms (Hack et al. 2007). Indeed, recent evidence in the visual system of the 
zebrafish has suggested that reelin may be expressed as a gradient, in order to attract 
retinal ganglion cell axons to their appropriate final destinations and counterbalance the 




two competing behaviours can occur in the same system include differential affinities of 
reelin to the receptors and receptor sorting at a surface level (Andersen et al. 2003; Duit 
et al. 2010).  
Expression of reelin in the CNS peaks just after birth and then begins to decline, however 
some reelin expression is still detectable in the adult brain (Alcántara et al. 1998). Reelin 
expression is present in the intermediate grey matter, the ventricular zone, the superficial 
dorsal horn, the intermedio-lateral nucleus and the Clarke nucleus of the adult rat spinal 
cord. Reelin+ motor neurons co-localised with choline acetyltransferase. Krzyzanowska 
and co-authors suggested that this may indicate a role for reelin in fore and hind limb 
locomotion in the adult (Krzyzanowska et al. 2020). As in development however, much 
research has focused on reelin expression in the cortex where, in the adult, it is expressed 
by layer I and layer II GABAergic interneurons which project to other cortical layers and 
a few extant cajal-retzius neurons which have persisted into postnatal life (Alcántara et 
al. 1998; Y. Chen et al. 2005). Reelin expression is also maintained in GABAergic cells 
of the hippocampus and spinal cord and glutamatergic cells of the cerebellum (Pesold et 
al. 1998; Kubasak et al. 2004; Sinagra et al. 2005; Qiu and Weeber 2007; Hochstim et 
al. 2008; Pujadas et al. 2010). The role of reelin in these regions appears to be in dendritic 
spine growth and modulation, synaptic function, neurotransmitter release and neuronal 
maturation. In the cortex, release of reelin from layer I and layer II GABAergic 
interneurons results in the surrounding of dendritic shafts and spines of pyramidal cells 
suggestive of a role for reelin in regulating dendritic spine morphology (Rodriguez et al. 
2000). In the hippocampus appropriate reelin expression is necessary for the expression 
of NMDAR subunits NR2A and NR2B, postsynaptic density-95 (a scaffolding protein) 
and the phosphatase PTEN, all necessary for efficient glutamatergic signalling through 
CREB-1 (Figure 5.1) (Ventruti et al. 2011). Addition of reelin to hippocampal slices 




implicated in membrane trafficking via small guanosine triphosphate (GTP)ases Rho and 
Rap(Y. Chen et al. 2005; Pujadas et al. 2010). It is clear that although present in lesser 
amounts in the adult CNS, reelin still plays a significant role synaptic functioning. 
Aberrations in reelin expression have been implicated in a number of structural anomalies 
of the brain, including lissencephally, polymicrogyria and heterotopia (Hamburgh 1963). 
However more recent research has identified an emerging role for reelin in the pathology 
of neurological and neuropsychiatric disorders such as schizophrenia, autism and epilepsy 
(Fatemi et al. 2000; Persico et al. 2001; Haas et al. 2002).  
A large body of research using post-mortem tissue from schizophrenic patients has 
identified decreases in reelin mRNA expression in the cortex, hippocampus, cerebellum 
and basal ganglia (Impagnatiello et al. 1998; Fatemi et al. 2000; Guidotti et al. 2000; 
Fatemi et al. 2005c; Veldic et al. 2007). Reelin has established roles in cell migration and 
positioning, synapse formation and plasticity, and regulating dendritic spine morphology, 
defects and deficiencies in which have been identified as features of schizophrenia (For 
review see (Lewis 2012)).  Epigenetic modulation of reelin mRNA expression has been 
proposed as a cause of this decrease (Grayson et al. 2005). Hypermethylation of the reelin 
promotor is one such modulation, with a post-mortem study indicating that DNA 
methyltransferase expression is three times higher in the reelin expressing GABAergic 
interneurons of layer I of the cortex of schizophrenic patients than healthy controls, which 
is associated with a two-fold decrease in reelin mRNA expression (Ruzicka et al. 2007). 
Another study has indicated that histone deacetylase is upregulated in the hippocampus 
of schizophrenic patients, hypoacetylating histones at the reelin gene locus, thereby 
reducing reelin transcription (Benes et al. 2007). Aside from epigenetic modifications, 
other studies have indicated that VLDLR expression is decreased in drug-naïve 
schizophrenic patients and may be a potential biomarker for schizophrenia (Suzuki et al. 




gene sequencing studies. Knockout of neuronal PAS domain protein 3 (NPAS3), a risk 
gene for schizophrenia, is associated with decreased reelin mRNA expression in adult 
mouse brain tissue. Similarly knockout of methylenetetrahydrofolate reductase (MTHFR) 
resulted in decreased reelin mRNA expression in the cerebellum of mice (Erbel-Sieler et 
al. 2004; Z. Chen et al. 2005). 
Investigations into the role of reelin in autism spectrum disorders have produced 
conflicting results. Autism is associated with grey and white matter structural anomalies 
and brain volume anomalies like macrocephaly with defects in cognition, communication 
and social abilities (For review see (Courchesne et al. 2005)). Given the role of reelin in 
cell migration, positioning and communication during development it has been suggested 
that alterations in reelin signalling may play a role in the aetiology of ASD. A number of 
studies have shown that reelin levels are reduced in the sera of autistic patients. A series 
of studies by Fatemi et al have shown decreases in reelin protein levels in the cerebella, 
superior frontal cortex and parietal cortex of patients with autism when compared with 
healthy controls (Fatemi et al. 2001; Fatemi et al. 2002b; Fatemi et al. 2005b). In the 
frontal cortex and cerebellum these decreases were associated with an increase in 
VLDLRs, which may serve as a compensatory mechanism (Fatemi et al. 2005b). Despite 
these studies gene association studies investigating the role of reelin in ASDs have 
provided conflicting findings. In 2001, a study by Persico et al in an Italian population, 
demonstrated an association between ASD and the length of a GGC repeat 5’ of the RELN 
gene initiation codon (Persico et al. 2001). This finding was confirmed by studies in North 
American populations and in a Slovakian population (Zhang et al. 2002; Skaar et al. 2005; 
Kelemenova et al. 2010). However, multiple other studies have demonstrated no 
association between this GCC repeat and ASD (Bonora et al. 2003; Devlin et al. 2004; 
Dutta et al. 2008). Similar issues have been identified in the association of reelin-related 




SNPs associated with ASDs and a number of others finding no association (Ashley-Koch 
et al. 2007; Dutta et al. 2008; Li et al. 2008; He et al. 2011). Given the heterogeneous 
nature of ASD such contradictory findings are perhaps unsurprising and further studies 
in smaller but more homogeneous populations may shed some light on the disagreement. 
Reelin has been linked to temporal lobe epilepsy in a number of studies, and is suggested 
to play a role in dentate gyrus granule cell dispersion, a key feature of temporal lobe 
epilepsy (Haas et al. 2002). These studies suggest that a decrease in reelin producing 
interneurons due to prolonged seizures results in ectopic granule cell migration and 
abnormalities in integration of newborn cells (Gong et al. 2007). Another study suggests 
that this effect may be due to hypermethylation of the reelin promotor, with another 
showing that this effect on granule cell dispersion can be alleviated by the addition of 
exogenous reelin (Kobow et al. 2009; Muller et al. 2009).  
To date, no studies on the effect of MIA on reelin expression in the developing CNS have 
been completed. Despite this, MIA has also been associated with the development of 
many of the neurological disorders in which alterations in reelin expression are believed 
to play a part (Fatemi et al. 2008b; Meyer et al. 2009). This chapter aims to investigate 
the effect of MIA with 100µg/kg LPS at E12 and E16 on reelin expression in the 
embryonic and postnatal spinal cord of offspring using immunohistochemical methods. 
Understanding of the cellular changes underpinning the effect of MIA on reelin 
expression is crucial to the investigation of the effect of MIA on reelin expression, and 
may provide another piece of the complex puzzle that is the aetiology of complex 
neurological disorders like schizophrenia, autism and epilepsy. It should be noted that 






5.3 Chapter Aims 
 
The objective of this study was: 
1. To investigate the expression of reelin in the E12, E16 and P14 spinal cord 
2. To investigate the co-localisation of reelin with neuronal, oligodendroglial, 
microglial and astroglial markers in the P14 spinal cord 
3. To investigate the early effects of maternal LPS injection at either E12 or E16 on 
reelin expression in the embryonic rat spinal cord 
4. To investigate the effects of maternal LPS injection at either E12 or E16 on reelin 



















5.4.1 Characterisation of reelin expression in the embryonic spinal cord at 
E12 and E16 during normal development; and following MIA at E12 and E16 
 
5.4.1.1 Reelin expression in the E12 spinal cord in normal development and post 
MIA with 100µg/kg LPS 
 
Immunofluorescent staining of reelin in the E12 spinal cord is very weak (Figure 5.2, A). 
Despite this, reelin expression in the E12 spinal cord can be detected, if unreliably, in the 
rostral, middle and caudal spinal cord sections. Reelin expression appears to follow the 
rostrocaudal axis of development, with higher levels of reelin expression in the more 
mature rostral spinal cord than in the intermediate and caudal spinal cord (Figure 5.3). 
Reelin expression can be detected within individual cells of the dorsolateral spinal cord 
(Figure 5.2, B) as well as diffusely in the same region (Figure 5.2, B). 
Reelin expression in the E12 spinal cord was not quantifiable using image analysis 
software due to low levels of reelin expression at this time point and high levels of 
background staining. Reelin expression 5h post MIA at E12 with 100µg/kg LPS was 
instead analysed in the spinal cords of these animals using semi-quantitative 
observational analysis (Figure 5.3). This analysis confirmed that reelin expression is 
highest in rostral regions of the spinal cord with progressively lower levels of expression 
in the middle and caudal sections. The analysis suggests that levels of diffuse reelin, as 
well as reelin+ processes, were lower in the rostral spinal cord of offspring of LPS treated 
animals, while more reelin was present in the roof plate of these animals than in saline 
controls. The expression of reelin in the roof plate and diffusely appears to be lower in 
the middle regions of spinal cords of offspring of mothers treated with LPS, but these 
animals appeared to have a higher number of reelin positive cells. In the caudal spinal 
cord offspring of LPS treated mothers appeared to have higher levels of reelin positive 





Figure 5.2 Reelin expression in the E12 spinal cord. At E12 reelin staining in the E12 
spinal cord is very weak. Diffuse reelin staining can be observed in the presumptive 
ventro-lateral grey matter of the rostral spinal cord (A,C). Reelin+ cells can also be 
observed in the same region (B).  
 
Figure 5.3. Semi-quantitative analysis of reelin expression in the E12 spinal cord 5h 
after MIA with 100μg/kg LPS. At E12 highest levels of reelin expression are observable 
in the rostral spinal cord, with no observable expression of diffuse reelin or reelin+ cells 




Reelin+ processes and diffuse reelin following MIA at E12. Reelin expression appears to 
increase in the rostral roof plate following MIA. ( - = no expression; + = weak expression; 
++ = moderate expression;  +++ =  high expression.  N=3 saline, N=5 LPS) 
 
5.4.1.2 Reelin expression in the E16 spinal cord in normal development and post 
MIA with 50µg/kg or 100µg/kg LPS 
 
Reelin was expressed in the rostral, middle and caudal spinal cord at E16 during normal 
development (Figure 5.5). At E16 reelin staining was largely diffuse, with some 
expression observed in individual cells (Figure 5.4 A, B). Reelin expression can be 
observed in the lateral marginal zone and ventricular zone in rostral, middle and caudal 
spinal cord sections (Figure 5.4 A,C,D). Reelin expression was present along the 
superficial edge of the dorsal horn in rostral samples only (Figure 5.4, B). 
Following MIA reelin expression was measured in whole sections of rostral, middle and 
caudal spinal cord using fluorescence intensity analysis. Reelin fluorescence intensity 
was decreased in the rostral, middle and caudal spinal cord 5h post MIA with 100µg/kg 
LPS at E16 (P<0.001 in all instances, N=5 saline N=6 LPS, Figure 5.5). No significant 
change in the fluorescence intensity of reelin in whole cord sections of rostral, middle and 
caudal cord was observed in a preliminary study using 50µg/kg LPS at the same time 





Figure 5.4 Reelin expression in the E16 spinal cord. In the E16 spinal cord reelin 
expression is largely diffuse (A-D), with some evidence of cellular expression (arrow, C). 
Areas of high expression include the presumptive dorsal horn (B), the dorsolateral grey 
matter (C) and the area around the central canal and ventricular zone (D). Scale bar: 









Figure 5.5. Reelin expression in the E16 spinal cord 5h post MIA. The mean 
fluorescence intensity of reelin is decreased 5h post MIA with 100µg/kg LPS in the 
rostral, middle and caudal spinal cord of offspring (P<0.001 in all instances). The mean 
fluorescence intensity of reelin is not significantly decreased in the spinal cords of 
offspring following 50µg/kg injection of LPS (P>0.05 in all instances). The differences 
between groups were determined by one-way analysis of variance (ANOVA) and groups 
were compared using Bonferroni multiple comparison hoc analysis. (N=6 saline, N=6 
50µg/kg LPS, N=6 100µg/kg LPS. * = P<0.05, ** = P<0.01, *** = P<0.001). AU = 
arbitrary units. 
 
5.4.2 Characterisation of reelin expression in the P14 spinal cord during 
normal development; and following MIA at E12 and E16 
 
5.4.2.1 Reelin expression in the rostral P14 spinal cord during normal postnatal 
development 
 
Reelin is expressed both diffusely and by distinct cell populations of the rostral P14 spinal 
cord (Figure 5.6). Reelin is expressed by a band of cells on the superficial edge of the 
dorsal horn (Figure 5.7, A,D), by cells of the medio-lateral grey matter (Figure 5.7 B,D) 





Figure 5.6. Reelin expression in the P14 spinal cord. At P14 reelin expression is far 
lower in the spinal cord than at E16. Expression is largely limited to individual cell types 
of the dorsal horn, medio-lateral grey matter and ventral white matter. Some diffuse 







Figure 5.7. Reelin is expressed by specific cell populations of the P14 spinal cord. 
Reelin expression in the P14 spinal cord is restricted to specific locations, namely a band 
of cells in the superficial dorsal horn (A), the medio-lateral grey matter (B), and the apical 
astrocytes of the white matter (C), represented schematically in (D). Scale Bars: A - 
50µm, B - 50µm, C - 20µm. 
 
5.4.2.2 Reelin expression in the P14 spinal cord following MIA with 100µg/kg LPS 
on E12 or E16 
 
Reelin expression in the medio-lateral grey matter and on the superficial edge of the 
dorsal horn were measured by cell counting at P14. Reelin+ cell number per unit volume 
was unchanged in the medio-lateral grey matter of the rostral P14 spinal cord following 
MIA at E12 (P>0.05 in all instances, N=6, Figure 5.8, A). Reelin+ cell number per unit 
volume was also unchanged in the superficial edge of the dorsal horn of the rostral P14 
spinal cord following MIA at E12 (P>0.05 in all instances, N=6, Figure 5.8, B). 
Reelin expression by cell populations in the medio-lateral grey matter and on the 




Reelin+ cell number per unit volume was again unchanged in the examined regions. 
(P>0.05 in all instances, N=6, Figure 5.9, A, B).  
 
 
Figure 5.8 Reelin expression in the P14 spinal cord following MIA with 100μg/kg 
LPS at E12. The number of reelin+ cells per unit volume is unchanged in the medio-
lateral grey matter and on the superficial dorsal horn edge in the rostral spinal cord of P14 
offspring following MIA at E12 with 100μg/kg LPS (P>0.05 in all instances). The 
differences between groups were determined by student’s t-test. (N=6 saline, N=6 LPS). 
 
Figure 5.9. Reelin expression in the P14 spinal cord following MIA with 100μg/kg 
LPS at E16. The number of reelin+ cells per unit volume is unchanged in the medio-
lateral grey matter and the on the superficial edge of the dorsal horn in the rostral spinal 
cord of P14 offspring following MIA at E16 with 100μg/kg LPS (P>0.05 in all instances). 





5.4.3 Co-localisation of reelin with markers of neurons, oligodendrocytes and 
microglia in the E16 and P14 spinal cords during normal development 
 
Reelin co-localisation with markers of neurons (NeuN), Oligodendrocytes (Olig2), and 
microglia (Iba-1) was examined at E16 and P14 during normal development. Reelin was 
expressed diffusely in the ventro-lateral grey matter of the developing spinal cord at E16 
(Figure 5.10, A-C). Microglia (A), oligodendrocytes (B) and Neurons (C) are also found 
in the ventro-lateral grey matter of the spinal cord. However, no discernible co-
localisation of reelin with Iba-1+ microglia (A) or Olig2+ oligodendrocytes (B) is 
observed at E16. Reelin does appear to co-localise with some NeuN+ neurons at E16 
(arrows, C). At P14 reelin expression is observed in a reelin+ cell population in the ventro-
lateral grey matter (D-F). These cells do not co-localise with markers of microglia (D) or 
oligodendrocytes (E) but, like at E16, reelin expression is observed in a number of NeuN 













































































































































































































































































































































































































































































































































Reelin is an extracellular matrix glycoprotein with a well-established role in cell 
migration and positioning during development and cell-cell communication and synaptic 
structural integrity in the adult. To date the effect of MIA during development on reelin 
expression has not been investigated despite numerous studies linking abberations in 
reelin expression to neurological disorders such as schizophrenia, autism and epilepsy, 
disorders in which MIA is proposed to play a role. This study investigated the immediate 
effect of MIA at E12 and E16 on reelin expression, as well as the effect postnatally at 
P14.  
Reelin was found to be expressed at low levels in the E12 embryonic spinal cord (Figure 
5.2). This low level of expression hindered quantitative analysis. Semi-quantitative 
analysis through a blinded observational study allowed for some characterisation of reelin 
expression in the E12 cord, and indicated that reelin is expressed both diffusely and by 
specific cells. This expression follows the rostro-caudal gradient of development.  These 
observations echo those of Ikeda et al who found that reelin expression is restricted to a 
subset of neurons in the ventral and intermediate spinal cord of mice at E9.5 and is visible 
ventrally and medially at E11.5 (Ikeda and Terashima 1997). The current E12 study in 
rats falls immediately between these investigative time points at around E10.5 in mice.  
The observational analysis of the effect of MIA with 100µg/kg LPS on reelin expression 
in the E12 spinal cord 5h after injection suggested a decrease in diffuse reelin in the rostral 
and middle spinal cord and in reelin positive processes in the rostral spinal cord. A small 
increase in the number of reelin+ cells in the middle spinal cord and in the reelin+ 
fluorescence in the roof plate following MIA was also observed. However these data 
should be viewed with caution due to the nature of the study and the low numbers of 




blotting or ELISA, may shed some light on the effect of MIA on reelin expression at E12. 
If reelin expression is changed at E12 this is indicative of an early effect on cellular 
migration within the spinal cord which may have prolonged consequences on offspring 
into postnatal life. 
Unlike at E12 reelin expression in the E16 spinal cord was robust, and quantifiable using 
fluorescence intensity analysis (Figure 5.5). At E16, reelin was expressed in the 
ventrolateral spinal cord, around the ventricular zone and in a band of cells in the 
superficial region of the dorsal horn. The expression pattern observed in this study was 
again comparable with previous research. Other studies have suggested that reelin is 
expressed in the ventrolateral spinal cord by E12.5 in mice (E14 in rats) and that this 
expression is maintained prenatally (Yip et al. 2000; Kubasak et al. 2004; Yip et al. 
2004a; Yip et al. 2004b). Similarly, another study has confirmed that reelin expression 
begins in the band of cells located in the superficial part of the dorsal horn, and in the 
ventricular zone between E13.5 and E14.5 (E15-16 in rats) (Kubasak et al. 2004). 
This study investigated the effect of MIA with 100µg/kg LPS on reelin expression in the 
E16 spinal cord 5h after LPS administration. MIA caused a significant decrease in reelin 
fluorescence intensity in whole cord slices of rostral, middle and caudal spinal cord. This 
decrease in reelin fluorescence intensity was consistent, and did not differ between rostral 
middle and caudal samples (P<0.001 in all instances, Figure 5.6) as observed in other 
studies in this thesis, for example the Iba-1 and Olig2 studies. Further investigations to 
determine whether these decreases are universal or specific to a certain type of expression 
(cellular or diffuse), or region of expression (Dorsal horn, ventrolateral cord, ventricular 
zone) would be interesting.  A preliminary study using a single litter was also undertaken 
but did not show a significant decrease in reelin fluorescence intensity following MIA 




To my knowledge this is the first study to investigate the effect of MIA on reelin 
expression in the developing CNS. As reelin is a key signalling molecule known to be 
involved in cell-cell communication as well as a known stop signal and modulator of cell 
migration the consequences of aberrant reelin expression during development could be 
far-reaching. Decreased reelin expression during development could result in subtle 
alterations in neuronal migration and subsequently mis-wiring of developing neuronal 
networks. Such alterations, if they exist, could persist postnatally, although further 
research remains to be completed in order to confirm such changes. 
At P14 reelin expression in the spinal cord appeared to be restricted to specific 
populations of cells in the rostral spinal cord (Figure 5.6, 5.7). Reelin expression was 
observed in a band of cells in the superficial region of the dorsal horn, in a number of 
cells in the medio-lateral grey matter, and in a subset of astrocytes in the ventral white 
matter. This pattern of expression matched that previously observed in other studies in 
the postnatal spinal cord. Reelin is known to be expressed in cells of the medio-lateral 
and ventrolateral grey matter. These are thought to be V1 and V2 interneurons due to the 
large amount of reelin expression observed around these cells during development (Yip 
et al. 2004b). The band of cells in the superficial dorsal horn, first observed during 
development between E13.5 and E14.5 in mice, are known to persist postnatally 
(Kubasak et al. 2004). According to existing literature, Reelin expression in the ventral 
white matter is known to be restricted to specific subsets of white matter astrocytes in the 
spinal cord. These may be Reelin+ Slit-1- or Reelin+ Slit-1+ astrocytes, and play a role 
in cell positioning during development (Hochstim et al. 2008). Their function in the 
postnatal spinal cord is still unknown. 
Analysis of the effects of MIA at E12 or E16 with 100µg/kg LPS on Reelin expression 
in the P14 spinal cord suggested that MIA did not effect reelin expression in the P14 




lateral grey matter or in the dorsal horn were observed. This suggests that the acute 
decrease in reelin fluorescence intensity observed 5h after injection at the E16 time point 
was transient, and that MIA at either E12 or E16 had no delayed effect observable at P14. 
The transient effect observed following the E16 injection could indicate that the decrease 
in reelin expression can be corrected by P14, without a lasting observable effect. Further 
studies into the cellular origin of the acute change in the level of reelin fluorescence 
intensity at E16 after MIA could provide valuable information as to why this transient 
effect occurs. As reelin expression is restricted to specific cell populations in the P14 
cord, a decrease in the diffusible reelin at E16 would not be visible in the P14 cord for 
example. Despite the transience of the E16 decrease it is important to note that a decrease 
in reelin expression at that age may have altered the positioning of a number of neuronal 
and glial cells in the spinal cord, and that this change in connectivity may persist 
postnatally.  
Changes in Reelin expression in the spinal cord can result in heterotopia. A number of 
studies have shown that loss of reelin expression can result in mis-migration of neurons, 
specifically SMNs in the spinal cord which may have postnatal effects on locomotion 
(Yip et al. 2000; Yip et al. 2003). Alterations in reelin expression have previously been 
associated with neurological disorders such as schizophrenia, autism and epilepsy, likely 
due to the role of reelin in the establishment of connectivity in the developing CNS 
(Fatemi et al. 2000; Persico et al. 2001; Haas et al. 2002). MIA during gestation is also 
an established risk factor for these disorders (Fatemi et al. 2005a; Fatemi et al. 2008b; 
Meyer et al. 2009). This project has suggested that MIA during gestation can alter the 
expression of reelin in the spinal cord during development. Further research should 
elaborate on the effects of this alteration of reelin expression due to MIA on neuron-
neuron interaction. A co-localisation experiment would have allowed for the 




the dorsal horn and would be an important next step. A combination of further imaging 
studies and behavioural models would seek to establish whether MIA could be a factor in 
the abnormal neuronal connectivity widely associated with these neurological disorders. 








































Chapter 6. Gene expression changes in 





















6.1 Chapter Abstract 
 
High throughput studies such as microarray and RNA seq have changed how we 
formulate research questions, handle data and design experiments, allowing a broad, 
unbiased approach to the investigation of the effect of a condition or treatment across the 
whole genome at a moment in time. 
In this chapter, the effect of MIA on the spinal cord at E12 or E16 was investigated 5hr 
post insult and at P14 using microarray and RNASeq studies respectively. 
Microarray analysis showed no differential gene expression 5h post MIA at E12 with 
100µg/kg LPS. RNA Seq showed that gene expression was also unchanged at P14 after 
MIA at E12. In contrast, microarray analysis identified 42 differentially regulated genes 
5h post MIA at E16. RNA Seq identified 16 differentially regulated genes at P14. The 16 
differentially regulated genes were identified, and PCR analysis was carried out. 
The results of this study again identify E16 as a period of specific early vulnerability to 
MIA, and also suggests that MIA at E16 continues to effect gene expression in the spinal 
cord postnatally. A subset of 7 genes differentially regulated in RNASeq at P14 following 
MIA at E16  identified peroxisomal function as a potential underlying factor in the 
consequences of MIA on the early postnatal spinal cord. However these results were not 











RNA expression profiling studies such as microarray and RNASeq have become common 
place in the laboratory environment over the past twenty years. These powerful, high 
throughput techniques can provide researchers with a snap shot of the gene expression 
landscape in a sample, opening numerous new pathways of investigation in the 
biomedical sciences. 
DNA microarray technology allows for the high throughput analysis of gene expression 
by quantification of relative abundance. The methodology involves an array of 
microscopic DNA spots called probes or oligos housed on a chip. The chip is washed 
with the sample of interest, which allows for hybridisation of complimentary DNA 
(cDNA) and the measurement of relative gene expression levels, usually through 
measurement of luminescence. In this chapter microarray methodology is used to 
investigate the effect of MIA on gene expression in the spinal cords of offspring following 
MIA with 100µg/kg LPS at either E12 or E16. 
RNA sequencing (RNASeq), first described by Wang et al. in 2009, has been rapidly 
replacing microarray technologies over the past decade. Like microarrays, RNASeq 
allows for the interrogation of differential gene expression. However, unlike microarrays 
it also allows for interrogation of non-coding RNA, splicing, and allele specific 
expression, as well as overall differential expression analysis.  Like microarray RNAseq 
utilises cDNA, but does so without need for probes. Instead a library is prepared; total 
RNA undergoes fragmentation, is poly A selected, and randomly primed before cDNA 
synthesis. cDNA undergoes end repair, phosphorylation and A-tailing. Finally, the 
samples undergo adapter ligation, PCR amplification and sequencing. One major 
advantage of RNA sequencing over microarray is that it removes the bias of probe 




has become more readily available RNAseq has become more cost effective, with the 
ability to run 6-30 samples multiplexed in a single sequencing well. In this chapter 
RNASeq analysis is used to investigate the effect of MIA on gene expression and 
microRNA expression in the P14 spinal cord after MIA with 100µg/kg LPS on either E12 
or E16. 
The advantages to high throughput screening such as gene expression analyses are multi-
fold, changing completely how we approach experimental design. Where traditional 
experimentation requires the establishment of a narrow research question expression 
profiling studies allow for broader questions, such as the effect of a condition or treatment 
across the whole genome at a moment in time. These studies also allow for a more 
unbiased view. Traditional experiments may favour the interrogation of genes or gene 
families which are already documented to play a role in the condition or treatment 
response of interest. Expression profiling studies, therefore, are an excellent way of 
identifying novel genes and pathways which may further elucidate the underlying genetic 
architecture of a condition or response to treatment, or provide us with new biomarkers 
and potentially druggable targets. The data produced from expression profiling studies 
may be probed repeatedly using bioinformatic techniques, ensuring these studies are cost 
effective way to produce the starting point for more traditional experimentation for many 
years after their completion.   
This chapter approaches the broad, unbiased question of the effects of MIA on gene 









6.3 Chapter Aims 
 
The objective of this study was: 
 
 To investigate using a microarray study the gene expression changes in the spinal 
cord of offspring 5hr after MIA with i.p injection of 100µg/kg LPS at E12 and 
E16 
 To investigate using RNASeq the gene expression changes in the spinal cords of 
offspring at P14 following MIA with i.p injection of 100µg/kg LPS at E12 and 
E16 
 To identify novel pathways and targets of interest from the genes identified to be 
differentially expressed following MIA with an i.p injection of 100µg/kg LPS at 























6.4.1 Microarray analysis 
 
6.4.1.1 Principal component analysis 
 
Principal component analysis uses orthogonal transformation to covert observations of 
possibly correlated variables (for example gene expression levels) into a smaller number 
of values of linear uncorrelated variables known as principal components. The first 
component accounts for as much of the variation within the data set as possible and the 
second has the highest variance possible under the constraint of being orthogonal 
(perpendicular, unrelated) to the first component (Jolliffe and Cadima 2016). This 
technique is used to reduce dimensionality of the data and simplify large volumes of data 
for analysis. In this instance, PCA is used to visualise the relatedness and genetic 
similarities between samples. Sample similarity correlates to distance on PCA plots, with 
like samples (relative to the defined principal components) plotted close to each other. To 
this end a PCA plot also allows for the identification of outliers, with samples differing 
from each other plotted at greater distances.  
The samples for microarray analysis from E12 and E16 LPS treated and control offspring 
were graphed on a principle component analysis (PCA) plot (Figure 6.1). E12 samples 
and E16 samples formed separate clusters along the principle component (PC)1 axis (X 
axis). Saline and LPS samples within the E12 and E16 groups did not form identifiable 
separate clusters along the PC2 axis (y-axis). At E12 Saline samples 2 and 3 clustered 
closely with LPS sample 3, while LPS samples 1 and 2 clustered closely. E12 saline 
sample 1 did not cluster with either group. At E16 LPS samples 1 and 2 clustered closely 
but were separate from E16 LPS sample 3 while saline samples 2 and 3 clustered 






Figure 6.1. Principle component analysis (PCA) plot of the 12 pooled samples used 
in the microarray study. This plot allows the visualisation of the relatedness and genetic 
similarities between the 12 samples. (N=3 saline, N=3 LPS for both E12 and E16 
treatment groups). Samples clustered along the PC1 axis (x axis), indicating that E12 and 
E16 samples were genetically different, however no clear clustering of samples was 
visible on the PC2 axis (y axis), indicating genetic similarity between the saline treated 
and LPS treated samples. 
 
6.4.1.2 Gene expression 5hr post MIA with 100µg/kg LPS at E12 or E16 
 
The microarray study identified no differential gene expression in the spinal cords of 
offspring 5hr after MIA at E12 with 100µg/kg LPS (N= 3 Saline N=3 LPS where each 




not shown). An adjusted P-value (or q-value) is used in this instance to minimise the error 
associated with multiple comparison analysis of thousands of variables using a small 
number of individuals. 
At E16 however, the microarray study identified differential expression of 42 genes in 
the spinal cords of offspring 5hr after MIA with 100µg/kg LPS (N= 3 Saline N=3 LPS 
where each sample is one pooled litter, Figure 6.2). A list of differentially regulated genes 
and their corresponding adjP values can be viewed in table 6.1. For a short synopsis of 
the function of each differentially regulated gene see appendix A, Table A.1.2.1. 
 
 
Figure 6.2 Heat map illustrating the 42 differentially expressed genes 5hr post MIA 




2F, LOC690507 and Olr115). 39 genes were downregulated (Blue, LOC683674, Med25, 
Ccdc5, Wars, Arhgap1, Tp53, Celf3, LOC10036317, Srm, Midn, Fscn1, S100a11, Clip3, 
Pcsk1n, Ubl7, Ftl1, Rab11b, LOC10035966, LOC10036008, RGD1305455, Pcgf2, Ctc1, 
Nrbp2, Fam189b, Cherp, Tox, E2f4, Ppif, Dpf2, Cnot3, Bcas3, Atf7, Mef2d, Lmf2, 
Pomt1, Emd, Sf3a2, Tbc1d25 and LOC10036238). For a full list of genes and brief 
synopsis of function see Appendix A.1.2 
 
Gene symbol Gene Name adjP value Up/Down 
Tp53 tumour protein p53 0.042210405 ↓ 
Olr115 olfactory receptor 115 0.042210405 ↑ 
E2f4 E2F transcription factor 4 0.042210405 ↓ 
LOC100363177 ferritin light chain 1-like 0.042210405 ↓ 
Sf3a2 splicing factor 3a, subunit 2 0.042210405 ↓ 
S100a11 S100 calcium binding protein A11 0.042210405 ↓ 
LOC100359668 ferritin light chain 2 0.042210405 ↓ 
Cherp calcium homeostasis endoplasmic 
reticulum protein 
0.042210405 ↓ 
Pomt1 protein-O-mannosyltransferase 1 0.042210405 ↓ 
LOC690507 similar to Vomeromodulin 0.042210405 ↑ 
Fam189b family with sequence similarity 
189, member B 
0.042210405 ↓ 
Ftl1 ferritin light chain 1 0.042210405 ↓ 
Fscn1 fascin actin-bundling protein 1 0.042210405 ↓ 
Clip3 CAP-GLY domain containing 





Tbc1d25 TBC1 domain family, member 25 0.042210405 ↓ 
Srm spermidine synthase 0.043194796 ↓ 
LOC100360087 ferritin light chain 1-like 0.043194796 ↓ 
Arhgap1 Rho GTPase activating protein 1 0.048417516 ↓ 
Spetex-2F Spetex-2F protein 0.049418636 ↑ 
RGD1305455 similar to hypothetical protein 
FLJ10925 
0.049430646 ↓ 
Ppif peptidylprolyl isomerase F 0.049430646 ↓ 
Emd emerin 0.049430646 ↓ 
Rab11b RAB11B, member RAS oncogene 
family 
0.049430646 ↓ 
Pcsk1n proprotein convertase 
subtilisin/kexin type 1 inhibitor 
0.049430646 ↓ 
Lmf2 lipase maturation factor 2 0.04944345 ↓ 
Mef2d myocyte enhancer factor 2D 0.050840562 ↓ 
Wars tryptophanyl-tRNA synthetase 0.053145487 ↓ 
Ubl7 ubiquitin-like 7 0.055027412 ↓ 
Ctc1 CST telomere replication complex 
component 1 
0.055027412 ↓ 
Tox thymocyte selection-associated high 
mobility group box 
0.057299302 ↓ 
Med25 mediator complex subunit 25 0.059658075 ↓ 
Dpf2 double PHD fingers 2 0.059658075 ↓ 
LOC100362384 ferritin light chain 1-like 0.062040982 ↓ 




Bcas3 BCAS3, microtubule associated cell 
migration factor 
0.062040982 ↓ 
Ccdc6 coiled-coil domain containing 6 0.062040982 ↓ 
Nrbp2 nuclear receptor binding protein 2 0.065076744 ↓ 
Celf3 CUGBP, Elav-like family member 
3 
0.065076744 ↓ 
Midn midnolin 0.065076744 ↓ 
Pcgf2 polycomb group ring finger 2 0.065076744 ↓ 
Atf7 activating transcription factor 7 0.065076744 ↓ 




Table 6.1 42 genes were differentially regulated in the spinal cords of E16 offspring 
5hr after MIA with 100µg/kg LPS. N=3 Saline, N=3 LPS where each sample is one 
pooled litter and the adjP <0.07. 
 
6.4.1.3 Bioinformatic interrogation of genes differentially expressed in the 
microarray analysis 5hr post MIA with 100µg/kg LPS at E16 
 
Gene ontology (GO) analysis of the 42 differentially expressed genes was attempted using 
webgestalt. No Biological process, molecular function or cellular component was found 
to be enriched within the 42 genes. Kyoto encyclopaedia of genes and genome (KEGG) 
pathway analysis did not identify any enriched pathways and uniprot keyword analysis 
did not identify any enriched keywords (data not shown). Protein-protein interaction (PPI) 
was investigated using STRING v11, an open source database of protein interactions 




STRING can be used to visualise genomic data at a systems level and identify pathways 
and groups of proteins of interest. 41 of the 42 differentially regulated genes mapped to a 
known protein in STRING, displayed in Figure 6.3. The PPI network did not display 
significantly more interactions than those expected by chance when interrogated at the 
medium confidence level (0.400). The confidence level is the approximate probability 
that a predicted link exists between two enzymes in the same metabolic map in the KEGG 
database (Szklarczyk et al. 2015). A medium confidence level uses a threshold limit of 
0.400, excluding predicted links below this with a view to reducing false positives. The 
PPI enrichment value was 0.195. A smaller PPI enrichment value would indicate that the 
nodes are not random and that the observed number of edges in the data is significant.  
This data indicates that the proteins differentially regulated 5hr after MIA at E16 were 
not functionally related. 
 
Figure 6.3 STRING analysis of the protein protein interactions between the 42 




with 100µg/kg LPS. The network did not display significantly more interactions than 
expected when interrogated at the medium confidence level (0.400) with a PPI enrichment 
value of p=0.124. 
 
6.4.2 RNASeq analysis 
 
6.4.2.1 Principal component analysis 
 
The P14 samples for RNASeq analysis from E12 and E16 LPS treated and control 
offspring were graphed on a PCA plot (Figure 6.4). E12 treated animals and E16 treated 
animals did not display differential clustering at P14. LPS treated animals and saline 
treated control animals did not cluster differently following intervention at either E12 or 
at E16. Two animals, one LPS treated and one saline treated, from the E12 group did 
show differential expression of the primary principle component (PC1) compared to other 
animals (Figure 6.4, samples E12 P14 S1 and E12 P14 L3). This differential expression 







Figure 6.4. PCA plot of the 12 samples used in the RNASeq study (N=3 saline, N=3 
LPS for both E12 and E16 treatment groups). Samples were not clearly clustered 
according to treatment group or time of intervention, indicative of an overall genetic 








6.4.2.2 Gene expression at P14 following MIA with 100µg/kg LPS at E12 or E16 
 
RNASeq identified no differential gene expression in the spinal cords of offspring at P14 
following MIA at E12 with 100µg/kg LPS (N= 3 Saline N=3 LPS adjP > 0.1 in all 
instances, with adjP<0.07 deemed significant. Appendix A, Figure A.2.2). 
RNASeq identified differential expression of 16 genes in the spinal cords of offspring at 
P14 after MIA at E16 with 100µg/kg LPS (N= 3 Saline N=3 LPS). These differentially 
expressed genes are displayed in red on the MA plot (Figure 6.5). An MA plot is an 
application of the Bland-Altman plot. Data is transformed to the M (log ratio, y-axis) and 
A (mean of normalised counts, x-axis) scales, in order to visualise the genetic differences 
between samples. A list of differentially regulated genes and their corresponding adjP 
values can be viewed in table 6.2. Genes with an adjP value <0.07 were deemed 
significant. These genes were both up and downregulated (Figure 6.6). For a short 






Figure 6.5: MA plot of the gene expression changes in offspring spinal cords at P14 
following MIA at E16 with 100µg/kg LPS. The MA plot is an application of a Bland-
Altman plot for visualising the genetic differences between two samples, in this case 
saline vs LPS samples. The data is transformed to the M (log ratio, y-axis) and A (mean 











Gene name padj Up/down 
Cat Catalase 1.32335338901198e-07 ↓ 
Txnip Thioredoxin interacting 
protein 
3.29264818451849e-06 ↑ 
Pmvk Phosphomevalonate Kinase 0.000268356859590681 ↓ 
Pex11a Peroxin 11A 0.000512221797613451 ↑ 
Spag7 Sperm Associated Antigen 7 0.00465501261640134 ↓ 
Idi1 Isopentenyl-diphosphate delta 
isomerase 1 
0.00922816789691003 ↓ 
Pxmp4 Peroxisomal membrane 
protein 4 
0.011402842421314 ↓ 
Scara3 Scavenger receptor class A 
member 3 
0.0198081109893107 ↑ 
Kif19 Kinesin Family Member 19 0.0251877569130536 ↓ 
Fzd9 Frizzled class receptor 9 0.0251877569130536 ↑ 




Mcam Melanoma cell adhesion 
molecule 
0.035168648168927 ↓ 
Pla2g3 Phospholipase A2 Group III 0.0370378271847036 ↑ 
Ppp1r10 Protein Phosphatase 1 
Regulatory Subunit 10 
0.0555721333954697 ↑ 
Emcn Endomucin 0.0592220084010742 ↓ 
 
Table 6.2. 16 genes were differentially regulated in the spinal cords of offspring at 
P14 following MIA with 100µg/kg LPS on E16. N=3 Saline, N=3 LPS where each 





Figure 6.6 16 genes were differentially expressed at P14 following MIA with 
100µg/kg LPS at E16. These genes were both upregulated and down regulated and are 
plotted as log2 of the fold change. N = 3 saline, N = 3 LPS. 
 
6.4.2.3 Bioinformatic interrogation of genes differentially expressed in RNASeq 
analysis at P14 post MIA with 100µg/kg LPS at E16 
 
Protein-protein interaction was investigated using STRING v11. The network displayed 
significantly more interactions than expected by chance when interrogated at the medium 
confidence level (0.400) with a PPI enrichment value of p = 0.00092. A small PPI 
enrichment value suggests the nodes are not random and that the observed number of 
edges in the data is significant (Figure 6.7). The network displayed five edges. The 




number of interactions each member of the network has on average. The average 
clustering coefficient was 0.105, indicating that the nodes of the network are connected. 
GO analysis using webgestalt identified a number of significantly enriched cellular 
components, the most significant of which were the ‘peroxisome’ and the ‘peroxisomal 
membrane’ (Tables 6.3). KEGG pathway analysis identified the pathways ‘peroxisome’ 
and ‘terpenoid backbone biosynthesis’ as the most significantly enriched (Table 6.4), 
while Uniprot keywords identified included ‘peroxisome’ and ‘cholesterol biosynthesis’ 
(Table 6.5). 
 
Figure 6.7 STRING analysis of the protein protein interactions between the 19 
differentially regulated genes in the spinal cords of offspring at P14 following MIA 
at E16 with 100µg/kg LPS. The network displayed significantly more interactions than 
expected when interrogated at the medium confidence level (0.400), with a PPI 
enrichment P-value of 0.00092. Edges = 5, average node degree = 0.526, average local 












GO:0005777 Peroxisome 4 of 92 0.00016 
GO:0005778 Peroxisomal membrane 3 of 34 0.00018 
GO:0005758 Mitochondrial intermembrane space 3 of 46 0.00025 
 
Table 6.3 Gene Ontology analysis showing enriched GO categories ‘peroxisome’, 








Rno04146 Peroxisome 4 of 82 0.0000295 
Rno00900 Terpenoid backbone biosynthesis 2 of 22 0.0038 
 
Table 6.4 KEGG pathways ‘peroxisome’ and ‘terpenoid backbone synthesis’ were 
enriched within the 19 differentially regulated genes. 
 
Uniprot Keywords 
Keyword Description Count in network False discovery rate 
KW-0576 Peroxisome 4 of 72 0.0000294 
KW-0152 Cholesterol biosynthesis 2 of 16 0.0035 
 
Table 6.5 Uniprot keywords ‘peroxisome’ and ‘cholesterol biosynthesis’ were enriched 







6.4.2.4 PCR confirmation of gene expression changes at P14 following MIA with 
100µg/kg LPS at E16 
 
PCR assay for the 16 genes which were differentially expressed at P14 after MIA at E16 
with 100µg/kg LPS was completed at n=7 (Table 6.2). Of the 16 differentially expressed 
genes 7 recapitulated the changes seen in the RNASeq data with some variation in log2FC 
values (Cat, Pmvk, Idi1, Pxmp4, Spag7, Kif19, and Snca). 3 genes differentially regulated 
in RNASeq showed little change in PCR analysis (S1pr1, Pla2g3 and Emcn). 4 genes 
which were upregulated in RNASeq were downregulated in PCR analysis (Txnip, 
Pex11a, Scara3 and Ppp1r10 ) while one gene which was originally downregulated 
showed upregulation on PCR analysis (Mcam) Figures 6.8 and 6.9. 
 
Figure 6.8 PCR expression of peroxisome-related genes identified as differentially 
expressed at P14 by RNASeq following MIA at E16 with 100µg/kg LPS.  Log2FC = 






































Figure 6.9 PCR expression of remaining genes identified as differentially expressed 
at P14 by RNASeq following MIA at E16 with 100µg/kg LPS.  Log2FC = log2 of the 






















































































High throughput studies such as microarray and RNA seq have changed how we 
formulate research questions, handle data and design experiments. This chapter has 
investigated the genome wide effects of MIA 5 hours and 14 days post maternal treatment 
with LPS at E12 or E16, with a view to forming an unbiased picture of the gene expression 
changes associated with MIA under the determined experimental conditions.  
Interestingly, at both 5hr and 14 days post treatment gene expression was unchanged in 
the spinal cords of offspring of dams treated with 100µg/kg LPS at E12 (Appendix A 
Figure A.2.4). This recapitulates the lack of change identified in many of the 
immunohistochemical studies in this project at E12, and further suggests that E12 may 
not be a particularly vulnerable period during rat spinal cord development for the 
investigated parameters.  
In contrast, MIA at E16 resulted in differential gene expression at both the 5hr and P14 
time points, further establishing E16 as a potential period of innate vulnerability to the 
effect of inflammation during rat spinal cord development. These gene expression 
changes differed between the embryonic and postnatal time points (Figure 6.2, 6.6) 
In the microarray study 42 genes were identified as differentially regulated 5hr after MIA 
at E16 (Table 6.1). These genes were largely unrelated to each other, showing very little 
interaction at a protein level when interrogated using STRING. GO analysis did not 
identify any enriched categories, KEGG analysis did not identify any pathways of interest 
and uniprot did not identify any enriched keywords within the 42 differentially regulated 
genes. However, these genes may be split into broader categories manually.  
Many of the differentially regulated genes play a role in the transcription machinery of 
the cell, for example, Mediator complex subunit 25 (Med25) encodes a part of the 




Polycomb group ring finger 2 (Pcgf2), is a negative regulator of transcription involved in 
the repression of genes involved in embryogenesis, cell cycle progression and 
tumourigenesis, while CST Telomere Replication Complex Component 1 (Ctc1), is a 
component of the CST complex, which may act to promote DNA replication under stress 
(Zakrzewska et al. 2011; Stewart et al. 2018).  
A number of the differentially regulated genes were involved in cell mobility and 
migration, including the microtubule associated cell migration factor Bcas3, which is 
involved in cytoskeletal rearrangement at the leading edge of the cell (Jain et al. 2012). 
Emerin (Emd), is an actin-binding and beta-tubulin-binding protein involved in the 
anchoring of the nuclear membrane to the cytoskeleton, the absence of which is associated 
with X-linked Emery–Dreifuss muscular dystrophy (Muntoni et al. 2006; Chang et al. 
2013). CAP-Gly Domain Containing Linker Protein 3 (Clip3), is a member of the 
cytoplasmic linker protein 170 family. Finally, fascin Actin-Bundling Protein 1 (Fscn1), 
plays critical roles in migration, motility, cell adhesion and cell-cell interactions (De 
Arcangelis et al. 2004; Kraft et al. 2006; Deng et al. 2012). The differential regulation of 
genes involved in migration during CNS development, a period of massive cellular 
migration, could be a factor which underpins a variety of potential outcomes of MIA 
during development. 
Many of the differentially regulated genes at the E16 5hr time point have known roles in 
the CNS, and more specifically in CNS development and maturation. Fscn1 is known to 
interact with the low-affinity nerve growth factor receptor (P75), and plays a role in 
neurite shape and trajectory (Kraft et al. 2006). Mutations in Med25 are associated with 
Charcot Marie Tooth disease, while Pcgf2 expression is limited to neural tissues where it 
is believed to modulate cytokine, chemokine and chemokine receptor function, which is 
interesting given the role of these molecules in neurodevelopment (Leal et al. 2009; 




and is assumed a regulator of genes related to neurogenesis due to nuclear/nucleolar-
restricted expression, meanwhile Proprotein Convertase Subtilisin/Kexin Type 1 
Inhibitor (Pcskn1)  inhibits prohormone convertase 1, which regulates the proteolytic 
cleavage of neuroendocrine peptide precursors (Tsukahara et al. 2000; Liu et al. 2012; 
Obara et al. 2019). Nuclear receptor binding protein 2 (Nrbp2) may regulate apoptosis of 
neural progenitor cells during their differentiation (Larsson et al. 2008). Myocyte 
Enhancer Factor 2D (Mef2d) is a member of the myocyte-specific enhancer factor 2 
(MEF2) family of transcription factors and is thought to play a role in neuronal 
development and differentiation (Assali et al. 2019). Mutations of Mef2d have been 
associated with the development of Parkinson’s disease (Yao et al. 2012). Other broad 
categories of genes differentially regulated 5hr after MIA at E16 included the Ras family 
of proteins, a number of tumor suppressor proteins and proteins involved in iron 
homeostasis. For a full list of the 42 genes differentially expressed in response to MIA 
and a short synopsis of their function see Appendix A, Table A.1.1. 
Contrary to the E16 5hr time point a number of the 16 genes differentially expressed at 
P14 following MIA at E16 were related, displaying protein-protein interaction on 
STRING analysis, as well as enrichment in gene ontology analysis, KEGG pathway 
analysis and uniprot keyword analysis (Figure 6.7, Table 6.2- 6.5). These 7 genes: 
(catalase (Cat), thioredoxin interacting protein (Txnip), phosphomevalonate kinase 
(Pmvk),  peroxisomal biogenesis factor 11 alpha (Pex11a), Isopentenyl-Diphosphate 
Delta Isomerase 1 (Idi1), peroxisomal membrane protein 4 (PXMP4) and scavenger 
receptor class A member 3 (Scara3),  were related to peroxisome structure and function.  
Peroxisomes are ubiquitous single-membrane organelles responsible for the catabolism 
of very long chain fatty acids, branched chain acids, D-amino acids and polyamines, as 
well as the synthesis of plasmalogens, cholesterol and bile acids (Smith and Aitchison 




are enriched in neural tissues and are expressed at higher levels during CNS development 
(Faust et al. 2005; Berger et al. 2016). A number of peroxisomal disorders effect the CNS 
including Zellweger syndrome and X-linked adrenoleukodystrophy. Peroxisomal 
disorders are known to result in abnormal neuronal migration, abnormalities or defects in 
the white matter and lipid inclusions (Faust et al. 2005). Oligodendrocytes, which are 
normally peroxisome-rich, are particularly vulnerable to peroxisomal deficits. Selective 
loss of peroxisomes in oligodendrocytes has been shown to result in demyelination, lipid 
inclusions, axonal death and inflammation (Paintlia et al. 2008). This may be due to the 
role of peroxisomes in plasmalogen and cholesterol biosysthesis, both of which are 
necessary building blocks of myelin. The seven peroxisomal genes differentially 
regulated at E16 play a variety of roles. Perhaps the best known, Cat is an anti-oxidant 
enzyme present in the peroxisome of all aerobic cells. It converts hydrogen peroxide to 
water and oxygen to prevent oxidative stress (Abramov and Wells 2011). Txnip is a 
negative regulator of thioredoxin, which protects against oxidative stress (Alhawiti et al. 
2017) . Pmvk and Idi1 meanwhile are peroxisomal enzymes involved in isoprenoid 
biosynthesis. Isoprenoids include cholesterol, haem, the steroid hormones and vitamin K 
(Lange et al. 2000). Pex11a and Pxmp4 both play roles in the peroxisomal membrane, 
interacting with Pex19 (Sacksteder et al. 2000). Pex11a is a membrane elongation protein, 
which has a role in increasing peroxisomal abundance in the cell (Koch et al. 2010). 
Pxmp4 is a component of the peroxisomal membrane the exact function of which is 
unknown. Differential expression of these genes suggest that MIA at E16 may result in 
unexpected changes in peroxisome function, which may underpin some of the effects of 
MIA on CNS development at this time point and later. Interestingly Scara3, which is a 
macrophage scavenger-like receptor that depletes ROS in the cell, is upregulated at P14 




in the cell in response to decreases in catalase and thioredoxin functioning (Han et al. 
1998). 
Similarly to the 5hr time point a number of genes differentially regulated at P14 following 
MIA at E16 included genes which may be involved in neuronal migration, cell motility 
and cell-environment interactions. These included the cell adhesion related genes 
Sphingosine-1-phosphate receptor 1 (S1pr1), activation of which causes cell-cell 
adhesion and the melanoma cell adhesion molecule (Mcam), which may be activated 
during the development of the neural crest (Motohashi et al. 2016; Jiang et al. 2017). 
Endomucin (Emcn) is known to inhibit interaction between the cells and the extracellular 
matrix (Zahr et al. 2016). Kinesin family member 19 (Kif19), a regulator of microtubule 
polymerisation in motile cilia, and phospholipase A2 group III (Pla2g3), which negatively 
regulates ciliogenesis, are also differentially expressed (Niwa et al. 2012; Gijs et al. 
2015). A number of genes related to the progression of the cell cycle were also altered at 
P14 following MIA at E16, including Protein Phosphatase 1 Regulatory Subunit 10 
(Ppp1r10) and frizzled class receptor 9 (Fzd9). 
The changes in gene expression identified in the spinal cords of offspring using 
sequencing studies at E16 and P14 following MIA at E16 with 100µg/kg LPS have 
provided evidence that MIA at E16 can affect the CNS at the level of gene expression. 
These changes differed at the 5hr and P14 time point further emphasising the complexity 
of the effect of MIA. The studies also confirmed that MIA with the relatively low dose of 
100µg/kg LPS was sufficient to provoke gene expression changes in offspring. RNA 
sequencing of spinal cords of P14 offspring identified the peroxisome as a cell organelle 
which is potentially vulnerable to MIA, and alterations in these single membrane 
structures may play a role in the effect of MIA at cellular level, particularly in the case of 
oligodendrocytes, a cell type already identified as particularly vulnerable to MIA. 




number of genes (Figure 6.8, 6.9). This could be due to differences in comparative 
methods between the studies, variations in gene expression between offspring sequenced 
in the relatively small n=3 study, or the increase in offspring number in the PCR study 
from n=3 to n=7. PCR analysis of the three animals used in the RNASeq experiment did 
not recapitulate the gene expression changes seen in the RNASeq experiment (data not 
shown), indicating that differences in methodologies is a factor in this instance. It is likely 
that a combination of all three possibilities is at play. The relatively small gene expression 
changes observed in the original RNASeq may also have contributed to this failure to 
confirm. Further investigation in both RNASeq and RT-PCR experiments would be 
necessary before drawing conclusions. These future studies would ideally use a greater 
number of litters and a single sex group. Analysis of specific regions of the spinal cord, 
such as the dorsal or ventral horn, or specific cell types such as oligodendrocytes 
following flow cytometry, may also prove useful for pinpointing the source of gene expression 





















Chapter 7. The role of miRNAs in 





















7.1 Chapter Abstract 
 
This study used in-silico analysis to investigate the role of miRNAs in 
oligodendrogliogenesis, with a view to identify potential proteins and pathways targeted 
by miRs which may be vulnerable to the effects of MIA. 
The study identified thousands of genes potentially targeted by the miRNAs miR-9, miR-
124, miR-138, miR-146a, miR-219(2-3p) and miR-338 . GO analysis, KEGG pathway 
analysis and STRING analysis of protein-protein interaction were used to further focus 
the results and identified  inflammatory pathways, developmental pathways and apoptotic 
pathways which may be modulated by microRNAs during development, and potential 
targets which may function in oligodendroglial response to MIA.  
This study suggests that miRNAs may be an interesting pathway for  further investigation 
















MicroRNAs (miRNAs, miRs) are small ~21-25 nucleotide (nt) long non-coding RNAs. 
miRNAs modulate translation of mRNA to protein by binding to an mRNA target 
sequence, usually at the 3’- untranslated region (UTR), as a part of the RNA-induced 
silencing complex (RISC)(R.C. Lee et al. 1993; He and Hannon 2004; Rodriguez et al. 
2004). Inhibition of translation occurs through mRNA cleavage, if the miRNA is an exact 
match for its target mRNA sequence, or more commonly in animals, through repression 
of translation or deadenylation, where the miRNA is an imperfect match(Brennecke et al. 
2005; Eulalio et al. 2009). This appears to be largely dependent on the perfect 
compatibility of nucleotides 2-7nt known as the ‘seed region’ with target mRNA, though 
non-canonical binding has been suggested (Lewis et al. 2005; Grimson et al. 2007; 
Helwak et al. 2013; Khorshid et al. 2013).  The ability of an miRNA to imperfectly match 
and repress an mRNA target ensures that each miRNA may have multiple mRNA targets 
on which they act. Indeed it is predicted that around 30% of the human genome is targeted 
by these miRNAs(Lewis et al. 2005; Lim et al. 2005). Since their discovery in 1993 
miRNAs have been implicated in a vast array of processes, including cancers, heart 
disease, inflammatory disorders, neurodevelopmental diseases and liver diseases, as well 
as normal physiological processes such as development (R.C. Lee et al. 1993; Ardekani 
and Naeini 2010; Sayed and Abdellatif 2011). For a full review of miRNA structure and 
function as well as the roles of miRNA in development see Chapter 1, 4.1-4.2. 
A number of microRNAs have been implicated in the process of oligodendrogliogenesis. 
Indeed, a study by Lau et al. has identified as many as 98 miRNAs associated with the 
OL lineage, 43 of which are differentially regulated during differentiation (Lau et al. 
2008). This chapter looks at six of the miRNAs most commonly associated with 




miR-219 and miR-338), and attempts to delineate the mechanisms and pathways these 
miRs target in order to alter oligodendrogliogenesis. 
miR-124 is a CNS specific miR reportedly neuronal in origin(Cheng et al. 2009). In HeLa 
cells, miR-124 is known to induce the expression of a neuronal phenotype(Lim et al. 
2005). miR-124 is downregulated during oligodendrogliogenesis, however selected 
knockdown of miR-124 in a zebrafish model has been shown to result in a decrease in 
oligodendrocyte number and myelination of axonal projections in the ventral hindbrain 
(Morris et al. 2015). 
miR-9 is a key regulator of differentiation, and is thought to repress NSC proliferation 
through binding of TLX (Zhao et al. 2009). In the 2008 study by Lau et al. a decrease in 
miR-9 was also found to promote oligodendrocyte proliferation (Lau et al. 2008). Levels 
of peripheral myelin protein 22 (PMP22) are known to inversely correlate to miR-9, with 
increasing levels of PMP22 associated with decreases in miR-9 (Verrier et al. 2009).  
miR-219 on the other hand is known to repress factors known to promote OPC 
proliferation (PDGFRα, Sox6, FoxJ3, Hes5 and ZFP238) thereby allowing differentiation 
to occur (Dugas et al. 2010). A study by Zhao et al. has also shown miR-219 to target the 
neurogenic transcription factors Isl1, NeuroD1 and Otx2 (Zhao et al. 2010). miR-219 
expression is induced 100-fold during oligodendrocyte differentiation, and is increased in 
both early and later stages. Expression of miR-219 and miR-138 is sufficient to induce 
differentiation (Dugas et al. 2010). ELOVL7 is a known target of miR-219, and is the 
main biochemical abnormality in x-linked Adrenoleukodystrophy, which results in the 
build-up of long chain fatty acids in the brain and ultimately myelin sheath destruction. 
This indicates that miR-219 may also have a role in the production and maintenance of 




In the same study that identified miR-219 and miR-138 as sufficient to induce OPC 
differentiation Dugas et al. also showed that miR-138 is increased during OPC 
differentiation. Use of a miR-138 mimetic showed that miR-138 promotes the expression 
of markers associated with early differentiation, not late, suggesting that it may serve to 
increase the time spent in early stages of differentiation, possibly to allow for correct axon 
selection and myelination (Dugas et al. 2010). A study by Birch et al. showed a delayed 
but significant increase in miR-138 and miR-338 following perinatal hypoxia ischemia 
(Birch et al. 2014).  
Aside from a role in hypoxia-ischemia miR-338 is known to promote OL differentiation, 
inhibiting proliferation (Lau et al. 2008; Zhao et al. 2010). Overexpression of miR-338 
through lentiviral infection is enough to induce the differentiation of human endometrial 
derived stromal cells to OLs (Ebrahimi-Barough et al. 2013).  
Similar to the role in hypoxia-ischemia and immune response identified in miR-138 and 
miR-338, miR-146a also appears to have a role in immune function. miR-146a is known 
to downregulate the TLR pathway and NFκB activation (Nahid et al. 2011; Santra et al. 
2014). IRAK1 and TRAF6 are both targets of miR-146a. Increase in miR-146a is 
associated with the increased maturation of OLs, while inhibition leads to a decrease in 
MBP expression (Santra et al. 2014; Liu et al. 2017). Interestingly miR-146a knockout 
has been examined in a model of MIA, where chronic LPS exposure accompanied by 
miR-146a knockout lead to a decrease in haemopoetic stem cell numbers, differentiation 
to dysfunctional lymphocytes and myeloid cells, and an increase in IRAK1, TRAF6 and 
NFkB, activating the IL-6 Pathway (Zhao et al. 2013). 
This chapter investigates the underlying mechanisms and pathways by which the above 
mentioned miRs effect oligodendrogliogenesis, through use of free-to-access software 




cost effective, allowing researchers to streamline projects and identify potential 






















7.3 Chapter Aims 
 
The objective of this study was: 
 
1. To use the literature to identify miRNAs which appear to play a role in 
oligodendrogliogenesis 
2. To use open source software to identify predicted targets of these miRNAs in 
order to further elucidate the mechanisms by which these miRNAs affect 
oligodendrogliogenesis 
3. To identify signalling networks targeted repeatedly by these miRNAs and 

























7.4.1 Identification of predicted targets 
 
Predicted targets of miR-9, miR-124, miR-138, miR-338, miR-219(2-3p) and miR-146a 
were identified using miRecords’ open source software 
(http://c1.accurascience.com/miRecords/prediction_query.php). Targets identified by 
one or more of the target identification softwares used by miRecords numbered in the 
thousands for each miRNA (miR-9 – 3766 predicted targets, miR-124 – 2080 predicted 
targets miR-138 – 2931 predicted targets, miR-338 – 2928 predicted targets, miR-219 (2-
3p) – 1845 predicted targets and miR-146a – 2682 predicted targets). These predicted 
targets were then further filtered using gene ontology (GO) analysis.  
7.4.2 Gene ontology analysis. 
 
Predicted targets identified using the miRecords software underwent GO analysis using 
webgestalt (http://bioinfo.vanderbilt.edu/webgestalt/), an open source, web-based gene 
set analysis toolkit. Enriched ontologies of interest included neurogenesis and nervous 
system development, with the most specific nervous system-related gene ontology 
category brought forward for further analysis. The miRNAs, enriched gene ontologies of 
interest, the number of potential targets in that category, and the adjusted P-Values of this 
enrichment can be viewed in table 7.1. A complete list of all predicted targets contained 
in the enriched GO categories of interest, either ‘neurogenesis’ or ‘nervous system 










miR-9 Neurogenesis 189 2.6 x 10-5 
miR-124 Neurogenesis 119 4.54 x 10-5 
miR-138 Nervous system development 224 1.26 x 10-7 
miR-146a Nervous system development 174 0.0052 
miR-219(2-3p) Nervous system development 138 0.0046 
miR-338 Nervous system development 204 8.89 x 10-5 
Table 7.1 Gene ontology analysis identified enriched ontologies of interest. The 
potential targets contained within these categories were brought forward for STRING 
analysis 
7.4.3 STRING analysis of protein-protein interactions 
 
Predicted targets contained within each enriched GO category of interest were imported 
into STRING (v.11) and their protein-protein interactions interrogated at the highest 
confidence level (0.900). To achieve a more manageable number of predicted targets for 
further investigation, and to allow investigation of key pathways which may be effected 
by miRNAs during oligodendrogliogenesis, nodes or proteins which were not connected 
to another potential target at the highest confidence level were excluded from further 
investigation. The remaining predicted targets were displayed in a STRING network 
using ‘molecular action’ as the meaning of the network edge to allow visualisation of the 







Line Colour Interaction Type 
Green Activation 
Red Inhibition 
Blue (royal) Binding 
Blue (turquoise)  Phenotype 
Purple Catalysis 




Table 7.2 Legend for the interaction type of predicted targets using ‘molecular 
action’ as the meaning of the network edges. 
 
Symbol Action effect 
→ Positive 
―I Negative 
 ―• Unspecified 
 
Table 7.3 – Definition of symbols present in the network analysis using ‘molecular 














The 189 predicted targets of miR-9 enriched in the gene ontology category ‘neurogenesis’ 
created a network with 60 edges, or interactions (Figure 7.1). The expected number of 
interactions or edges for a random group of proteins of similar size is 30, resulting in a 
PPI enrichment p-value of  1.32 x 10-6.  
 
 
Figure 7.1. STRING v11 output for the molecular interaction of predicted targets of 
miR-9 contained within the GO category ‘neurogenesis’. Number of nodes – 188, 
Number of edges – 60, Average node degree – 0.638, Average local clustering co-
efficient – 0.276, Expected number of edges – 30, PPI enrichment P-value – 1.32 x 10-6. 






The 119 predicted targets of miR-124 enriched in the GO category neurogenesis created 
a network with 32 edges (Figure 7.2). The expected number of edges for a random group 
of proteins of a similar size is 15 edges, resulting in a PPI enrichment p-value of 7.61 x 
10-5. 
 
Figure 7.2. STRING v11 output for the molecular interaction of predicted targets of 
miR-124 contained within the GO category ‘neurogenesis’. Number of nodes – 119, 
Number of edges – 32, Average node degree – 0.538, Average local clustering co-
efficient – 0.215, Expected number of edges – 15, PPI enrichment P-value – 7.61 x 10-5. 









The 224 predicted targets of miR-138 enriched in the GO category ‘nervous system 
development’ created a network with 89 edges (Figure 7.3). The expected number of 
edges for a random group of proteins of a similar size is 36 edges, resulting in a PPI 
enrichement p-value of 6.14 x 10-14. 
 
Figure 7.3. STRING v11 output for the molecular interaction of predicted targets of 
miR-138 contained within the GO category ‘nervous system development’. Number of 
nodes – 224, Number of edges – 89, Average node degree – 0.795, Average local 
clustering co-efficient – 0.272, Expected number of edges – 36, PPI enrichment P-value 






The 174 predicted targets of miR-146a enriched in the GO category ‘nervous system 
development’ created a network with 68 edges (Figure 7.4). The expected number of 
edges for a random group of proteins of a similar size is 28 edges, resulting in a PPI 
enrichement p-value of 1.75 x 10-10. 
 
Figure 7.4. STRING v11 output for the molecular interaction of predicted targets of 
miR-146a contained within the GO category ‘nervous system development’. Number of 
nodes – 174, Number of edges – 68, Average node degree – 0.786, Average local 
clustering co-efficient – 0.328, Expected number of edges – 28, PPI enrichment P-value 








The 138 predicted targets of miR-219 (2-3p) enriched in the GO category ‘nervous system 
development’ created a network with 50 edges (Figure 7.5). The expected number of 
edges for a random group of proteins of a similar size is 23 edges, resulting in a PPI 
enrichement p-value of 1.09 x 10-6. 
 
Figure 7.5. STRING v11 output for the molecular interaction of predicted targets of 
miR-219 (2-3p) contained within the GO category ‘nervous system development’. 
Number of nodes – 138, Number of edges – 50, Average node degree – 0.735, Average 
local clustering co-efficient – 0.243, Expected number of edges – 23, PPI enrichment P-
value – 1.09 x 10-6. Unconnected nodes not shown. Gene symbol abbreviations appendix 





The 204 predicted targets of miR-338 enriched in the GO category ‘nervous system 
development’ created a network with 60 edges (Figure 7.6). The expected number of 
edges for a random group of proteins of a similar size is 33 edges, resulting in a PPI 
enrichement p-value of 1.89 x 10-5. 
 
Figure 7.6. STRING v11 output for the molecular interaction of predicted targets of 
miR-338 contained within the GO category ‘nervous system development’. Number of 
nodes – 204, Number of edges – 60, Average node degree – 0.594, Average local 
clustering co-efficient – 0.229, Expected number of edges – 33, PPI enrichment P-value 








STRING analysis of the enriched pathways associated with the predicted targets of the 
selected miRNAs yielded some unexpected results. Possibly counter intuitively just two 
miRNAs, miR-9 and miR-146a, yielded predicted targets traditionally associated with 
oligodendrocyte function (Appendix B, Table B.1 and Table B.4). miR-9 was predicted 
to target both Olig2 and Sox10. The bHLH transcription factor Olig2 is expressed by 
newly arisen oligodendrocyte lineage cells and is necessary for the activation of HMG-
domain transcription factor Sox10, a key component in oligodendrocyte maturation 
(Küspert et al. 2011). Previous research by Lau et al. has indicated that miR-9 is 
downregulated in Oligodendrocytes during differentiation. In OPCs mir-9 is expressed at 
high levels while miR-9 targets are expressed at low levels. In OLs the opposite occurs 
(Lau et al. 2008). Decreases in miR-9 levels at differentiation are suggestive of decreased 
regulation of the Olig2 mediated activation of Sox10 allowing for the maturation of OPCs 
to OLs. miR-146a meanwhile, was predicted to target MBP and PLP (proteolipid protein). 
PLP and MBP are located within the myelin sheath and comprise 80% of all myelin 
proteins (Baumann and Pham-Dinh 2001). MBP and PLP bind each other, and appear to 
be responsible for the compaction of myelin during the myelination process. They are 
markers of mature oligodendrocytes. Interestingly previous work has indicated that miR-
146a expression is upregulated during oligodendrocyte differentiation (Lau et al. 2008). 
This suggests that, should its predicted targets MBP and PLP1 be validated, fine tuning 
of the myelination process may be necessary. This is in line with research which suggests 
that increased expression of miR-146a promotes the differentiation of OPC’s to MBP 
expressing OLs and that the inhibition of miR-146a may lead to the inhibition of MBP 
expression (Santra et al. 2014; Liu et al. 2017). Other work has suggested that increases 




indicative of the fine balance necessary for the induction of correct myelination (Karim 
et al. 2007). 
Although the number of traditionally oligodendrocyte-associated pathways identified was 
low, a number of pathways predicted to be targeted by the selected miRNAs were 
common to multiple miRNAs. Predicted targets associated with pathways involving 
MAPK8, or c-Jun N-terminal kinase 1 (JNK1) signalling were common to five of the six 
investigated miRs; miR-9, miR-138, miR146a, miR-219 and miR-338. JNK1 itself was a 
predicted target of all five miRs. miR-124, which is downregulated during differentiation, 
did not have potential targets related to JNK signalling. JNK signalling is traditionally 
associated with inflammatory processes. Indeed, IRAK1 and Traf6 are both validated 
targets of miR-146a. miR-146a knock out in a chronic LPS model was enough to decrease 
haemopoetic stem cell numbers and induce differentiation of dysfunctional lymphocytes, 
increasing IRAK1, TRAF6 and NFkB expression. During oligodendrogliogenesis 
modulation of inflammatory pathways is of incredible importance as oligodendrocytes 
are particularly prone to inflammatory injury (for review see (Volpe et al. 2011)). JNK 
signalling is also associated with a number of developmental processes including 
differentiation, proliferation, cell death, cell survival and protein expression. It is 
therefore unsurprising that predicted targets associated with this pathway are numerous, 
and span miRNAs both upregulated and downregulated during oligodendrocyte 
differentiation (Lau et al. 2008). Previous research has shown oligodendrocyte 
development to rely on p38-MAPK mediated Sox-10 regulation and cross talk with the 
parallel JNK pathway to repress c-Jun activity. Inhibition of c-jun accumulation and p38-
MAPK inhibition promotes the expression of myelin genes and developmental 
progression to OL (Chew et al. 2010). In this study just one miRNA potentially targeted 
Jun directly, miR-338. miR-338 has been previously validated as playing a role in 




mutants show decreased expression(Lau et al. 2008; Zhao et al. 2010). Contrary to this a 
study by Dugas et al has suggested that miR-338 alone is not necessary for myelination 
to occur (Dugas et al. 2010). This was confirmed in a study by Wang et al, who found 
that miR-338 -/- mice showed normal myelination. miR-338 knock out did however 
exasperate a dysmyelination phenotype shown by miR-219 -/- mice, indicating that these 
miRNAs may cooperate with one another (Wang et al. 2017). Nuclear factor kB (NFkB) 
activation is a potential outcome of JNK signalling. Traditionally a pathway associated 
with inflammation and cell death the role of NFkB in normal myelination is uncertain. 
One study has shown that patients with additional copies of the IKBKG gene, which 
encodes the NFkB essential modulator (NEMO), have myelination defects, suggesting 
NFkB is needed for myelination, however a number of transgenic animal studies have 
suggested that NFkB signalling is dispensable (Raasch et al. 2011; Philippe et al. 2013; 
Kretz et al. 2014). Regardless of the uncertainty to NFkB’s developmental role in 
oligodendrocytes, five of the six miRNAs investigated in the study had potential targets 
such as Tumour necrosis factor receptor associated factor 6 (TRAF6; miR-138, miR-
146a, miR-219), Protein kinase C iota (PRKCI; miR-9, miR-146a, miR-219) and Nerve 
growth factor receptor (NGFR; miR-9, miR-219, miR-338). Traf6 and Prkci bind and 
form part of a complex with Ngf (nerve growth factor), Ngfr and interleukin 1 receptor 
associated kinase (Irak1) which favours NfkB activation (Mamidipudi et al. 2004). miR-
138, which only had one potential target in the complex, is the only miRNA to potentially 
target REL associated protein (Rela). Also known as p65 Rela is a member of the NFkB 
family and is involved in NFkB heterodimer formation, nuclear translocation and 
activation (Chen and Greene 2004). Negative regulation of NFkB signalling by miR-138, 
miR-146a, miR-219 and miR-338 is in line with studies showing that NFkB signalling is 




downregulated during differentiation, and Jun itself by miR-338 are indicative of the 
complex signalling pathways at play (Raasch et al. 2011; Kretz et al. 2014). 
In line with the activation of NFkB and potentially apoptotic pathways miR-138, miR-
146a, miR-219 and to a lesser extent miR-338, all had targets in or related to the caspase 
family, a family of protease enzymes with roles in programmed cell death or apoptosis. 
Capsases are responsible for programmed cell death in the oligodendrocyte and apoptosis 
of excess OPCs is a normal part of oligodendrocyte development. Unsurprisingly spatial 
and temporal control of this process is crucial and apoptosis of more mature, MBP+ 
oligodendrocytes impacted myelination. This impact was transitory, however did effect 
remyelination in the animals as adults (Gu et al. 1999; Caprariello et al. 2015). Neither 
miR-9 or miR-124, both of which are downregulated at differentiation, displayed targets 
within the Caspase family, perhaps indicative of the role of apoptosis in early 
development, when both miRNAs are strongly upregulated. miR-338, the only miR which 
targeted NFkB signalling through the Ngfr, but not through Traf6 or Prkci, targeted just 
a single member of the Caspase family, Casp 2, suggesting that miR-338 may be more 
involved in the potential regulation of JNK targets other than NFkB signalling and cell 
death. 
miR-138 and miR-338 have previously been characterised in a study investigating 
oligodendroglial response to Hypoxia-ischemia (HI), which damages the vulnerable 
white matter and causes cerebral palsy and leukomalacia when occurring perinatally 
(Volpe et al. 2011). The study showed that both miR-138 and miR-338 underwent 
delayed upregulation in response to perinatal HI at P7 (Birch et al. 2014). This delay in 
upregulation is counterintuitive as miR-138 and miR-338 are both upregulated during 
differentiation, a process HI is known to negatively effect (Dugas et al. 2010). It is 
possible that HI transiently inhibits dicer and that this delayed upregulation is a rebound 




miR-138 and miR-338 have potential targets involved in HI. miR-138 displayed potential 
targets Hypoxia inducible factor 1a (Hif1a), Aryl hydrocarbon receptor nuclear 
translocator (Arnt) and Heparin-binding EGF-like growth factor (Hbegf). Hif1a and Arnt 
are both components of Hif1. Hifs, or hypoxia inducible factors are bHLH transcription 
factors upregulated in response to low cellular oxygen or hypoxia. During embryonic 
development Hifs are important for angiogenesis. This role for Hifs in angiogenesis is 
particularly important in OPCs, which display large metabolic requirements as they 
produce myelin and therefore require adequate blood supply. A study by Yeun et al has 
shown that postnatal myelination is dependent on oxygen levels in the cell, as mediated 
by OPC encoded Hif (Yuen et al. 2014). Under normoxic conditions Hifs are 
hydroxylated at conserved proline residues which marks them for ubiquitination. During 
hypoxia the Hif prolyl-hydroxylase is inhibited and Hifs are stabilised. Constitutive 
stabilisation of Hif1/2α (hypoxic conditions) resulted in the arrest of OPC maturation 
through autocrine activation of canonical Wnt7a/7b, while OPC-specific Hif1/2α loss of 
function leads to insufficient angiogenesis in corpus callosum and catastrophic axon loss. 
As well as Hif1a and Arnt, components of Hif1, this study has also suggested that Hbegf 
is also a potential target of miR-138. Hbegf is upregulated in response to hypoxia-
ischemia and has been shown to stimulate neurogenesis in response to HI (Jin et al. 2002). 
Hbegf is expressed in oligodendrocytes and is a physiological ligand of the EGF receptor, 
recent evidence suggests that EGF is an important mitogen in oligodendrocyte 
development suggesting that HI induced Hbegf expression may cause 
oligodendrogliogenesis (Hayase et al. 1998; Yang et al. 2017). Negative regulation of 
Hbegf by miR-138 may help to prevent the spurious development of oligodendrocytes, a 
process that is under physiological conditions, strongly temporally and spatially 
controlled, in response to HI. miR-338 similarly to miR-138 potentially targets both Hif1a 




development of oligodendrocytes and angiogenesis, and in oligodendrocyte response to 
HI. 
As suggested in the study by Yuen et al WNT signalling plays a key role in both 
oligodendrocyte development and development as a whole. WNT signalling is involved 
in axon patterning, cell fate specification, proliferation and migration and is tightly 
regulated. Of the investigated miRNAs miR-138, miR-146a, miR-219 and miR-338 
potentially negatively regulate wnt signalling during oligodendrocyte differentiation. 
These miRs display potential targets such as the WNT proteins (miR-138, miR-146a, 
miR-219 and miR338) and Frizzled (Fzd1; miR-146a) themselves as well as co-receptor 
lipoprotein receptor-related protein 6 (LRP6; miR-138 and miR-219) and negative 
regulators Axin1, Dickkopf (DKK; miR-219) and Secreted frizzled related protein 1 
(Sfrp1; miR-146a). WNT related functions like axis patterning, cell fate determination 
and cell proliferation are unnecessary in later development, as such negative regulation is 
sensible. miR-9 and miR-124, the miRNAs upregulated during development, do not 
display potential targets in the Wnt signalling pathway. 
Across the miRNAs in this study proteins involved in axon guidance have been common 
potential targets. miR-9, miR-124, miR138, miR-146a and miR-338 all potentially target 
members of the Ephrin family. Ephrins and their receptors, Eph, are membrane bound. 
Contact between Eph and Ephrin ligands and the bidirectional signalling that results is 
necessary for the control of cytoskeletal dynamics in both axons and dendrites and the 
development of functional circuits and synapses (Xu and Henkemeyer 2012). In the 
oligodendrocyte, Ephrins have been shown to be regulators of the intial axo-glio 
interaction that precedes myelination. The distinct bidirectional signalling exhibited by 
Eph and Ephrin has opposite and opposing effects on myelination. Both Epha and Ephb 
forward signalling have a negative effect on myelin sheath formation whereas ephrin-B 




suggests that Ephrins may play a role in the selection of which axons are myelinated 
(Linneberg et al. 2015). The potential negative modulation of Ephrin and Eph family 
members by miRNAs during this process adds another layer of complexity to the 
bidirectional process. Two of the miRNAs, miR-9 and miR-124 are downregulated during 
oligodendrocyte differentiation but upregulated during early development. Both 
potentially target Ephrins suggesting a role for Ephrins in early development. Indeed 
Eph/ephrin bidirectional signalling appears to regulate the migration of OPCs in the optic 
axonal tracts to their target locations (Prestoz et al. 2004). 
The semaphorin family, and their receptors, the plexins, are another group of proteins 
involved in axonal guidance that are potential targets of a number of the miRs investigated 
in this study. miR-138, miR-146a, and miR-338 all have potential targets within the 
family. In the oligodendrocyte semaphorins are known as inhibitory molecules. 
Semaphorin 4D is expressed during myelination and has been shown to have a strongly 
inhibitory effect on axonal growth (Moreau-Fauvarque et al. 2003). Likewise Semaphorin 
6A is highly expressed during myelination. Interestingly Sema6A deficient mice show 
delayed and disturbed myelination, suggesting that the expression of Sema6A is a 
necessary part of the myelination process (Bernard et al. 2012).  The same group found 
in an in-vitro study that differentiation of purified oligodendrocytes lacking Sema6A was 
perturbed and this correlated with a reduction of the expression level of Myelin Basic 
Protein. Negative modulation of the semaphorin family during differentiation by miRs 
like miR-138, miR-146a and miR-338 may play an important role in oligodendrocyte 
differentiation and later myelination. 
This in-silico investigation into the role of microRNAs in oligodendrogliogenesis has 
yielded a number of potential pathways of particular interest. The roles of miRNAs in 
oligodendrogliogenesis seem to be diverse and overlapping. Fine tuning of complex cell 




potential targets, is important for normal oligodendroglial development. As illustrated 
regulation of spatial and temporal expression can be the difference between migration 
and myelination in the case of the Ephrin family, and well-timed and spurious 
neurogenesis in the case of the hypoxia protein Hbegf. miR-9 and miR-124 displayed 
markedly different enriched pathways to miR-138, miR146a, miR-219, and miR-338, in 
line with their differential expression during oligodendrocyte development. Pathways 
common to both, such as the NFkB pathway in the case of miR-9, and the Ephrins,  have 
significant roles to play in both pre and post differentiation. The results were in line with 
the existing literature on validated targets of the miR’s investigated, in particular in the 
case of miR-138 and miR-338 and their demonstrated role in HI, suggesting that this 
study provides an excellent starting point for an investigation of the downstream targets 












































Since epidemiological studies first suggested a link between MIA and the occurrence of 
neurodevelopmental and neuropsychiatric disorders researchers have been attempting to 
further delineate the critical periods during neurodevelopment at which the adverse 
effects of MIA are felt. These studies have largely utilised animal models of MIA, which 
allow researchers to more directly observe the effects of MIA in offspring; with tighter 
control over variables such as insult type, dose and timing during gestation. This project 
aimed to investigate both the immediate and longer-term cellular and molecular 
consequences of MIA on the cytoarchitecture of the developing spinal cord of rats, 
focusing on a number of cell types and insult time points. 
Over the course of this research E16 has emerged as a developmental stage of partiular 
vulnerability to MIA in the developing rodent spinal cord. More specifically, inducing 
MIA at E16 with an i.p injection of 100µg/kg LPS appeared to have an acute effect on 
oligodendrocytes and microglia of offspring, as well as on the expression of reelin. In 
sequencing studies MIA at E16 had an acute effect on gene expression in offspring, as 
well as an effect on gene expression at P14, which differed from that at the 5h time point. 
E16 in the rat spinal cord is a period of significant developmental change. Neurogenesis, 
microglial invasion, astrogliogenesis and oligodendrogliogenesis have all begun (Barry 
and McDermott 2005; Cai et al. 2005; Gotz and Huttner 2005; Rigato et al. 2011). There 
is a considerable amount of cell and axonal migration occurring in order to establish the 
correct neuro-circuitry as well as laying the framework for later processes such as 
myelination and synaptic refinement. In humans, this time period correlates to roughly 
midway through the second trimester of pregnancy, a period already identified as 
potentially vulnerable to MIA in a number of epidemiological studies (Atladottir et al. 
2010; A. S. Brown and E. J. Derkits 2010; Patten et al. 2014). 
The findings of this project suggests that the acute changes observed in oligodendrocytes, 




of factors, and transience in the effect of MIA has been regularly reported in previous 
studies (Rousset et al. 2006; M. Makinodan et al. 2008; Rousset et al. 2013). It may 
simply be the case that the spinal cord has recovered from the insult due to the high 
plasticity of the developing CNS (Kaas 2001). In the case of microglia it may be that 
colonisation of the cord was simply delayed by MIA, as these cells arise outside the CNS. 
It is also possible that changes in cell number and marker expression observed 5h after 
MIA at E16 are masked by synaptic pruning and apoptosis,  which occur as part of normal 
development in the CNS (Riccomagno and Kolodkin 2015). The fact that the acute 
changes did not persist at P14 could also be the result of decisions made at an 
experimental level. The use of broad markers such as Olig2 and Iba-1 for example, which 
allow for cell counting but may not necessarily illustrate the increasingly complex 
environment of the spinal cord. Cell counts, while extremely robust, may not reflect more 
delicate changes in the examined cell populations. It is possible that changes in the cord 
postnatally are simply too subtle for these observation protocols. 
Despite the observed transience in the effect of MIA on the spinal cord changes at a 
cellular level at E16 may have long lasting consequences for neuronal positioning and 
connectivity, as well as myelination of the mature spinal cord. Although the methods 
chosen in the immunohistochemical section of this project may not capture it, changes at 
a cellular level at E16 could facilitate more subtle molecular changes postnatally. Indeed 
RNA Seq changes did indicate postnatal molecular changes. These subtle changes in 
neuronal connectivity, myelination and gene expression could serve to ‘prime’ the CNS 
to further insult.  
The studies contained within this thesis used a spinal cord model to investigate the cellular 
and molecular changes resulting from MIA to good effect. Using the spinal cord model, 
it was able to illustrate gross cellular changes as well as molecular changes in response 




any given embryonic and early postnatal age made it possible to demonstrate the 
importance and constraints of timing and anatomical location on the effect of MIA on 
offspring while simultaneously demonstrating the complexity of the CNS response to 
MIA in a presumed simple model. Unfortunately, relatively little work has looked at the 
effect of maternal infection on the human spinal cord in the past. Congenital varicella 
syndrome, an extremely rare disorder usually resulting from maternal varicella infection 
at 8-20 weeks gestation, is known to effect the spinal cord, leading to nerve damage and 
denervation. Following the primary infection the virus is believed to remain dormant in 
the sensory root ganglion of the spinal cord. Viral inflammation of this ganglion is 
believed to be the cause of the skin lesions, muscular skeletal deficits, and problems 
encountered in autonomic nervous system in the periphery as a result of infection(Adams 
Waldorf and McAdams 2013). Both cerebral palsy and PVL have known links to maternal 
infection in the human also. Both effect communication between the motor cortex and the 
spinal cord leading to spasticity, problems with coordination and sensory processing, and 
in the case of cerebral palsy, potential upper motor neuron lesion of the 
corticospinal/pyramidal tracts, however much of the neurological research in these 
diseases is focused in the brain (Bar-On et al. 2015). Despite this, the rat spinal cord has 
proven to be a robust model for the investigation of the effect of MIA on the developing 
CNS. Many of the observations of normal cellular development in control animals 
recapitulated previous studies on spinal cord development which is encouraging in 
relation to the validity of the model. 
Acknowledgement of the limitations of experimentation is important, and careful 
interpretation of results is key to effective scientific enquiry. Accordingly a number of 
limitations of the studies presented in this thesis must acknowledged. A number of the 
studies in this thesis were affected by a small sample size, in particular the sequencing 




three in embryonic studies where each sample was a pooled litter. This is also true of the 
E12 5h reelin immunofluorescence study, in which the saline group number was also 
three. Ideally, in all studies a higher number of litters would have better served to 
eliminate the effects of inter-litter variability. The small sample sizes in these studies were 
multi-factorial in nature but included problems with the availability of tissue, issues with 
the quantities of embryonic spinal cord tissue recovered during dissection, and time 
constraints in relation to the preparation and processing of whole spinal cords for 
immunohistochemical study. Nonetheless, I believe the data produced from the available 
animals to be robust and informative. 
Some may consider the breadth of this study a limitation of its effectiveness. Indeed many 
studies have investigated the effect of MIA on individual cell types at deeper levels, using 
more markers and multiple molecular studies. Future studies could perhaps investigate 
migration of cells in the spinal cord more closely, using BrdU studies to track migrating 
oligodendrocytes, astrocytes or microglia, or markers of cells at different developmental 
time points to further elucidate the developmental status of the cells. A transgenic 
approach to this effect is also a possibility. Few studies, however, have investigated the 
effect of MIA induced by the same dose of immunostimulant at a single time point during 
gestation over two survival periods and across multiple cell types. This is the strength of 
this study, and provides significant insights into what might underpin the potentially 
deleterious effect of MIA on a whole CNS region such as the spinal cord. Due to 
commonalities of cell type and molecular control mechanisms during development, such 
regional effects may well be replicated in other CNS regions or in the CNS as a whole. 
Finally as with all experiments utilising animal models one must acknowledge that 
rodents and humans are not the same. Animal models have, for many years, provided an 
excellent avenue of investigation for scientific studies, including this one. It is important 




many developmental studies in general, are not possible in humans. The animal models 
used in these studies provide insight into events which are unobservable in humans, 
despite this it is necessary to caution against over-interpretation of results observed in 
animal models in a human context, and to acknowledge that what is true in animals may 
not necessarily be true in humans.  
Much of the research reported here would benefit from future work. In all studies 
expansion of the litter number to target inter-litter variability in a more meaningful way 
would be useful for example. It would also be interesting to reintroduce the E14 insult 
time point to all studies. This time point of investigation was excluded from all but the 
earliest studies due to constraints of timing and animal availability, however it did display 
vulnerability to MIA in the early microglial studies.  Finally, with higher sample sizes 
available, future studies would benefit from the use of single-sex groups. This would 
make this research more comparable to other studies in the field, most of which use 
single-sex populations. This is important as many studies have illustrated marked sex 
differences, including a number of MIA studies (Zager et al. 2012; Bergeron et al. 2013; 
Lena Wischhof et al. 2015). In the context of neurodevelopmental and neuropsychiatric 
disorders use of a single sex population is also crucial as many disorders, including autism 
and schizophrenia occur at higher rates in males. 
In relation to each individual study there are a number of further investigations which 
could be carried out. In the oligodendrocyte study (Chapter 3) I would like to look more 
closely at the olig2 cell count in whole spinal cord slices, and to investigate 
oligodendrocyte migration more closely, potentially using timelapse microscopy in slice 
cultures. I would also like to look at Olig2 and MBP expression using western blot or 
possibly ELISA protocols. In the postnatal age group I would like to look at other markers 




In chapter 4, the effect of MIA on microglia and astrocytes was investigated. In relation 
to microglia, it would be useful to investigate the number of Iba-1+ cells in the immediate 
vicinity of the spinal cord in order to answer the question as to whether a delay in 
colonisation is responsible for the decreased numbers of Iba-1+ cells in the E16 cord 5h 
post MIA. In the astrocyte study it would be interesting to introduce other markers to 
better identify the astrocytic subtypes, for example slit-1 and reelin, which mark specific 
populations of white matter astrocytes in the spinal cord (Hochstim et al. 2008). In both 
studies I would like to quantify the activation status of the cells to determine the 
inflammatory environment of the cord. Both studies would benefit from use of lightsheet 
or confocal microscopy to do this as it would give a clearer view of the cellular processes, 
In chapter 5, the reelin study, it would be interesting to investigate the presence of reelin 
at E12 using other protocols such as western blot or ELISA, as this time point did not 
prove amenable to immunofluorescent investigation. It would also be important to 
identify a method to quantify the reelin expression in the white matter astrocytes of the 
P14 cord. 
In the sequencing studies of chapter 6 an important factor in future studies would be 
increasing the sample size, and potentially restricting the study to a single sex, in order to 
better elucidate the gene expression changes in response to MIA. In relation to the in-
silico studies of chapter 7 it would be interesting to look at the effects of miRs on 
oligodendrogliogenesis in an in-vitro study. 
Future studies aside, this thesis has demonstrated that the effects of MIA on the 
developing spinal cord are robust, measurable, and diverse in nature. It has illustrated the 
importance of the timing of immune insult, identifying a period of critical vulnerability 




CNS for recovery, while cautioning to the long lasting and potentially profound 
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Tp53 Tumour suppressor which plays a role in 
apoptosis, genomic stability, and inhibition of 
angiogenesis. p53 is maintained at low levels in 
human (h)ESCs to maintain stemness. Activation 
of p53 leads to rapid differentiation. p53 knockout 
delays differentiation while exogenous p53 
treatment causes spontaneous differentiation. 
(Jain and Barton 2018) 
Olr115 Interacts with odourant molecules in the nose to 
trigger smell perception. G-protein coupled 
receptor. 
(Gibbs et al. 2004) 
E2f4 The E2F family is involved in the control of cell 
cycle and action of tumour suppressor proteins. 
E2f4 binds the tumour supressors pRB, p107 and 
p130. Mutation of E2f4 and increased expression 
may be associated with human cancer. 
(Hsu and Sage 2016) 
LOC100363
177 
Ferritin light chain 1-like. Stores iron in a soluble, 
non-toxic, readily available form. Important for 
iron homeostasis.  
(Carmona et al. 2014) 
Sf3a2 Encodes subunit 2 of the splicing factor 3a protein 
complex which is necessary for the in vitro 
conversion of 15S U2 snRNP into an active 17S 
particle that performs pre-mRNA splicing. 
Subunit 2 may also function as a microtubule-
binding protein. 
(Pellacani et al. 2018) 
S100a11 A member of the S100 family of proteins. S100 
proteins are involved in the regulation of a number 
of cellular processes such as cell cycle progression 
and differentiation. S100a11 inhibits cell growth 
when phosphorylated by activating p21.  
(Sakaguchi et al. 2008) 
LOC100359
668 
Ferritin light chain 2. Encodes a protein that 
exhibits ferric iron binding. Involved in iron ion 
transport  
 
Cherp Responsible for intracellular Ca2+ mobilization 
and cell growth. Controls Ca2+ release from the 
endoplasmic reticulum. Depletion of CHERP 
results in endoplasmic reticulum stress induced 
apoptosis. CHERP has been associated with the 
maintenance of neuroblastoma cell proliferation 
and tumorigenicity 
(Lin-Moshier et al. 
2013) 
Pomt1 O-mannosylation (glycosylation) of proteins. 
Found in the membrane of the endoplasmic 
reticulum. Defects in this gene are a cause of 
Walker-Warburg syndrome (WWS) and limb-
girdle muscular dystrophy type 2K (LGMD2K) 
(Willer et al. 2004; van 




LOC690507 Similar to Vomeromodulin. Involved in the 
sensory perception of smell. Also known as 
Bpifb5.  
(Khew-Goodall et al. 
1991) 
Fam189b Also known as COTE1. Associated with Gaucher 
disease.  Expression of COTE1 was correlated 
with endogenous SREBP-1 activation in-vitro and 
may play a role in lipid metabolism . Potential 
binding partner of a WW domain-containing 
protein which 
is involved in tumour suppression.  
(Kallin et al. 2007; 
Zhang et al. 2014) 
Ftl1 Ferritin light chain 1. Stores iron, maintains iron 
homeostasis. Delivery of iron to cells. It infers 
protection against sepsis induced organ injury and 
inflammation. 
(Carmona et al. 2014; 
Zarjou et al. 2019) 
Fscn1 Member of the fascin family of actin-binding 
proteins. Fascin proteins organize F-actin into 
parallel bundles and are involved in cell migration, 
motility, adhesion and cellular interactions. 
Overexpression may play a role in the metastasis 
of multiple types of cancer by increasing cell 
motility 
(De Arcangelis et al. 
2004; Kraft et al. 2006; 
Sonego et al. 2013) 
Clip3 Encodes a member of the cytoplasmic linker 
protein 170 family. Members of this family 
mediate the interaction of microtubules and 
cellular organelles.  Plays a role in T cell apoptosis 
by facilitating the association of tubulin and the 
lipid raft ganglioside GD3.  
(Deng et al. 2012) 
Tbc1d25 Involved in vesicle-mediated transport. Functions 
as a Rab GTPase activating protein. The encoded 
protein is involved in the fusion of 
autophagosomes with endosomes and lysosomes.  
(Itoh et al. 2011) 
Srm Spermidine Synthase. Spermidine is a ubiquitous 
polyamine and mediates cell growth and 
differentiation. Spermidine synthase is one of four 
enzymes in the polyamine-biosynthetic pathway 
and carries out the final step of spermidine 
biosynthesis. This enzyme catalyses the 
conversion of putrescine to spermidine. 
(Lee et al. 2005) 
LOC100360
087 
Ferritin light chain 1-like. Encodes a protein that 
exhibits iron ion binding. Involved in iron ion 
transport and found in the intracellular ferritin 
complex. 
(Carmona et al. 2014) 
Arhgap1 Member of a large family of proteins that activate 
Rho-type guanosine triphosphate (GTP) 
metabolizing enzymes 
(Clay and Halloran 
2013) 
Spetex-2F Spetex2 mRNA is highly expressed in testis and 
spleen. Very little is known about it. It was 
upregulated in the dorsal root ganglion of rats 
subject  to a complete Freund's adjuvant induced 
intraplantar inflammation. 






Also known as Microtubule associated protein 
(map) 11. Has alpha-tubulin binding activity as 
well as a role in proliferation. Predicted to localise 
to several cellular components including the 
microtubule cytoskeleton, midbody, and plasma 
membrane 
(Perez et al. 2019) 
Ppif Peptidylprolyl Isomerases catalyse the cis-trans 
isomerization of proline imidic peptide bonds in 
oligopeptides and accelerate protein folding. 
Activates oxidative stress-induced necrosis in 
cooperation with mitochondrial Tp53. 
(Baines et al. 2005) 
Emd Member of the nuclear lamina-associated protein 
family. Mediates membrane anchorage to the 
cytoskeleton. Stabilises and promotes the 
formation of a nuclear actin cortical network, 
linking centrosomes to the nuclear envelope via 
microtubule association. Dreifuss-Emery 
muscular dystrophy is the result of a mutation of 
Emd. 
(Muntoni et al. 2006; 
Chang et al. 2013) 
Rab11b Member RAS Oncogene Family. Rab family 
proteins play a critical role in regulating 
exocytotic and endocytotic pathways, as well as 
intracellular membrane trafficking, from the 
formation of transport vesicles to their fusion with 
membranes 
(Vernoud et al. 2003) 
Pcsk1n Functions as an inhibitor of prohormone 
convertase 1, which regulates the proteolytic 
cleavage of neuroendocrine peptide precursors. 
(Liu et al. 2012) 
Lmf2 Involved in the maturation of specific proteins in 
the endoplasmic reticulum. Possibly required for 
maturation and transport of active lipoprotein 
lipase (LPL) through the secretory pathway. 
(Xu et al. 2017) 
Mef2d Member of myocyte-specific enhancer factor 2 
(MEF2) family of transcription factors. Involved 
in control of muscle and neuronal cell 
differentiation and development. Regulated by 
class II histone deacetylases it plays a critical role 
in neuronal apoptosis and has been linked to 
Parkinson's disease. 
(Yao et al. 2012) 
Wars Tryptophanyl-TRNA Synthetase. Aminoacyl-
tRNA synthetases catalyze the aminoacylation of 
tRNA by their cognate amino acid. It appears to 
play a role in immune control. 
(Jin 2019) 
Ubl7 Ubiquitination. Affects proteins in many ways. 
Can mark them for degradation via the 
proteasome, alter their cellular location, affect 
their activity, and promote or prevent protein 
interactions. 




Ctc1 A compnent of the telomere replication complex. 
Promotes DNA replication under conditions of 
replication stress or natural barriers to replication 
such as teleomere duplex. Inhibits telomerase 
maintaining teleomere length. 
(Stewart et al. 2018) 
Tox Thymocyte Selection Associated High Mobility 
Group Box. The protein encoded by this gene 
contains a HMG box DNA binding domain 
involved in chromatin assembly, transcription and 
replication. May function to regulate T-cell 
development. 
(Aliahmad et al. 2011) 
Med25 Mediator complex subunit 25. Encodes a 
component of the transcriptional co-activator 
known as the mediator complex. Required for the 
transcription of most of the RNA Pol II-dependent 
genes. Mutations are associated with Charcot 
Marie Tooth disease 
(Lee et al. 2007; Rana 
et al. 2011) 
Dpf2 Transcription factor necessary for apoptotic 
response following deprivation of survival factors. 
Regulates rapid hematopoietic cell growth and 
turnover.  It binds RNA polymerase II core 
promoter proximal region.  
(Gabig et al. 1994) 
LOC100362
384 
Ferritin. Stores iron in a soluble, non-toxic, readily 
available form. Important for iron homeostasis.  
(Carmona et al. 2014) 
LOC683674 Similar to Protein C7orf26 homolog. Well 
conserved. It interacts with RNA polymerase II 
and the Integrator complex, which regulates a 
number of aspects of gene transcription.  
(Boeing et al. 2016) 
Bcas3 Microtubule Associated Cell Migration Factor. 
Participates in the regulation of cell polarity and 
directional endothelial cell migration. Promotes 
filipodia formation. Functions synergistically with 
PELP1 as a transcriptional coactivator of estrogen 
receptor-responsive genes. Stimulates histone 
acetyltransferase activity. Binds chromatin. 
(Jain et al. 2012) 
Ccdc6 May function as a tumour suppressor. 
Chromosomal rearrangement resulting in the 
expression of a fusion gene containing a portion of 
this gene and the intracellular kinase-encoding 
domain of the ret proto-oncogene is the causes 
thyroid papillary carcinoma. 
(Morra et al. 2015) 
Nrbp2 May regulate apoptosis of neural progenitor cells 
during differentiation. Downregulation did not 
affect cell fate but did affect the amount of 
apoptosis occurring so Nrbp2 may be involved in 
cell survival. Expression is temporally and 
spatially regulated during development. 




Celf3 CUGBP Elav-Like Family Member 3. Regulates 
pre-mRNA alternative splicing and may also be 
involved in mRNA editing, and translation. 
(Ladd et al. 2001) 
Midn Facilitates ubiquitin-independent proteasomal 
degradation of polycomb protein CBX4. Has been 
associated with familial Parkinson's disease in 
both a Japanese and British cohort. MIDN 
regulates neurite outgrowth and Parkin expression 
in neuronal cells. 
(Tsukahara et al. 2000; 
Obara et al. 2019) 
Pcgf2 Polycomb group gene products form complexes 
via protein-protein interaction and maintain the 
transcriptional repression of genes involved in 
embryogenesis, cell cycles, and tumorigenesis.  
The expression of this gene  is limited in neural 
organs in normal tissues. Knockout studies in mice 
have suggested that this protein may negatively 
regulate the expression of different cytokines, 
chemokines, and chemokine receptors. 
(Zakrzewska et al. 
2011) 
Atf7 Plays a role in early cell signalling by binding 
cAMP response element (CRE) – present in many 
cellular promotors. Has no intrinsic transcriptional 
activity, but activates transcription on formation 
of JUN or FOS heterodimers. Also binds TRE 
promoter sequences when heterodimerized with 
JUN family members. Involved in SMAD 
Signaling Network and TNFR1 Pathway. 
(Vinson et al. 2002; 
Maekawa et al. 2018) 
Cnot3 Component of the CCR4-NOT complex which is 
one of the major cellular mRNA deadenylases. 
Involved in bulk mRNA degradation, miRNA-
mediated repression, translational repression and 
general transcription regulation. Involed in the 
maintenance of ESC identity. Downregulation 
causes ESC differentiation. 
(Zheng et al. 2012) 
 
Table A.1.1 Synopsis of function - genes differentially regulated 5hr post MIA with 









A.2 Postnatal Sequencing 
 
A.2.1 Quality control 
 
Figure A.2.1 – Q scores for RNA Seq. All samples were >99.9% accurate where Q > 30 
= 99.9% accurate or ~1 in 1000 bases miscalled. 
 
Figure A.2.2 – (A) N content across all bases. Where N = undetermined base. The graph 
shows the relative number of undetermined bases when compared to the overall number 
of bases called at each position in the reads derived from the forward primer. (B) Quality 






Figure A.2.3 Sample to sample heat map indicative of similarity between samples in 
















Figure A.2.4. MA plot of the mean of the gene expression changes in offspring spinal 
cords at P14 following MIA at E12 with 100µg/kg LPS. M = log ratio, A = mean of 












Cat A key antioxidant enzyme. Protects against 
oxidative stress. Found in the peroxisome of 
nearly all aerobic cells. Catalase converts 
hydrogen peroxide to water and oxygen.  
(Faust et al. 2005; 
Berger et al. 2016) 
Txnip Major regulator of cellular redox signalling 
which protects cells from oxidative stress. 
Inhibits the antioxidative function of 
thioredoxin resulting in the accumulation ROS 
and cellular stress.  
(Alhawiti et al. 2017) 
Pmvk Peroxisomal enzyme involved in isoprenoid 
biosynthesis. The encoded protein catalyzes 
the conversion of mevalonate 5-phosphate to 
mevalonate 5-diphosphate, which is the fifth 
step in the mevalonate pathway of isoprenoid 
biosynthesis.  
(Lange et al. 2000) 
Pex11a A membrane elongation factor involved in 
regulation of peroxisome maintenance and 
proliferation. This gene product interacts with 
PEX19 and may respond to outside stimuli to 
increase peroxisome abundance.  
(Sacksteder et al. 
2000) 
Spag7 Function relatively unknown.  
Idi1 Peroxisomal enzyme involved in isoprenoid 
biosynthesis.The encoded protein catalyses the 
interconversion of isopentenyl diphosphate 
(IPP) to its isomer, dimethylallyl diphosphate 
(DMAPP).  
(Lange et al. 2000) 
Pxmp4 Component of the peroxisome membrane. 
Exact function unknown. Known to bind 
PEX19. 
(Sacksteder et al. 
2000) 
Scara3 Macrophage scavenger receptor-like protein. 
Shown to deplete reactive oxygen species.. The 
expression of this gene is induced by oxidative 
stress 
 
Kif19 A microtubule-dependent motor protein. 
Regulates the length of motile cilia by 
mediating depolymerisation of microtubules at 
ciliary tips. 
(Niwa et al. 2012) 
Fzd9 Receptor for Wnt signaling proteins. Negative 
regulator of neuromuscular junction (NMJ) 
assembly through the beta-catenin canonical 
signaling pathway. Role in NPC viability 
through the beta-catenin canonical signaling 
pathway by negatively regulating cell cycle 
arrest leading to inhibition of neuron apoptotic 
process.  
(Ranheim et al. 2005) 
Snca Member of the synuclein family. Abundantly 
expressed in the brain. Defects in SNCA have 
been implicated in the pathogenesis of 
Parkinson disease. SNCA peptides are a major 




component of amyloid plaques in AD. Induces 
fibrillisation of microtubule-associated protein 
tau.  
S1pr1 Binds the ligand sphingosine-1-phosphate. 
Activation of this receptor induces cell-cell 
adhesion. Plays an important role in cell 
migration, likely due to a role in the 
reorganisation of the actin cytoskeleton and the 
formation of lamellipodia in response to 
stimuli that increase the activity of the 
sphingosine kinase (SPHK1).  
(Jiang et al. 2017) 
Mcam Role in cell adhesion. May function as a cell 
adhesion molecule active in neural crest cells 
during embryonic development.  
(Motohashi et al. 
2016) 
Pla2g3 The encoded enzyme functions in lipid 
metabolism. A negative regulator of 
ciliogenesis, Associated with oxidative stress. 
Polymorphisms in this gene are linked to risk 
for Alzheimer's disease 
(Gijs et al. 2015) 
Ppp1r10 Roles in cell cycle progression, DNA repair 
and apoptosis by regulating the activity of 
protein phosphatase 1.  
(Fisher et al. 2014) 
Emcn Interferes with the assembly of focal adhesion 
complexes. Inhibits cell-ECM interaction. 
(Zahr et al. 2016) 
Table A.2.1 Synopsis of function - genes differentially regulated at P14 following 
















Gene symbol Gene 
Ssh2 slingshot homolog 2 (Drosophila) 
Foxa2 forkhead box A2 
Golga2 golgin A2 
Scrib scribbled homolog (Drosophila) 
Rtn1 reticulon 1 
Cops2 COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) 
Cd24 CD24 molecule 
Arl3 ADP-ribosylation factor-like 3 
Tnn tenascin N 
Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 4 
Oprm1 opioid receptor, mu 1 
Exoc4 exocyst complex component 4 
Ctf1 cardiotrophin 1 
Uhmk1 U2AF homology motif (UHM) kinase 1 
Olig2 oligodendrocyte lineage transcription factor 2 
Ube2v2 ubiquitin-conjugating enzyme E2 variant 2 
Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, 
Drosophila) 
Drd2 dopamine receptor D2 
Ank3 ankyrin 3, node of Ranvier 
Fas Fas (TNF receptor superfamily, member 6) 
Shc1 SHC (Src homology 2 domain containing) transforming protein 1 
Snph syntaphilin 
Cdh1 cadherin 1 
Ext1 exostosin 1 
Gnat1 guanine nucleotide binding protein (G protein), alpha transducing activity 
polypeptide 1 
Calu calumenin 
Ndrg1 N-myc downstream regulated 1 
Lamc1 laminin, gamma 1 
Hhip Hedgehog-interacting protein 
Ube4b ubiquitination factor E4B 
Gas7 growth arrest specific 7 
Dynlt1 dynein light chain Tctex-type 1 
Gsx2 GS homeobox 2 
Stk24 serine/threonine kinase 24 
Socs2 suppressor of cytokine signaling 2 
Pax2 paired box 2 
Tal1 T-cell acute lymphocytic leukemia 1 
Synj1 synaptojanin 1 




Cln5 ceroid-lipofuscinosis, neuronal 5 
Ppp2r3a protein phosphatase 2, regulatory subunit B'', alpha 
Epha4 Eph receptor A4 
Cdc42 cell division cycle 42 (GTP binding protein) 
Adm adrenomedullin 
Cntn2 contactin 2 (axonal) 
Gdf11 growth differentiation factor 11 
Dpysl5 dihydropyrimidinase-like 5 
Lzts1 leucine zipper, putative tumor suppressor 1 
Uqcrq ubiquinol-cytochrome c reductase, complex III subunit VII 
Sema5a sema domain, seven thrombospondin repeats (type 1 and type 1-like), 
transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 
5A 
Efna1 ephrin A1 
Prickle2 prickle homolog 2 (Drosophila) 
Pvrl1 poliovirus receptor-related 1 
Tcf7 transcription factor 7 (T-cell specific, HMG-box) 
Foxg1 forkhead box G1 
Dmd dystrophin 
Kcnma1 potassium large conductance calcium-activated channel, subfamily M, alpha 
member 1 
Lyn v-yes-1 Yamaguchi sarcoma viral related oncogene homolog 
Foxa1 forkhead box A1 
LOC689826 hypothetical protein LOC689826 
Nlgn1 neuroligin 1 
Ctdsp1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small 
phosphatase 1 
Psd2 pleckstrin and Sec7 domain containing 2 
Klf7 Kruppel-like factor 7 (ubiquitous) 
Lmo4 LIM domain only 4 
Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase 
Pmp22 peripheral myelin protein 22 
Hdac11 histone deacetylase 11 
Nrcam neuronal cell adhesion molecule 
Prdm6 PR domain containing 6 
Eomes eomesodermin 
Nr4a3 nuclear receptor subfamily 4, group A, member 3 
Ulk2 Unc-51 like kinase 2 (C. elegans) 
Ptprm protein tyrosine phosphatase, receptor type, M 
Dgkg diacylglycerol kinase, gamma 
Tcf12 transcription factor 12 
Grm4 glutamate receptor, metabotropic 4 
Sall3 sal-like 3 (Drosophila) 
Aspa aspartoacylase 
Ppp1r9b protein phosphatase 1, regulatory subunit 9B 
Bbs4 Bardet-Biedl syndrome 4 




Gpc1 glypican 1 
Twist1 twist homolog 1 (Drosophila) 
Nkx2-1 NK2 homeobox 1 
L1cam L1 cell adhesion molecule 
Fgf13 fibroblast growth factor 13 
Nbn nibrin 
Ep300 E1A binding protein p300 
Six4 SIX homeobox 4 
Cxcl12 chemokine (C-X-C motif) ligand 12 
Mapk8 mitogen-activated protein kinase 8 
Nab1 Ngfi-A binding protein 1 
Itm2c integral membrane protein 2C 
Cspg4 chondroitin sulfate proteoglycan 4 
RGD1305560 similar to RIKEN cDNA 9430031J16 
Robo2 roundabout homolog 2 (Drosophila) 
Lhx6 LIM homeobox 6 
Nphp1 nephronophthisis 1 (juvenile) homolog (human) 
Prkci protein kinase C, iota 
Tnr tenascin R (restrictin, janusin) 
Myo16 myosin XVI 
Hmg20a high mobility group 20A 
Grn granulin 
Ngfr nerve growth factor receptor 
Vcan versican 
Lhx5 LIM homeobox 5 
Slc1a3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 
Hipk1 homeodomain interacting protein kinase 1 
Ctnna1 catenin (cadherin-associated protein), alpha 1, 102kDa 
Mtpn myotrophin 
Esr2 estrogen receptor 2 (ER beta) 
Epo erythropoietin 
Ppp1cc protein phosphatase 1, catalytic subunit, gamma isozyme 
Mdga1 MAM domain containing glycosylphosphatidylinositol anchor 1 
Actr3 ARP3 actin-related protein 3 homolog (yeast) 
Cln8 ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental 
retardation) 
Plxnb1 plexin B1 
Foxb1 forkhead box B1 
Dcx doublecortin 
Ret ret proto-oncogene 
Snap25 synaptosomal-associated protein 25 
Mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma derived 
(avian) 
Nrl neural retina leucine zipper 
Cdkn1c cyclin-dependent kinase inhibitor 1C 




Bbs1 Bardet-Biedl syndrome 1 
Cthrc1 collagen triple helix repeat containing 1 
Mdga2 MAM domain containing glycosylphosphatidylinositol anchor 2 
Cdh11 cadherin 11 
Ephb2 Eph receptor B2 
Galr2 galanin receptor 2 
Cntn4 contactin 4 
Pou3f1 POU class 3 homeobox 1 
Nptx1 neuronal pentraxin I 
Pafah1b1 platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 
Cntnap1 contactin associated protein 1 
Prrxl1 paired related homeobox protein-like 1 
P2ry2 purinergic receptor P2Y, G-protein coupled, 2 
Caprin1 cell cycle associated protein 1 
Lmx1a LIM homeobox transcription factor 1 alpha 
Tgfbr1 transforming growth factor, beta receptor 1 
Ttc3 tetratricopeptide repeat domain 3 
Bok BCL2-related ovarian killer 
Cdon Cdon homolog (mouse) 
Hes5 hairy and enhancer of split 5 (Drosophila) 
Cxcr4 chemokine (C-X-C motif) receptor 4 
Ncam1 neural cell adhesion molecule 1 
Hmbs hydroxymethylbilane synthase 
En1 engrailed homeobox 1 
Bcl2 B-cell CLL/lymphoma 2 
Rarb retinoic acid receptor, beta 
Dst dystonin 
Gad1 glutamate decarboxylase 1 
Dag1 dystroglycan 1 (dystrophin-associated glycoprotein 1) 
Wdr62 WD repeat domain 62 
Rnf6 ring finger protein (C3H2C3 type) 6 
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, 
Drosophila) 
Sema6a sema domain, transmembrane domain (TM), and cytoplasmic domain, 
(semaphorin) 6A 
Kirrel3 kin of IRRE like 3 (Drosophila) 
Bdnf brain-derived neurotrophic factor 
Jak2 Janus kinase 2 
Slitrk6 SLIT and NTRK-like family, member 6 
Efna3 ephrin A3 
Pld2 phospholipase D2 
Ak1 adenylate kinase 1 
Tacc1 transforming, acidic coiled-coil containing protein 1 
Apbb2 amyloid beta (A4) precursor protein-binding, family B, member 2 
Ptpru protein tyrosine phosphatase, receptor type, U 




Trpv2 transient receptor potential cation channel, subfamily V, member 2 
Btg2 BTG family, member 2 
Dclk1 doublecortin-like kinase 1 
Syne1 spectrin repeat containing, nuclear envelope 1 
Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1 
Etv4 ets variant 4 
Slitrk5 SLIT and NTRK-like family, member 5 
Sclt1 sodium channel and clathrin linker 1 
Sfrp4 secreted frizzled-related protein 4 
P2ry1 purinergic receptor P2Y, G-protein coupled, 1 
Dner delta/notch-like EGF repeat containing 
Ccdc88a coiled coil domain containing 88A 
Dnmt3b DNA (cytosine-5-)-methyltransferase 3 beta 
Acsl4 acyl-CoA synthetase long-chain family member 4 
Itgb1 integrin, beta 1 
Dixdc1 DIX domain containing 1 
Nlgn3 neuroligin 3 
Top2a topoisomerase (DNA) II alpha 
Sox10 SRY-related HMG-box 10 
 
Table B.1: Predicted targets of miR-9 GO category ‘Neurogenesis’ C=1033; O=189; 
E=133.20; R=1.42; rawP=1.69e-07; adjP=2.61e-05. ( C = the number of reference genes 
in the category, O= the number of genes in the gene set and also in the category, E= the 
expected number in the category, R = ratio of enrichment,  rawP = raw P-value from 




















Prkd1 protein kinase D1 
Foxa2 forkhead box A2 
Snapap SNAP-associated protein 
Golga2 golgin A2 
Efnb1 ephrin B1 
Sphk1 sphingosine kinase 1 
Plp1 proteolipid protein 1 
Lhx6 LIM homeobox 6 
Foxa3 forkhead box A3 
Cd24 CD24 molecule 
Gja1 gap junction protein, alpha 1 
Hmg20a high mobility group 20A 
Jag1 jagged 1 
Kcnip2 Kv channel-interacting protein 2 
Adnp2 ADNP homeobox 2 
Ssh3 slingshot homolog 3 (Drosophila) 
Ube2v2 ubiquitin-conjugating enzyme E2 variant 2 
Ptprr protein tyrosine phosphatase, receptor type, R 
Shc1 SHC (Src homology 2 domain containing) transforming protein 1 
Wee1 wee 1 homolog (S. pombe) 
Vcan versican 
Calu calumenin 
Lamc1 laminin, gamma 1 
Nrg1 neuregulin 1 
Myh10 myosin, heavy chain 10, non-muscle 
Hipk1 homeodomain interacting protein kinase 1 
Hoxa2 homeo box A2 
Clrn1 clarin 1 
Hipk2 homeodomain interacting protein kinase 2 
Nkx2-5 NK2 homeobox 5 
Cdh2 cadherin 2 
Ptk6 PTK6 protein tyrosine kinase 6 
Pldn pallidin homolog (mouse) 
Cln8 ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental 
retardation) 
Ighmbp2 immunoglobulin mu binding protein 2 
Fzd1 frizzled family receptor 1 
Lpar1 lysophosphatidic acid receptor 1 
Stk24 serine/threonine kinase 24 
Tal1 T-cell acute lymphocytic leukemia 1 




Smarca1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 1 
Dact1 dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) 
Dlx5 distal-less homeobox 5 
Myo6 myosin VI 
Cln5 ceroid-lipofuscinosis, neuronal 5 
Rora RAR-related orphan receptor A 
Ptprz1 protein tyrosine phosphatase, receptor-type, Z polypeptide 1 
Vim vimentin 
Ache acetylcholinesterase 
Trpv4 transient receptor potential cation channel, subfamily V, member 4 
Dpysl5 dihydropyrimidinase-like 5 
Napa N-ethylmaleimide-sensitive factor attachment protein, alpha 
Lzts1 leucine zipper, putative tumor suppressor 1 
Cntf ciliary neurotrophic factor 
Erbb2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, 
neuro/glioblastoma derived oncogene homolog (avian) 
Xrcc6 X-ray repair complementing defective repair in Chinese hamster cells 6 
Sema5a sema domain, seven thrombospondin repeats (type 1 and type 1-like), 
transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A 
Agt angiotensinogen (serpin peptidase inhibitor, clade A, member 8) 
Klf15 Kruppel-like factor 15 
Nf1 neurofibromin 1 
Gpm6a glycoprotein m6a 
Pafah1b1 platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 
Ezh2 enhancer of zeste homolog 2 (Drosophila) 
Pax3 paired box 3 
Tgfbr1 transforming growth factor, beta receptor 1 
Jag2 jagged 2 
Gsn gelsolin 
Cdon Cdon homolog (mouse) 
Sgk1 serum/glucocorticoid regulated kinase 1 
Egr2 early growth response 2 
Ctdsp1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small 
phosphatase 1 
Psd2 pleckstrin and Sec7 domain containing 2 
Lmo4 LIM domain only 4 
Pex5 peroxisomal biogenesis factor 5 
Bcl11b B-cell CLL/lymphoma 11B (zinc finger protein) 
Dag1 dystroglycan 1 (dystrophin-associated glycoprotein 1) 
Rnf6 ring finger protein (C3H2C3 type) 6 
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, 
Drosophila) 
Nrcam neuronal cell adhesion molecule 
Slitrk6 SLIT and NTRK-like family, member 6 
Flot1 flotillin 1 




Sema4f sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) 
and short cytoplasmic domain, (semaphorin) 4F 
Efna3 ephrin A3 
Gnao1 guanine nucleotide binding protein (G protein), alpha activating activity 
polypeptide O 
Stmn2 stathmin-like 2 
Foxe1 forkhead box E1 (thyroid transcription factor 2) 
Tsku tsukushi small leucine rich proteoglycan homolog (Xenopus laevis) 
Lamc3 laminin gamma 3 
Apbb2 amyloid beta (A4) precursor protein-binding, family B, member 2 
Btg2 BTG family, member 2 
Nr4a3 nuclear receptor subfamily 4, group A, member 3 
Pcsk1 proprotein convertase subtilisin/kexin type 1 
Bmpr1a bone morphogenetic protein receptor, type IA 
Fgfr3 fibroblast growth factor receptor 3 
Epha2 Eph receptor A2 
Clcf1 cardiotrophin-like cytokine factor 1 
Ppp1r9b protein phosphatase 1, regulatory subunit 9B 
Arhgap4 Rho GTPase activating protein 4 
Nde1 nudE nuclear distribution gene E homolog 1 (A. nidulans) 
Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) 
Slitrk5 SLIT and NTRK-like family, member 5 
Sox8 SRY (sex determining region Y)-box 8 
Axin1 axin 1 
Gpc1 glypican 1 
Sfrp4 secreted frizzled-related protein 4 
Slit1 slit homolog 1 (Drosophila) 
Kdr kinase insert domain receptor 
Gfap glial fibrillary acidic protein 
Itgb1 integrin, beta 1 
Ccdc88a coiled coil domain containing 88A 
Cdkn2c cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) 
Ndn necdin homolog (mouse) 
Six4 SIX homeobox 4 
Cxcl12 chemokine (C-X-C motif) ligand 12 
Sema3f sema domain, immunoglobulin domain (Ig), short basic domain, secreted, 
(semaphorin) 3 F 
Dll4 delta-like 4 (Drosophila) 
Itm2c integral membrane protein 2C 
 
Table B.2: Predicted targets of miR-124 GO category ‘Neurogenesis’. C=1033; 
O=119; E=75.44; R=1.58; rawP=2.63e-07; adjP=4.54e-05. (C = the number of reference 




E= the expected number in the category, R = ratio of enrichment,  rawP = raw P-value 

































Gene Symbol Gene 
Bak1 BCL2-antagonist/killer 1 
Cdh22 cadherin 22 
Ssh2 slingshot homolog 2 (Drosophila) 
Cfl1 cofilin 1, non-muscle 
Nnat neuronatin 
Ngef neuronal guanine nucleotide exchange factor 
Sox9 SRY-box containing gene 9 
Men1 multiple endocrine neoplasia I 
Gfra1 GDNF family receptor alpha 1 
Scn5a sodium channel, voltage-gated, type V, alpha subunit 
Fmr1 fragile X mental retardation 1 
Tnn tenascin N 
Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 4 
Gja1 gap junction protein, alpha 1 
Exoc4 exocyst complex component 4 
Cdk5 cyclin-dependent kinase 5 
Alx1 ALX homeobox 1 
Prkch protein kinase C, eta 
Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, 
Drosophila) 
Fas Fas (TNF receptor superfamily, member 6) 
Ext1 exostosin 1 
Gnat1 guanine nucleotide binding protein (G protein), alpha transducing activity 
polypeptide 1 
Nkx6-1 NK6 homeobox 1 
Ndrg1 N-myc downstream regulated 1 
Lamc1 laminin, gamma 1 
Eif2b2 eukaryotic translation initiation factor 2B, subunit 2 beta 
Hbegf heparin-binding EGF-like growth factor 
Myh10 myosin, heavy chain 10, non-muscle 
Camk2b calcium/calmodulin-dependent protein kinase II beta 
Sema4d sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) 
and short cytoplasmic domain, (semaphorin) 4D 
Nrxn2 neurexin 2 
Bcan brevican 
Gas7 growth arrest specific 7 
Mapk8ip3 mitogen-activated protein kinase 8 interacting protein 3 
Dynlt1 dynein light chain Tctex-type 1 
Id4 inhibitor of DNA binding 4 
Stk24 serine/threonine kinase 24 
Shox2 short stature homeobox 2 
Dicer1 dicer 1, ribonuclease type III 
Map3k7 mitogen activated protein kinase kinase kinase 7 




Rab23 RAB23, member RAS oncogene family 
Ppard peroxisome proliferator-activated receptor delta 
Cln5 ceroid-lipofuscinosis, neuronal 5 
Slc7a11 solute carrier family 7 (anionic amino acid transporter light chain, xc- 
system), member 11 
Epha4 Eph receptor A4 
Ank2 ankyrin 2, neuronal 
Pllp plasmolipin 
Gfra2 GDNF family receptor alpha 2 
Cbfa2t2 core-binding factor, runt domain, alpha subunit 2; translocated to, 2 
Cntn2 contactin 2 (axonal) 
Aplp2 amyloid beta (A4) precursor-like protein 2 
Prom1 prominin 1 
Dpysl5 dihydropyrimidinase-like 5 
Sncg synuclein, gamma (breast cancer-specific protein 1) 
Chrdl1 chordin-like 1 
Sema4a sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) 
and short cytoplasmic domain, (semaphorin) 4A 
Uqcrq ubiquinol-cytochrome c reductase, complex III subunit VII 
Afg3l2 AFG3 ATPase family gene 3-like 2 (S. cerevisiae) 
Uchl1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) 
Nid67 putative small membrane protein NID67 
Sema5a sema domain, seven thrombospondin repeats (type 1 and type 1-like), 
transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 
5A 
Pou4f3 POU class 4 homeobox 3 
Pgap1 post-GPI attachment to proteins 1 
Cdk5rap3 CDK5 regulatory subunit associated protein 3 
Pgrmc1 progesterone receptor membrane component 1 
Prickle2 prickle homolog 2 (Drosophila) 
Nlgn2 neuroligin 2 
Hif1a hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription 
factor) 
Tcf7 transcription factor 7 (T-cell specific, HMG-box) 
Pax3 paired box 3 
Stk4 serine/threonine kinase 4 
Wnt10b wingless-type MMTV integration site family, member 10B 
Npap60 nuclear pore associated protein 
Kcnma1 potassium large conductance calcium-activated channel, subfamily M, alpha 
member 1 
Foxa1 forkhead box A1 
Limk1 LIM domain kinase 1 
Ntrk2 neurotrophic tyrosine kinase, receptor, type 2 
Pitx1 paired-like homeodomain 1 
Pura purine rich element binding protein A 
Lrp6 low density lipoprotein receptor-related protein 6 




Klf7 Kruppel-like factor 7 (ubiquitous) 
Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, 
Drosophila) 
Mobp myelin-associated oligodendrocyte basic protein 
Tbx19 T-box 19 
Ptk2 PTK2 protein tyrosine kinase 2 
Pip5k1c phosphatidylinositol-4-phosphate 5-kinase, type I, gamma 
Lphn1 latrophilin 1 
Arhgef2 rho/rac guanine nucleotide exchange factor (GEF) 2 
Wnt3a wingless-type MMTV integration site family, member 3A 
Rrm1 ribonucleotide reductase M1 
Tsku tsukushi small leucine rich proteoglycan homolog (Xenopus laevis) 
Lamc3 laminin gamma 3 
Nova1 neuro-oncological ventral antigen 1 
Tcf3 transcription factor 3 
Nrxn3 neurexin 3 
Nr4a3 nuclear receptor subfamily 4, group A, member 3 
Ak7 adenylate kinase 7 
Dgkg diacylglycerol kinase, gamma 
Rara retinoic acid receptor, alpha 
Grm4 glutamate receptor, metabotropic 4 
Ppp1r9b protein phosphatase 1, regulatory subunit 9B 
Ina internexin neuronal intermediate filament protein, alpha 
Arhgap4 Rho GTPase activating protein 4 
Nde1 nudE nuclear distribution gene E homolog 1 (A. nidulans) 
Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) 
Sox8 SRY (sex determining region Y)-box 8 
Pde5a phosphodiesterase 5A, cGMP-specific 
Foxp3 forkhead box P3 
Sstr3 somatostatin receptor 3 
Nr3c1 nuclear receptor subfamily 3, group C, member 1 
Axin1 axin 1 
Gpc1 glypican 1 
Ipmk inositol polyphosphate multikinase 
Nkx2-1 NK2 homeobox 1 
Ahsg alpha-2-HS-glycoprotein 
Gfap glial fibrillary acidic protein 
Kit v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 
Cxcl12 chemokine (C-X-C motif) ligand 12 
Mapk8 mitogen-activated protein kinase 8 
Atg7 autophagy related 7 
Palm paralemmin 
RGD1305560 similar to RIKEN cDNA 9430031J16 
Sox4 SRY (sex determining region Y)-box 4 
Atxn2 ataxin 2 




Inppl1 inositol polyphosphate phosphatase-like 1 
Ncoa6 nuclear receptor coactivator 6 
Epha8 Eph receptor A8 
Tnr tenascin R (restrictin, janusin) 
Hmg20a high mobility group 20A 
Dbn1 drebrin 1 
Gbx2 gastrulation brain homeobox 2 
Timp4 tissue inhibitor of metalloproteinase 4 
Dlc1 deleted in liver cancer 1 
Gabrb1 gamma-aminobutyric acid (GABA) A receptor, beta 1 
Tmem126a transmembrane protein 126A 
Eif2b5 eukaryotic translation initiation factor 2B, subunit 5 epsilon 
Luzp1 leucine zipper protein 1 
Kremen1 kringle containing transmembrane protein 1 
Sox12 SRY (sex determining region Y)-box 12 
Vcan versican 
Lhx5 LIM homeobox 5 
Slc1a3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 
Srd5a1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-
dehydrogenase alpha 1) 
Adnp activity-dependent neuroprotector homeobox 
Prkdc protein kinase, DNA activated, catalytic polypeptide 
Tpp1 tripeptidyl peptidase I 
Akr1c14 aldo-keto reductase family 1, member C14 
Cdh2 cadherin 2 
Scn3b sodium channel, voltage-gated, type III, beta 
Sh2b2 SH2B adaptor protein 2 
Synj2 synaptojanin 2 
Mal mal, T-cell differentiation protein 
Hrh3 histamine receptor H3 
Ncdn neurochondrin 
Rb1 retinoblastoma 1 
Plxnb1 plexin B1 
Prox1 prospero homeobox 1 
Dcx doublecortin 
Snap25 synaptosomal-associated protein 25 
Kidins220 kinase D-interacting substrate 220 
Pcsk2 proprotein convertase subtilisin/kexin type 2 
Cdkn1c cyclin-dependent kinase inhibitor 1C 
Bbs1 Bardet-Biedl syndrome 1 
Casp3 caspase 3 
Chn1 chimerin (chimaerin) 1 
Vim vimentin 
Napa N-ethylmaleimide-sensitive factor attachment protein, alpha 
Plag1 pleiomorphic adenoma gene 1 




Slc11a2 solute carrier family 11 (proton-coupled divalent metal ion transporters), 
member 2 
Rgma RGM domain family, member A 
Cttn cortactin 
Pafah1b1 platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 
Olig1 oligodendrocyte transcription factor 1 
Unc5c unc-5 homolog C (C. elegans) 
Zeb1 zinc finger E-box binding homeobox 1 
P2ry2 purinergic receptor P2Y, G-protein coupled, 2 
Ezh2 enhancer of zeste homolog 2 (Drosophila) 
Zhx2 zinc fingers and homeoboxes 2 
Caprin1 cell cycle associated protein 1 
Tgfbr1 transforming growth factor, beta receptor 1 
Ptprf protein tyrosine phosphatase, receptor type, F 
Rbp3 retinol binding protein 3, interstitial 
Htr5a 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 
Foxp2 forkhead box P2 
Clic5 chloride intracellular channel 5 
Smad1 SMAD family member 1 
Robo3 roundabout homolog 3 (Drosophila) 
Heyl hairy/enhancer-of-split related with YRPW motif-like 
Rarb retinoic acid receptor, beta 
Ywhah tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, 
eta polypeptide 
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, 
Drosophila) 
Traf6 Tnf receptor-associated factor 6 
Arsa arylsulfatase A 
Lppr4 lipid phosphate phosphatase-related protein type 4 
Pld2 phospholipase D2 
Ak1 adenylate kinase 1 
Sdc2 syndecan 2 
Apbb2 amyloid beta (A4) precursor protein-binding, family B, member 2 
Cd44 Cd44 molecule 
Notch3 notch 3 
Lhx4 LIM homeobox 4 
H3f3b H3 histone, family 3B 
Pcsk1 proprotein convertase subtilisin/kexin type 1 
Dclk1 doublecortin-like kinase 1 
Nkx6-2 NK6 homeobox 2 
Syne1 spectrin repeat containing, nuclear envelope 1 
Lrp4 low density lipoprotein receptor-related protein 4 
Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1 
Scn2a1 sodium channel, voltage-gated, type II, alpha 1 
Msx1 msh homeobox 1 
Abr active BCR-related 




Twsg1 twisted gastrulation homolog 1 (Drosophila) 
Atp2b2 ATPase, Ca++ transporting, plasma membrane 2 
Chrd chordin 
Dmbx1 diencephalon/mesencephalon homeobox 1 
Ccdc88a coiled coil domain containing 88A 
Itgb1 integrin, beta 1 
Scn3a sodium channel, voltage-gated, type III, alpha 
Arnt2 aryl hydrocarbon receptor nuclear translocator 2 
 
Table B.3 Predicted targets of miR-138 GO category ‘Nervous System 
Development’. C=1543; O=224; E=150.92; R=1.48; rawP=1.86e-10; adjP=1.26e-07. (C 
= the number of reference genes in the category, O= the number of genes in the gene set 
and also in the category, E= the expected number in the category, R = ratio of enrichment, 























Gene symbol Gene 
Sstr1 somatostatin receptor 1 
Arf4 ADP-ribosylation factor 4 
Plp1 proteolipid protein 1 
Gfra1 GDNF family receptor alpha 1 
Cd24 CD24 molecule 
Tnn tenascin N 
Slc7a5 solute carrier family 7 (amino acid transporter light chain, L system), 
member 5 
Spast spastin 
Sema7a semaphorin 7A, GPI membrane anchor 
Ube2v2 ubiquitin-conjugating enzyme E2 variant 2 
Gli2 GLI family zinc finger 2 
Snph syntaphilin 
Ext1 exostosin 1 
Pafah1b2 platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 
Dlg4 discs, large homolog 4 (Drosophila) 
Mapt microtubule-associated protein tau 
Bcan brevican 
Gas7 growth arrest specific 7 
Snx27 sorting nexin family member 27 
Stxbp3 syntaxin binding protein 3 
Pbx1 pre-B-cell leukemia homeobox 1 
Stk24 serine/threonine kinase 24 
Tal1 T-cell acute lymphocytic leukemia 1 
Mbp myelin basic protein 
Synj1 synaptojanin 1 
Rab23 RAB23, member RAS oncogene family 
Ppard peroxisome proliferator-activated receptor delta 
Sod2 superoxide dismutase 2, mitochondrial 
Cln5 ceroid-lipofuscinosis, neuronal 5 
Ppp2r3a protein phosphatase 2, regulatory subunit B'', alpha 
Slc7a11 solute carrier family 7 (anionic amino acid transporter light chain, 
xc- system), member 11 
Epha4 Eph receptor A4 
Ank2 ankyrin 2, neuronal 
Mafb v-maf musculoaponeurotic fibrosarcoma oncogene homolog B 
(avian) 
Cntn2 contactin 2 (axonal) 
Gdf11 growth differentiation factor 11 
Aplp2 amyloid beta (A4) precursor-like protein 2 
Chrdl1 chordin-like 1 
Lzts1 leucine zipper, putative tumor suppressor 1 
Uqcrq ubiquinol-cytochrome c reductase, complex III subunit VII 




Nid67 putative small membrane protein NID67 
Sema5a sema domain, seven thrombospondin repeats (type 1 and type 1-like), 
transmembrane domain (TM) and short cytoplasmic domain, 
(semaphorin) 5A 
Pgrmc1 progesterone receptor membrane component 1 
Pvrl1 poliovirus receptor-related 1 
Prickle2 prickle homolog 2 (Drosophila) 
Kcnma1 potassium large conductance calcium-activated channel, subfamily 
M, alpha member 1 
Ptpra protein tyrosine phosphatase, receptor type, A 
Foxa1 forkhead box A1 
Olfm3 olfactomedin 3 
Pura purine rich element binding protein A 
Klf7 Kruppel-like factor 7 (ubiquitous) 
Fos FBJ osteosarcoma oncogene 
RGD1561431 similar to homeobox-containing transcription factor 
Hdac11 histone deacetylase 11 
Gas6 growth arrest specific 6 
Stxbp1 syntaxin binding protein 1 
Prdm6 PR domain containing 6 
Wnt3a wingless-type MMTV integration site family, member 3A 
Tgif1 TGFB-induced factor homeobox 1 
Nova1 neuro-oncological ventral antigen 1 
Nr4a3 nuclear receptor subfamily 4, group A, member 3 
Thbs2 thrombospondin 2 
Chl1 cell adhesion molecule with homology to L1CAM 
Csrp1 cysteine and glycine-rich protein 1 
Klk6 kallikrein related-peptidase 6 
Hook3 hook homolog 3 (Drosophila) 
Sox8 SRY (sex determining region Y)-box 8 
Mapk9 mitogen-activated protein kinase 9 
Sstr3 somatostatin receptor 3 
Vangl2 vang-like 2 (van gogh, Drosophila) 
Gpc1 glypican 1 
Ipmk inositol polyphosphate multikinase 
Fgf13 fibroblast growth factor 13 
Ywhag tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, gamma polypeptide 
Cxcl12 chemokine (C-X-C motif) ligand 12 
Mapk8 mitogen-activated protein kinase 8 
Lama2 laminin, alpha 2 
Snapap SNAP-associated protein 
Star steroidogenic acute regulatory protein 
Gdf5 growth differentiation factor 5 
Cables1 Cdk5 and Abl enzyme substrate 1 
Grin2b glutamate receptor, ionotropic, N-methyl D-aspartate 2B 




Ccng1 cyclin G1 
Cbln2 cerebellin 2 precursor 
Rgs6 regulator of G-protein signaling 6 
Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 
Sfrp5 secreted frizzled-related protein 5 
Prkci protein kinase C, iota 
Zfhx3 zinc finger homeobox 3 
Timp4 tissue inhibitor of metalloproteinase 4 
Sh3tc2 SH3 domain and tetratricopeptide repeats 2 
Atxn10 ataxin 10 
Pls3 plastin 3 
Pak1 p21 protein (Cdc42/Rac)-activated kinase 1 
Luzp1 leucine zipper protein 1 
Lrp2 low density lipoprotein receptor-related protein 2 
Vcan versican 
Nrg1 neuregulin 1 
Adnp activity-dependent neuroprotector homeobox 
Prkdc protein kinase, DNA activated, catalytic polypeptide 
Hipk1 homeodomain interacting protein kinase 1 
Tpp1 tripeptidyl peptidase I 
Akr1c14 aldo-keto reductase family 1, member C14 
Cdh2 cadherin 2 
Sall2 sal-like 2 (Drosophila) 
Epo erythropoietin 
Scn3b sodium channel, voltage-gated, type III, beta 
Synj2 synaptojanin 2 
Actr3 ARP3 actin-related protein 3 homolog (yeast) 
Ncdn neurochondrin 
C1s complement component 1, s subcomponent 
Fzd1 frizzled family receptor 1 
Ctnnd1 catenin (cadherin associated protein), delta 1 
Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-
terminal domain, 2 
Ppp2r2b protein phosphatase 2, regulatory subunit B, beta 
T2 brachyury 2 
Dcx doublecortin 
Casp3 caspase 3 
Vim vimentin 
S1pr1 sphingosine-1-phosphate receptor 1 
Cdh11 cadherin 11 
Hhex hematopoietically expressed homeobox 
Cntf ciliary neurotrophic factor 
Slc11a2 solute carrier family 11 (proton-coupled divalent metal ion 
transporters), member 2 
Hap1 huntingtin-associated protein 1 




Acsl3 acyl-CoA synthetase long-chain family member 3 
Unc5c unc-5 homolog C (C. elegans) 
Prrxl1 paired related homeobox protein-like 1 
Zeb1 zinc finger E-box binding homeobox 1 
Tgfbr1 transforming growth factor, beta receptor 1 
Uchl5 ubiquitin carboxyl-terminal hydrolase L5 
Htr5a 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 
Cxcr4 chemokine (C-X-C motif) receptor 4 
Gdf10 growth differentiation factor 10 
Hmbs hydroxymethylbilane synthase 
Pcsk9 proprotein convertase subtilisin/kexin type 9 
Rfx4 regulatory factor X, 4 (influences HLA class II expression) 
Oxct1 3-oxoacid CoA transferase 1 
Smad1 SMAD family member 1 
Dlx1 distal-less homeobox 1 
Rarb retinoic acid receptor, beta 
Gad1 glutamate decarboxylase 1 
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo 
homolog, Drosophila) 
Traf6 Tnf receptor-associated factor 6 
Lppr4 lipid phosphate phosphatase-related protein type 4 
Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) 
Efna3 ephrin A3 
Pld2 phospholipase D2 
Apbb2 amyloid beta (A4) precursor protein-binding, family B, member 2 
Cd44 Cd44 molecule 
Trim32 tripartite motif-containing 32 
Btg2 BTG family, member 2 
Dclk1 doublecortin-like kinase 1 
Nkx6-2 NK6 homeobox 2 
Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1 
Scn2a1 sodium channel, voltage-gated, type II, alpha 1 
Hmg20b high mobility group 20 B 
Areg amphiregulin 
Pebp1 phosphatidylethanolamine binding protein 1 
Slitrk5 SLIT and NTRK-like family, member 5 
Qk quaking 
Hey2 hairy/enhancer-of-split related with YRPW motif 2 
Sfrp4 secreted frizzled-related protein 4 
P2ry1 purinergic receptor P2Y, G-protein coupled, 1 
Dmbx1 diencephalon/mesencephalon homeobox 1 
Plxna2 plexin A2 
Dnmt3b DNA (cytosine-5-)-methyltransferase 3 beta 
RGD1310964 similar to RIKEN cDNA 9430031J16 
Gfi1 growth factor independent 1 transcription repressor 




Sfrp1 secreted frizzled-related protein 1 
 
Table B.4: Predicted targets of miR-146a GO category ‘Nervous System 
Development’. C=1543; O=174; E=130.30; R=1.34; rawP=2.62e-05; adjP=0.0052. (C = 
the number of reference genes in the category, O= the number of genes in the gene set 
and also in the category, E= the expected number in the category, R = ratio of enrichment, 





















Gene symbol Gene 
Sepp1 selenoprotein P, plasma, 1 
Oprm1 opioid receptor, mu 1 
Exoc4 exocyst complex component 4 
Slc7a5 solute carrier family 7 (amino acid transporter light chain, L system), 
member 5 
Uhmk1 U2AF homology motif (UHM) kinase 1 
Ube2v2 ubiquitin-conjugating enzyme E2 variant 2 
Drd2 dopamine receptor D2 
Fas Fas (TNF receptor superfamily, member 6) 
Pou3f4 POU class 3 homeobox 4 
Camk2b calcium/calmodulin-dependent protein kinase II beta 
Ube4b ubiquitination factor E4B 
Mapk8ip3 mitogen-activated protein kinase 8 interacting protein 3 
Snx27 sorting nexin family member 27 
RGD1560691 similar to calcium/calmodulin-dependent protein kinase 1D 
Pldn pallidin homolog (mouse) 
Srf serum response factor (c-fos serum response element-binding transcription 
factor) 
Dscam Down syndrome cell adhesion molecule 
Pbx1 pre-B-cell leukemia homeobox 1 
Lpar1 lysophosphatidic acid receptor 1 
Shox2 short stature homeobox 2 
Mbp myelin basic protein 
Synj1 synaptojanin 1 
Grip1 glutamate receptor interacting protein 1 
Shank3 SH3 and multiple ankyrin repeat domains 3 
Ppp2r3a protein phosphatase 2, regulatory subunit B'', alpha 
Slc7a11 solute carrier family 7 (anionic amino acid transporter light chain, xc- 
system), member 11 
Dynll2 dynein light chain LC8-type 2 
Itga3 integrin, alpha 3 
Dpysl5 dihydropyrimidinase-like 5 
Kif2a kinesin family member 2A 
Pou4f3 POU class 4 homeobox 3 
Ncam2 neural cell adhesion molecule 2 
Pou4f2 POU class 4 homeobox 2 
Rapgef4 Rap guanine nucleotide exchange factor (GEF) 4 
Hif1a hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription 
factor) 
Pvrl1 poliovirus receptor-related 1 
Olfm3 olfactomedin 3 
S100b S100 calcium binding protein B 
Lrp6 low density lipoprotein receptor-related protein 6 




Sstr2 somatostatin receptor 2 
Ss18l1 synovial sarcoma translocation gene on chromosome 18-like 1 
Ncor1 nuclear receptor co-repressor 1 
Lphn1 latrophilin 1 
Wnt3a wingless-type MMTV integration site family, member 3A 
Gabra5 gamma-aminobutyric acid (GABA) A receptor, alpha 5 
Tgif1 TGFB-induced factor homeobox 1 
Ghsr growth hormone secretagogue receptor 
Ak7 adenylate kinase 7 
Thbs2 thrombospondin 2 
Tmed2 transmembrane emp24 domain trafficking protein 2 
Ina internexin neuronal intermediate filament protein, alpha 
Foxp3 forkhead box P3 
Axin1 axin 1 
Ipmk inositol polyphosphate multikinase 
Alk anaplastic lymphoma receptor tyrosine kinase 
Dkk1 dickkopf 1 homolog (Xenopus laevis) 
Cxcl12 chemokine (C-X-C motif) ligand 12 
Six4 SIX homeobox 4 
Mapk8 mitogen-activated protein kinase 8 
Itm2c integral membrane protein 2C 
Snapap SNAP-associated protein 
RGD1305560 similar to RIKEN cDNA 9430031J16 
Sox4 SRY (sex determining region Y)-box 4 
Spp1 secreted phosphoprotein 1 
Robo2 roundabout homolog 2 (Drosophila) 
Ccng1 cyclin G1 
Ptpro protein tyrosine phosphatase, receptor type, O 
Pex13 peroxisomal biogenesis factor 13 
Tmem57 transmembrane protein 57 
Cbln2 cerebellin 2 precursor 
Sfrp5 secreted frizzled-related protein 5 
Prkci protein kinase C, iota 
Prpf19 PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae) 
Zfhx3 zinc finger homeobox 3 
Eng endoglin 
Tnr tenascin R (restrictin, janusin) 
Ngfr nerve growth factor receptor 
Tmem126a transmembrane protein 126A 
Luzp1 leucine zipper protein 1 
Six1 SIX homeobox 1 
Hipk1 homeodomain interacting protein kinase 1 
Nefm neurofilament, medium polypeptide 
Scn3b sodium channel, voltage-gated, type III, beta 
Sall2 sal-like 2 (Drosophila) 




Mal mal, T-cell differentiation protein 
Scn1b sodium channel, voltage-gated, type I, beta 
Pax8 paired box 8 
Dcx doublecortin 
Ednrb endothelin receptor type B 
Casp3 caspase 3 
Cyb5d2 cytochrome b5 domain containing 2 
RGD1311558 similar to 4930506M07Rik protein 
Lamb2 laminin, beta 2 
Cntn4 contactin 4 
Acsl3 acyl-CoA synthetase long-chain family member 3 
Pafah1b1 platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 
Olig1 oligodendrocyte transcription factor 1 
Skil SKI-like oncogene 
Unc5c unc-5 homolog C (C. elegans) 
Ptprf protein tyrosine phosphatase, receptor type, F 
Lmx1a LIM homeobox transcription factor 1 alpha 
Tgfbr1 transforming growth factor, beta receptor 1 
Htr5a 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 
Gdf10 growth differentiation factor 10 
Wnt7a wingless-type MMTV integration site family, member 7A 
Robo3 roundabout homolog 3 (Drosophila) 
Nkx2-6 NK2 homeobox 6 
Stk3 serine/threonine kinase 3 
Heyl hairy/enhancer-of-split related with YRPW motif-like 
Rarb retinoic acid receptor, beta 
Dst dystonin 
Gad1 glutamate decarboxylase 1 
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, 
Drosophila) 
Traf6 Tnf receptor-associated factor 6 
Casp8 caspase 8 
Slitrk6 SLIT and NTRK-like family, member 6 
Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) 
Ccl3 chemokine (C-C motif) ligand 3 
Sdc2 syndecan 2 
Rock2 Rho-associated coiled-coil containing protein kinase 2 
Gata2 GATA binding protein 2 
Lbx1 ladybird homeobox 1 
Pcsk1 proprotein convertase subtilisin/kexin type 1 
Pcdh9 protocadherin 9 
Scn2a1 sodium channel, voltage-gated, type II, alpha 1 
Slitrk5 SLIT and NTRK-like family, member 5 






Dmbx1 diencephalon/mesencephalon homeobox 1 
Shank2 SH3 and multiple ankyrin repeat domains 2 
Dixdc1 DIX domain containing 1 
Sema3c sema domain, immunoglobulin domain (Ig), short basic domain, secreted, 
(semaphorin) 3C 
Slit2 slit homolog 2 (Drosophila) 
Mafk v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) 
Nptn neuroplastin 
 
Table B.5: Predicted targets of miR-219(2-3p) GO category ‘Nervous System 
Development’. C=1543; O=138; E=97.64; R=1.41; rawP=1.20e-05; adjP=0.0046. (C = 
the number of reference genes in the category, O= the number of genes in the gene set 
and also in the category, E= the expected number in the category, R = ratio of enrichment, 


















Gene Symbol Gene 
Neurog1 neurogenin 1 
Ssh2 slingshot homolog 2 (Drosophila) 
Arhgef15 Rho guanine nucleotide exchange factor (GEF) 15 
Irs2 insulin receptor substrate 2 
Cops2 COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) 
Tnn tenascin N 
Gja1 gap junction protein, alpha 1 
Pdx1 pancreatic and duodenal homeobox 1 
Uhmk1 U2AF homology motif (UHM) kinase 1 
Coq7 coenzyme Q7 homolog, ubiquinone (yeast) 
Bbc3 Bcl-2 binding component 3 
Mpdz multiple PDZ domain protein 
Spast spastin 
Sema7a semaphorin 7A, GPI membrane anchor 
Prkch protein kinase C, eta 
Drd2 dopamine receptor D2 
Ndst1 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 
Gli2 GLI family zinc finger 2 
Cdh1 cadherin 1 
Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 
Gnat1 guanine nucleotide binding protein (G protein), alpha transducing 
activity polypeptide 1 
Syngap1 synaptic Ras GTPase activating protein 1 
Calu calumenin 
Ndrg1 N-myc downstream regulated 1 
Lamc1 laminin, gamma 1 
Nfib nuclear factor I/B 
Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 
Gas7 growth arrest specific 7 
Snx27 sorting nexin family member 27 
RGD1560691 similar to calcium/calmodulin-dependent protein kinase 1D 
Ets1 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) 
Stxbp3 syntaxin binding protein 3 
Pbx1 pre-B-cell leukemia homeobox 1 
Cast calpastatin 
Ihh Indian hedgehog 
Dicer1 dicer 1, ribonuclease type III 
Tal1 T-cell acute lymphocytic leukemia 1 
Dact1 dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) 
Synj1 synaptojanin 1 
Tmem30a transmembrane protein 30A 
Bcl11a B-cell CLL/lymphoma 11A (zinc finger protein) 
Slc7a11 solute carrier family 7 (anionic amino acid transporter light chain, xc- 




Epha4 Eph receptor A4 
Ank2 ankyrin 2, neuronal 
Dynll2 dynein light chain LC8-type 2 
Mafb v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) 
Adm adrenomedullin 
Psd3 pleckstrin and Sec7 domain containing 3 
RGD1306772 similar to RIKEN cDNA 1110008J03 
Prom1 prominin 1 
Dpysl5 dihydropyrimidinase-like 5 
Chrdl1 chordin-like 1 
Lzts1 leucine zipper, putative tumor suppressor 1 
Wnt8b wingless-type MMTV integration site family, member 8B 
Nid67 putative small membrane protein NID67 
Sema5a sema domain, seven thrombospondin repeats (type 1 and type 1-like), 
transmembrane domain (TM) and short cytoplasmic domain, 
(semaphorin) 5A 
Egf epidermal growth factor 
Nrp1 neuropilin 1 
Hif1a hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix 
transcription factor) 
Prickle2 prickle homolog 2 (Drosophila) 
Stk4 serine/threonine kinase 4 
Gfra3 GDNF family receptor alpha 3 
Pitx1 paired-like homeodomain 1 
Jun jun proto-oncogene 
Nlgn1 neuroligin 1 
LOC689826 hypothetical protein LOC689826 
Lig4 ligase IV, DNA, ATP-dependent 
Klf7 Kruppel-like factor 7 (ubiquitous) 
Aqp1 aquaporin 1 
Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, 
Drosophila) 
Hdac1 histone deacetylase 1 
Nrcam neuronal cell adhesion molecule 
Cux1 cut-like homeobox 1 
Pip5k1c phosphatidylinositol-4-phosphate 5-kinase, type I, gamma 
Mkks McKusick-Kaufman syndrome 
Stxbp1 syntaxin binding protein 1 
Prdm6 PR domain containing 6 
Foxe1 forkhead box E1 (thyroid transcription factor 2) 
Id3 inhibitor of DNA binding 3 
Lamc3 laminin gamma 3 
Nova1 neuro-oncological ventral antigen 1 
Eomes eomesodermin 
Ak7 adenylate kinase 7 
Hexa hexosaminidase A 




RGD1307443 similar to mKIAA0319 protein 
Ppp1r9b protein phosphatase 1, regulatory subunit 9B 
Bbs4 Bardet-Biedl syndrome 4 
Ina internexin neuronal intermediate filament protein, alpha 
Stmn1 stathmin 1 
Mapk8ip2 mitogen-activated protein kinase 8 interacting protein 2 
Rab11a RAB11a, member RAS oncogene family 
Slc1a2 solute carrier family 1 (glial high affinity glutamate transporter), 
member 2 
Gpc1 glypican 1 
Kdr kinase insert domain receptor 
Gfap glial fibrillary acidic protein 
Fgf13 fibroblast growth factor 13 
Ywhag tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, gamma polypeptide 
Nr2f1 nuclear receptor subfamily 2, group F, member 1 
Cxcl12 chemokine (C-X-C motif) ligand 12 
Six4 SIX homeobox 4 
Mapk8 mitogen-activated protein kinase 8 
Anapc2 anaphase promoting complex subunit 2 
Snapap SNAP-associated protein 
Lgi4 leucine-rich repeat LGI family, member 4 
RGD1305560 similar to RIKEN cDNA 9430031J16 
Sox4 SRY (sex determining region Y)-box 4 
Atxn2 ataxin 2 
Robo2 roundabout homolog 2 (Drosophila) 
Lhx6 LIM homeobox 6 
Grin2b glutamate receptor, ionotropic, N-methyl D-aspartate 2B 
Acvr1b activin A receptor, type IB 
Eif2b1 eukaryotic translation initiation factor 2B, subunit 1 alpha 
Ccng1 cyclin G1 
Cbln2 cerebellin 2 precursor 
Rgs6 regulator of G-protein signaling 6 
Cckar cholecystokinin A receptor 
Epha8 Eph receptor A8 
Tnr tenascin R (restrictin, janusin) 
Cldn11 claudin 11 
Hmg20a high mobility group 20A 
Ngfr nerve growth factor receptor 
Gabrb1 gamma-aminobutyric acid (GABA) A receptor, beta 1 
Luzp1 leucine zipper protein 1 
Lrp2 low density lipoprotein receptor-related protein 2 
Lhx5 LIM homeobox 5 
Sulf2 sulfatase 2 
Hipk1 homeodomain interacting protein kinase 1 





Mtmr2 myotubularin related protein 2 
Ppp1cc protein phosphatase 1, catalytic subunit, gamma isozyme 
Foxd1 forkhead box D1 
Pkd2 polycystic kidney disease 2 homolog (human) 
Mal mal, T-cell differentiation protein 
Il1b interleukin 1 beta 
Plxnb1 plexin B1 
Etv1 ets variant 1 
Prox1 prospero homeobox 1 
Dcx doublecortin 
Kidins220 kinase D-interacting substrate 220 
Mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma 
derived (avian) 
Nrl neural retina leucine zipper 
Lzic leucine zipper and CTNNBIP1 domain containing 
Bbs1 Bardet-Biedl syndrome 1 
Atp2b1 ATPase, Ca++ transporting, plasma membrane 1 
RGD1311558 similar to 4930506M07Rik protein 
Fkbp4 FK506 binding protein 4 
Cdh11 cadherin 11 
Pou3f1 POU class 3 homeobox 1 
Rgma RGM domain family, member A 
Drd1a dopamine receptor D1A 
Pafah1b1 platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 
Tgfbr1 transforming growth factor, beta receptor 1 
Jag2 jagged 2 
Foxp2 forkhead box P2 
Cxcr4 chemokine (C-X-C motif) receptor 4 
Gdf10 growth differentiation factor 10 
Reln reelin 
En1 engrailed homeobox 1 
Wnt7a wingless-type MMTV integration site family, member 7A 
Smad1 SMAD family member 1 
Kctd11 potassium channel tetramerisation domain containing 11 
Htt huntingtin 
Rarb retinoic acid receptor, beta 
Dag1 dystroglycan 1 (dystrophin-associated glycoprotein 1) 
Acan aggrecan 
Ywhae tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, epsilon polypeptide 
Cspg5 chondroitin sulfate proteoglycan 5 (neuroglycan C) 
Mef2c myocyte enhancer factor 2C 
Lppr4 lipid phosphate phosphatase-related protein type 4 
Jak2 Janus kinase 2 




Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) 
C5ar1 complement component 5a receptor 1 
Ak1 adenylate kinase 1 
Sdc2 syndecan 2 
Tacc1 transforming, acidic coiled-coil containing protein 1 
Tspan2 tetraspanin 2 
Cd44 Cd44 molecule 
Ptpru protein tyrosine phosphatase, receptor type, U 
Lhx4 LIM homeobox 4 
Pcsk1 proprotein convertase subtilisin/kexin type 1 
Adra2b adrenoceptor alpha 2B 
Dclk1 doublecortin-like kinase 1 
Syne1 spectrin repeat containing, nuclear envelope 1 
Pcdh9 protocadherin 9 
Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1 
Scn2a1 sodium channel, voltage-gated, type II, alpha 1 
Casp2 caspase 2 
Twsg1 twisted gastrulation homolog 1 (Drosophila) 
Qk quaking 
Dner delta/notch-like EGF repeat containing 
Dmbx1 diencephalon/mesencephalon homeobox 1 
Eif2b3 eukaryotic translation initiation factor 2B, subunit 3 
Hoxc10 homeo box C10 
Plxna2 plexin A2 
Ccdc88a coiled coil domain containing 88A 
Thra thyroid hormone receptor alpha 
Dixdc1 DIX domain containing 1 
Sec16a SEC16 homolog A (S. cerevisiae) 
Cadm1 cell adhesion molecule 1 
Sfrp1 secreted frizzled-related protein 1 
Arnt2 aryl hydrocarbon receptor nuclear translocator 2 
 
Table B.6: Predicted targets of miR-338 GO category ‘Nervous System 
Development’. C=1543; O=204; E=146.91; R=1.39; rawP=2.99e-07; adjP=8.89e-05. (C 
= the number of reference genes in the category, O= the number of genes in the gene set 
and also in the category, E= the expected number in the category, R = ratio of enrichment, 









Figure C.1 Representative images of controls for Olig2 (A,C) and MBP (B,D) 
immunofluorescence experiments. Olig2 controls, negative (A) and positive (C) are in 
P40 rat brain tissue. The negative control for MBP experiments (B) is in P40 rat brain 
tissue. The positive control for the MBP antibody (D) is a diffuse neurosphere culture. 





Figure C.2 Representative images of controls for Iba-1 (A,C) and GFAP (B,D) 
experiments. Negative (A) and positive (C) control images for Iba-1 experiments were 
taken in P40 rat brain samples. Negative (B) control images for GFAP experiment were 
taken in P140 rat brain (B). Positive control image is a disassociated neurosphere 





Figure C.3 Representative images of controls for Reelin (A, C) and NeuN (B, D) 
immunofluorescence staining. Reelin negative (A) and positive (C) controls are in P40 
rat brain tissue. NeuN negative (B) and positive control (D) are also in P40 rat brain 
tissue. Scale = 50 µm (A-C) and 20µm (D) 
